| 1 |
Elalouf A. Infections after organ transplantation and immune response. Transpl Immunol 2023;77:101798. [PMID: 36731780 DOI: 10.1016/j.trim.2023.101798] [Reference Citation Analysis]
|
| 2 |
Rao N, Carcella T, Patel N, Bartlett F, Posadas MA, Casey M, Dubay DA, Taber DJ. Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation. Pharmacogenet Genomics 2023;33:59-65. [PMID: 36877088 DOI: 10.1097/FPC.0000000000000494] [Reference Citation Analysis]
|
| 3 |
Atlas-Lazar A, Levy-Erez D. Approach to acute kidney injury following paediatric kidney transplant. Curr Opin Pediatr 2023;35:268-74. [PMID: 36591982 DOI: 10.1097/MOP.0000000000001216] [Reference Citation Analysis]
|
| 4 |
Pedreira-Robles G, Garcimartín P, Sevilla-Guerra S, Bach-Pascual A, García-Martínez M, Morín-Fraile V. Nurse-led clinical activity in kidney transplantation care in Spain: A cross-sectional observational study. J Ren Care 2023. [PMID: 36906846 DOI: 10.1111/jorc.12463] [Reference Citation Analysis]
|
| 5 |
Peretti A, Scorpio DG, Kong WP, Pang YS, McCarthy MP, Ren K, Jackson M, Graham BS, Buck CB, McTamney PM, Pastrana DV. A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques. Vaccine 2023;41:1735-42. [PMID: 36764908 DOI: 10.1016/j.vaccine.2023.02.002] [Reference Citation Analysis]
|
| 6 |
Sofue T, Oguchi H, Yazawa M, Tsujita M, Futamura K, Nishihira M, Toyoda M, Kano T, Suzuki H. Serological and histopathological assessment of galactose-deficient immunoglobulin A1 deposition in kidney allografts: A multicenter prospective observational study. PLoS One 2023;18:e0281945. [PMID: 36795799 DOI: 10.1371/journal.pone.0281945] [Reference Citation Analysis]
|
| 7 |
Scuderi C, Parker S, Jacks M, John GT, McWhinney B, Ungerer J, Mallett A, Healy H, Roberts J, Staatz C. Fingerprick Microsampling Methods Can Replace Venepuncture for Simultaneous Therapeutic Drug Monitoring of Tacrolimus, Mycophenolic Acid, and Prednisolone Concentrations in Adult Kidney Transplant Patients. Ther Drug Monit 2023;45:69-78. [PMID: 36097333 DOI: 10.1097/FTD.0000000000001024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Veenhof H, Koster RA, Junier LAT, Zweipfenning P, Touw DJ. Results From a Proficiency Testing Pilot for Immunosuppressant Microsampling Assays. Ther Drug Monit 2023;45:61-8. [PMID: 35971674 DOI: 10.1097/FTD.0000000000001019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Gołębiewska JE, Krawczyk B, Wysocka M, Dudziak A, Dębska-Ślizień A. Asymptomatic Bacteriuria in Kidney Transplant Recipients-A Narrative Review. Medicina (Kaunas) 2023;59. [PMID: 36837399 DOI: 10.3390/medicina59020198] [Reference Citation Analysis]
|
| 10 |
Kocur A, Marszałek D, Rubik J, Czajkowska A, Pawiński T. Therapeutic Drug Monitoring of Tacrolimus Based on Volumetric Absorptive Microsampling Technique (VAMS) in Renal Transplant Pediatric Recipients-LC-MS/MS Method Development, Hematocrit Effect Evaluation, and Clinical Application. Pharmaceutics 2023;15. [PMID: 36678927 DOI: 10.3390/pharmaceutics15010299] [Reference Citation Analysis]
|
| 11 |
Tramper T, Roelen DL, Brand-Schaaf SH, Kal-van Gestel JA, Kho MML, Reinders MEJ, Roodnat JI, van de Wetering J, Betjes MGH, de Weerd AE. The detrimental effect of donor-specific antibodies is irrespective of its level in highly-immunized living donor kidney transplant recipients: A case-control series. Front Immunol 2022;13:1093359. [PMID: 36703958 DOI: 10.3389/fimmu.2022.1093359] [Reference Citation Analysis]
|
| 12 |
Dall'Era M, Kalunian K, Eaddy M, Ogbonnaya A, Farrelly E, Turowski E, Birardi V, Solomons N, Randhawa S, Mina-Osorio P. Real-world treatment utilization and economic implications of lupus nephritis disease activity in the United States. J Manag Care Spec Pharm 2023;29:36-45. [PMID: 36190835 DOI: 10.18553/jmcp.2022.21496] [Reference Citation Analysis]
|
| 13 |
Masset C, Kerleau C, Blancho G, Hourmant M, Walencik A, Ville S, Kervella D, Cantarovich D, Houzet A, Giral M, Garandeau C, Dantal J; Nantes DIVAT Consortium. Very Low Dose Anti-Thymocyte Globulins Versus Basiliximab in Non-Immunized Kidney Transplant Recipients. Transpl Int 2023;36:10816. [PMID: 36819125 DOI: 10.3389/ti.2023.10816] [Reference Citation Analysis]
|
| 14 |
Hewavisenti RV, Arena J, Ahlenstiel CL, Sasson SC. Human papillomavirus in the setting of immunodeficiency: Pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk. Front Immunol 2023;14:1112513. [PMID: 36960048 DOI: 10.3389/fimmu.2023.1112513] [Reference Citation Analysis]
|
| 15 |
Zhao Y, Zeng Y, Lu R, Wang Z, Zhang X, Wu N, Zhu T, Wang Y, Zhang C. Rapid point-of-care detection of BK virus in urine by an HFman probe-based loop-mediated isothermal amplification assay and a finger-driven microfluidic chip. PeerJ 2023;11:e14943. [PMID: 36915661 DOI: 10.7717/peerj.14943] [Reference Citation Analysis]
|
| 16 |
Engen RM, Verghese PS. Pediatric Kidney Transplantation: A Historic View. Pediatric Solid Organ Transplantation 2023. [DOI: 10.1007/978-981-19-6909-6_1] [Reference Citation Analysis]
|
| 17 |
Marantidis J, Sussman RD. Unmet Needs in Complicated Urinary Tract Infections: Challenges, Recommendations, and Emerging Treatment Pathways. Infect Drug Resist 2023;16:1391-405. [PMID: 36937144 DOI: 10.2147/IDR.S382617] [Reference Citation Analysis]
|
| 18 |
Yamada M, Shoji K, Miyairi I, Kasahara M, Saitoh A. Pediatric Infectious Diseases Related to Transplantation: Insights From Japan. Pediatr Infect Dis J 2023;42:e18-25. [PMID: 36476531 DOI: 10.1097/INF.0000000000003731] [Reference Citation Analysis]
|
| 19 |
Charnaya O, Moudgil A, Puliyanda D. Induction Therapy in Pediatric Renal Transplant Recipients. Pediatric Solid Organ Transplantation 2023. [DOI: 10.1007/978-981-19-6909-6_9] [Reference Citation Analysis]
|
| 20 |
Gadelha DD, Filho WA, Brandão MAJ, Montenegro RM Jr. Is parathyroid allotransplantation a viable option in the treatment of permanent hypoparathyroidism? A review of the literature. Endocrine 2022. [PMID: 36583826 DOI: 10.1007/s12020-022-03292-5] [Reference Citation Analysis]
|
| 21 |
Medeiros LKAD, Borba AKDOT, Sette GCS, Maciel CDG, Quirino APDS, Pereira MPL, Silva JRRD, Santos JLD. FATORES ASSOCIADOS À ADESÃO A TERAPIA IMUNOSSUPRESSORA EM INDIVÍDUOS TRANSPLANTADOS RENAIS. Enfermagem em Foco 2022;13. [DOI: 10.21675/2357-707x.2022.v13.e-202244] [Reference Citation Analysis]
|
| 22 |
Sallaberger S, Buchwinkler L, Eder S, Schneeberger S, Mayer G, Pirklbauer M. Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS). J Clin Med 2022;11. [PMID: 36556037 DOI: 10.3390/jcm11247421] [Reference Citation Analysis]
|
| 23 |
Massicotte-Azarniouch D, Sood MM, Fergusson DA, Chassé M, Tinmouth A, Knoll GA. The association of venous thromboembolism with blood transfusion in kidney transplant patients. Transfusion 2022;62:2480-9. [PMID: 36325656 DOI: 10.1111/trf.17154] [Reference Citation Analysis]
|
| 24 |
Santithanmakorn C, Vanichanan J, Townamchai N, Jutivorakool K, Wattanatorn S, Sutherasan M, Opanuruk J, Kerr SJ, Praditpornsilpa K, Avihingsanon Y, Udomkarnjananun S. Bacterial Urinary Tract Infection and Early Asymptomatic Bacteriuria in Kidney Transplantation Still Negatively Affect Kidney Transplant Outcomes in the Era of Modern Immunosuppression and Cotrimoxazole Prophylaxis. Biomedicines 2022;10. [PMID: 36428552 DOI: 10.3390/biomedicines10112984] [Reference Citation Analysis]
|
| 25 |
Park Y, Lee H, Eum SH, Ko EJ, Min JW, Yoon S, Hwang W, Yun S, Yang CW, Shin J, Chung BH. Combined impact of the inter and intra-patient variability of tacrolimus blood level on allograft outcomes in kidney transplantation. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1037566] [Reference Citation Analysis]
|
| 26 |
Chen S, Chang S, Wang D, Chen J, Guo H, Shi H, Jiang J, Chen ZK, Chen Z, Zhang W. Successful Unilateral Dual-Kidney Transplant of Discarded Kidneys From Two Expanded Criteria Donors. Exp Clin Transplant 2022;20:1035-9. [PMID: 36524890 DOI: 10.6002/ect.2022.0064] [Reference Citation Analysis]
|
| 27 |
Ponticelli C, Campise M. COVID-19 Vaccination in Kidney Transplant Candidates and Recipients. Vaccines 2022;10:1808. [DOI: 10.3390/vaccines10111808] [Reference Citation Analysis]
|
| 28 |
Kostalova B, Mala-ladova K, Sulkova SD, Denhaerynck K, De Geest S, Maly J. Comparison of different methods to assess tacrolimus concentration intra-patient variability as potential marker of medication non-adherence. Front Pharmacol 2022;13:973564. [DOI: 10.3389/fphar.2022.973564] [Reference Citation Analysis]
|
| 29 |
Reis Pereira P, Almeida M, Ribeiro B, Oliveira J, Costa L, Pedroso S, Martins LS, Dias L, Malheiro J. Biologically Unrelated Living Donor for Kidney Transplantation Associated With Higher Acute Rejection Rate but With Similar Graft Survival of a Related Living Donor. Cureus 2022. [DOI: 10.7759/cureus.30189] [Reference Citation Analysis]
|
| 30 |
Banjongjit A, Phirom S, Phannajit J, Jantarabenjakul W, Paitoonpong L, Kittanamongkolchai W, Wattanatorn S, Prasithsirikul W, Eiam-Ong S, Avihingsanon Y, Hansasuta P, Vanichanan J, Townamchai N. Benefits of Switching Mycophenolic Acid to Sirolimus on Serological Response after a SARS-CoV-2 Booster Dose among Kidney Transplant Recipients: A Pilot Study. Vaccines (Basel) 2022;10:1685. [PMID: 36298550 DOI: 10.3390/vaccines10101685] [Reference Citation Analysis]
|
| 31 |
Peitz T, Möhlendick B, Eisenberger U, Siffert W, Heinemann FM, Kribben A, Friebus-Kardash J. CC Genotype of GNAS c.393C>T (rs7121) Polymorphism Has a Protective Effect against Development of BK Viremia and BKV-Associated Nephropathy after Renal Transplant. Pathogens 2022;11. [PMID: 36297195 DOI: 10.3390/pathogens11101138] [Reference Citation Analysis]
|
| 32 |
Peretti A, Scorpio DG, Kong W, Pang YS, Mccarthy M, Ren K, Jackson M, Graham BS, Buck CB, Mctamney PM, Pastrana DV. A Multivalent Polyomavirus Vaccine Elicits Durable Neutralizing Antibody Responses in Macaques.. [DOI: 10.1101/2022.09.26.509096] [Reference Citation Analysis]
|
| 33 |
Chen T, Li X, Wang J, Wang X, Zhu T, Rong R, Yang C. Basiliximab for the therapy of acute T cell–mediated rejection in kidney transplant recipient with BK virus infection: A case report. Front Immunol 2022;13:1017872. [DOI: 10.3389/fimmu.2022.1017872] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 34 |
Buyukdemirci S, Oguz EG, Cimen SG, Sahin H, Cimen S, Ayli MD. Vitamin D deficiency may predispose patients to increased risk of kidney transplant rejection. World J Transplant 2022; 12(9): 299-309 [DOI: 10.5500/wjt.v12.i9.299] [Reference Citation Analysis]
|
| 35 |
George J. Low Cost Immunosuppressive Strategies in Renal Transplantation. Immunosuppression and Immunomodulation [Working Title] 2022. [DOI: 10.5772/intechopen.107361] [Reference Citation Analysis]
|
| 36 |
Grootjans H, Verschuuren EAM, van Gemert JP, Kerstjens HAM, Bakker SJL, Berger SP, Gan CT. Chronic kidney disease after lung transplantation in a changing era. Transplant Rev (Orlando) 2022;36:100727. [PMID: 36152358 DOI: 10.1016/j.trre.2022.100727] [Reference Citation Analysis]
|
| 37 |
Zattarin A, Francini-pesenti F, Da Col C, Spinella P, Alessi M, Stefanelli LF, Calò LA. Approccio nutrizionale all’ipofosforemia post-trapianto di rene: uno studio pilota. G Clin Nefrol Dial 2022;34:74-79. [DOI: 10.33393/gcnd.2022.2472] [Reference Citation Analysis]
|
| 38 |
Khan AG, Akhtar N, Tariq Z, Arif M. Role of procalcitonin in chronic kidney diseases patients undergoing renal therapy.. [DOI: 10.1101/2022.09.05.22279116] [Reference Citation Analysis]
|
| 39 |
Sedej I, Štalekar M, Tušek Žnidarič M, Goričar K, Kojc N, Kogovšek P, Dolžan V, Arnol M, Lenassi M. Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injury. J Extracell Vesicles 2022;11:e12268. [PMID: 36149031 DOI: 10.1002/jev2.12268] [Reference Citation Analysis]
|
| 40 |
Betjes MGH, Peereboom ETM, Otten HG, Spierings E. The number of donor HLA-derived T cell epitopes available for indirect antigen presentation determines the risk for vascular rejection after kidney transplantation. Front Immunol 2022;13:973968. [DOI: 10.3389/fimmu.2022.973968] [Reference Citation Analysis]
|
| 41 |
Susomboon T, Kunlamas Y, Vadcharavivad S, Vongwiwatana A. The effect of the very low dosage diltiazem on tacrolimus exposure very early after kidney transplantation: a randomized controlled trial. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-18552-7] [Reference Citation Analysis]
|
| 42 |
Fang Y, Zhang C, Wang Y, Yu Z, Wu Z, Zhou Y, Yan Z, Luo J, Xia R, Zeng W, Deng W, Xu J, Chen Z, Miao Y. Dynamic risk prediction of BK polyomavirus reactivation after renal transplantation. Front Immunol 2022;13:971531. [DOI: 10.3389/fimmu.2022.971531] [Reference Citation Analysis]
|
| 43 |
Jehn U, Wiedmer N, Boeckel GR, Pavenstädt H, Thölking G, Reuter S. Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation. Int J Mol Sci 2022;23. [PMID: 36012395 DOI: 10.3390/ijms23169131] [Reference Citation Analysis]
|
| 44 |
Raval AD, Ganz ML, Fraeman K, Lorden AL, Saravanan S, Tang Y, Santos CAQ. Real-World Treatment Patterns of Antiviral Prophylaxis for Cytomegalovirus Among Adult Kidney Transplant Recipients: A Linked USRDS-Medicare Database Study. Transpl Int 2022;35:10528. [DOI: 10.3389/ti.2022.10528] [Reference Citation Analysis]
|
| 45 |
Tang Y, Song T, Gao L, Yin S, Ma M, Tan Y, Wu L, Yang Y, Wang Y, Lin T, Li F. A CRISPR-based ultrasensitive assay detects attomolar concentrations of SARS-CoV-2 antibodies in clinical samples. Nat Commun 2022;13:4667. [PMID: 35945418 DOI: 10.1038/s41467-022-32371-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 46 |
Wu J, Huang J, Zhu J, He Z, Chen M, Gao S, Liang D, Yu X, Lu C. Immune checkpoint inhibitors increase the risk of kidney transplant rejection: a real-world pharmacovigilance study. Expert Opin Drug Saf 2022. [PMID: 35929998 DOI: 10.1080/14740338.2022.2110234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Crane C, Loop L, Anterasian C, Geng B, Ingulli E. Balancing B cell responses to the allograft: implications for vaccination. Front Immunol 2022;13:948379. [DOI: 10.3389/fimmu.2022.948379] [Reference Citation Analysis]
|
| 48 |
Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK Virus Nephropathy in Kidney Transplantation: A State-of-the-Art Review. Viruses 2022;14:1616. [PMID: 35893681 DOI: 10.3390/v14081616] [Reference Citation Analysis]
|
| 49 |
Jarmi T, Spaulding AC, Jebrini A, Sella DM, Alexander LF, Nussbaum S, Shoukry M, White L, Wadei HM, Farres H. Association of Abdominal Arterial Calcification Score with Patients' Survival and Kidney Allograft Function after Kidney Transplant. World J Surg 2022. [PMID: 35854013 DOI: 10.1007/s00268-022-06665-z] [Reference Citation Analysis]
|
| 50 |
Spasovski G, Trajceska L, Rambabova-Bushljetik I. Pharmacotherapeutic options for the prevention of kidney transplant rejection: the evidence to date. Expert Opin Pharmacother 2022. [PMID: 35835450 DOI: 10.1080/14656566.2022.2102418] [Reference Citation Analysis]
|
| 51 |
Cuadrado-payán E, Diekmann F, Cucchiari D. Medical Aspects of mTOR Inhibition in Kidney Transplantation. IJMS 2022;23:7707. [DOI: 10.3390/ijms23147707] [Reference Citation Analysis]
|
| 52 |
Pośpiech M, Kolonko A, Nieszporek T, Kozak S, Kozaczka A, Karkoszka H, Winder M, Chudek J. Transplanted kidney loss during colorectal cancer chemotherapy: A case report. World J Clin Cases 2022; 10(19): 6647-6655 [DOI: 10.12998/wjcc.v10.i19.6647] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 53 |
Lee H, Min JW, Kang H, Lee H, Eum SH, Park Y, Yang CW, Chung BH, Oh E. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients. IJMS 2022;23:7357. [DOI: 10.3390/ijms23137357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Shah CG, Ohri AJ, Udani AH. Primary Hyperoxaluria Type 1: A great masquerader. WJWCH 2022;1:13-17. [DOI: 10.25259/wjwch_2022_05] [Reference Citation Analysis]
|
| 55 |
Kwong AM, Luke PPW, Bhattacharjee RN. Carbon monoxide mechanism of protection against renal ischemia and reperfusion injury. Biochem Pharmacol 2022;202:115156. [PMID: 35777450 DOI: 10.1016/j.bcp.2022.115156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 56 |
Gaiffe E, Vernerey D, Bardiaux L, Leroux F, Meurisse A, Bamoulid J, Courivaud C, Saas P, Tiberghien P, Ducloux D. Early Post-Transplant Red Blood Cell Transfusion Is Associated With an Increased Risk of Transplant Failure: A Nationwide French Study. Front Immunol 2022;13:854850. [PMID: 35711440 DOI: 10.3389/fimmu.2022.854850] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Merino-Ribas A, Araujo R, Pereira L, Campos J, Barreiros L, Segundo MA, Silva N, Costa CFFA, Quelhas-Santos J, Trindade F, Falcão-Pires I, Alencastre I, Dumitrescu IB, Sampaio-Maia B. Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study. Biomolecules 2022;12. [PMID: 35883423 DOI: 10.3390/biom12070867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 58 |
Zhang Q, Tian X, Chen G, Yu Z, Zhang X, Lu J, Zhang J, Wang P, Hao X, Huang Y, Wang Z, Gao F, Yang J. A Prediction Model for Tacrolimus Daily Dose in Kidney Transplant Recipients With Machine Learning and Deep Learning Techniques. Front Med (Lausanne) 2022;9:813117. [PMID: 35712101 DOI: 10.3389/fmed.2022.813117] [Reference Citation Analysis]
|
| 59 |
Borresen SW, Klose M, Glintborg D, Watt T, Andersen MS, Feldt-Rasmussen U. Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency. J Clin Endocrinol Metab 2022;107:2065-76. [PMID: 35302603 DOI: 10.1210/clinem/dgac151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 60 |
Jaszczuk S, Natarajan S, Papalois V. Anaesthetic Approach to Enhanced Recovery after Surgery for Kidney Transplantation: A Narrative Review. J Clin Med 2022;11:3435. [PMID: 35743505 DOI: 10.3390/jcm11123435] [Reference Citation Analysis]
|
| 61 |
Anwar IJ, DeLaura IF, Gao Q, Ladowski J, Jackson AM, Kwun J, Knechtle SJ. Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions. Front Immunol 2022;13:903068. [PMID: 35757745 DOI: 10.3389/fimmu.2022.903068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 62 |
Schuster A, Steines L, Müller K, Zeman F, Findeisen P, Banas B, Bergler T. Dickkopf 3-A New Indicator for the Deterioration of Allograft Function After Kidney Transplantation. Front Med (Lausanne) 2022;9:885018. [PMID: 35646976 DOI: 10.3389/fmed.2022.885018] [Reference Citation Analysis]
|
| 63 |
Wu E, Lee JY, Gelarden I, Engen RM. Nondestructive versus advanced post-transplant lymphoproliferative disorder in a single-center pediatric kidney transplant population. Pediatr Transplant 2022;26:e14238. [PMID: 35098630 DOI: 10.1111/petr.14238] [Reference Citation Analysis]
|
| 64 |
Jung H, Jeon Y, Huh KH, Park JB, Kim M, Lee S, Han S, Ro H, Yang J, Ahn C, Cho J, Park S, Kim Y, Kim C. Pretransplant and Posttransplant Alcohol Consumption and Outcomes in Kidney Transplantation: A Prospective Multicenter Cohort Study. Transpl Int 2022;35:10243. [DOI: 10.3389/ti.2022.10243] [Reference Citation Analysis]
|
| 65 |
Cooper M, Schnitzler M, Nilubol C, Wang W, Wu Z, Nordyke RJ. Costs in the Year Following Deceased Donor Kidney Transplantation: Relationships With Renal Function and Graft Failure. Transpl Int 2022;35:10422. [DOI: 10.3389/ti.2022.10422] [Reference Citation Analysis]
|
| 66 |
Castle EM, Dijk G, Asgari E, Shah S, Phillips R, Greenwood J, Bramham K, Chilcot J, Greenwood SA. The Feasibility and User-Experience of a Digital Health Intervention Designed to Prevent Weight Gain in New Kidney Transplant Recipients—The ExeRTiOn2 Trial. Front Nutr 2022;9:887580. [DOI: 10.3389/fnut.2022.887580] [Reference Citation Analysis]
|
| 67 |
Christensen HD, Madelung AB, Nielsen AL, Knudtzen FC. Severe Bartonella henselae bone infection in a kidney transplanted young man. BMJ Case Rep 2022;15:e247805. [PMID: 35584856 DOI: 10.1136/bcr-2021-247805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 68 |
Ando T, Nakashima S, Abe S, Watanabe D, Iwasaki K, Shinohara M, Kai T, Hata S, Shibuya T, Shin T. Mamushi bites in a kidney transplant recipient. IJU Case Reports. [DOI: 10.1002/iju5.12460] [Reference Citation Analysis]
|
| 69 |
Cabezas L, Jouve T, Malvezzi P, Janbon B, Giovannini D, Rostaing L, Noble J. Tocilizumab and Active Antibody-Mediated Rejection in Kidney Transplantation: A Literature Review. Front Immunol 2022;13:839380. [DOI: 10.3389/fimmu.2022.839380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Tawhari M, Radwi M. A Three-Year Experience With Overseas Kidney Transplantation in a Tertiary Transplant Center in Saudi Arabia. Cureus 2022. [DOI: 10.7759/cureus.23988] [Reference Citation Analysis]
|
| 71 |
Tan MH, Yee SY, Yahya R. Lessons of the month 2: A case of inappropriate drug-drug interaction in kidney transplant. Clin Med (Lond) 2022;22:169-71. [PMID: 35304379 DOI: 10.7861/clinmed.2021-0789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 72 |
Nassar M, Nso N, Lakhdar S, Kondaveeti R, Buttar C, Bhangoo H, Awad M, Sheikh NS, Soliman KM, Munira MS, Radparvar F, Rizzo V, Daoud A. New onset hypertension after transplantation. World J Transplant 2022; 12(3): 42-54 [DOI: 10.5500/wjt.v12.i3.42] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 73 |
Bodnar-broniarczyk M, Warzyszyńska K, Czerwińska K, Marszałek D, Dziewa N, Kosieradzki M, Pawiński T. Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients. Pharmaceutics 2022;14:632. [DOI: 10.3390/pharmaceutics14030632] [Reference Citation Analysis]
|
| 74 |
Devresse A, Jassogne C, Hubinont C, Debiève F, De Meyer M, Mourad M, Darius T, Buemi A, Goffin E, Kanaan N. Pregnancy Outcomes After Kidney Transplantation and Long-Term Evolution of Children: A Single Center Experience. Transplant Proc 2022:S0041-1345(22)00099-9. [PMID: 35277258 DOI: 10.1016/j.transproceed.2022.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 75 |
Murakami N, Webber AB, Nair V. Transplant Onconephrology in Patients With Kidney Transplants. Adv Chronic Kidney Dis 2022;29:188-200.e1. [PMID: 35817526 DOI: 10.1053/j.ackd.2021.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 76 |
Hong MS, Lee YH, Kong JM, Kwon OJ, Jung CW, Yang J, Kim MS, Han HW, Nam SM, Korean Organ Transplantation Registry Study Group. Personalized Prediction of Kidney Function Decline and Network Analysis of the Risk Factors after Kidney Transplantation Using Nationwide Cohort Data. J Clin Med 2022;11. [PMID: 35268350 DOI: 10.3390/jcm11051259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 77 |
Abdel-fattah MA, Othman NA, Goher N, Khalil AM. Predicting Chronic Kidney Disease Using Hybrid Machine Learning Based on Apache Spark. Computational Intelligence and Neuroscience 2022;2022:1-12. [DOI: 10.1155/2022/9898831] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 78 |
Mira FS, Oliveira J, Sousa F, Antunes D, Figueiredo AC, Borges A, Pais MSJ, Galvão A, Moura P, Alves R. Kidney graft function before pregnancy as a predictor of graft, maternal and fetal outcomes in pregnant renal transplant recipients. J Perinat Med 2022;50:185-91. [PMID: 34727592 DOI: 10.1515/jpm-2021-0102] [Reference Citation Analysis]
|
| 79 |
Baker LA, March DS, Wilkinson TJ, Billany RE, Bishop NC, Castle EM, Chilcot J, Davies MD, Graham-Brown MPM, Greenwood SA, Junglee NA, Kanavaki AM, Lightfoot CJ, Macdonald JH, Rossetti GMK, Smith AC, Burton JO. Clinical practice guideline exercise and lifestyle in chronic kidney disease. BMC Nephrol 2022;23:75. [PMID: 35193515 DOI: 10.1186/s12882-021-02618-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 80 |
Schuller M, Pfeifer V, Kirsch AH, Klötzer KA, Mooslechner AA, Rosenkranz AR, Stiegler P, Schemmer P, Sourij H, Eller P, Prietl B, Eller K. B Cell Composition Is Altered After Kidney Transplantation and Transitional B Cells Correlate With SARS-CoV-2 Vaccination Response. Front Med (Lausanne) 2022;9:818882. [PMID: 35187002 DOI: 10.3389/fmed.2022.818882] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 81 |
Kohlbrenner D, von Moos S, Schmid-mohler G. Criterion Validity and Test-Retest Reliability of a Modified Version of the International Physical Activity Questionnaire–Short Form (IPAQ-SF) in Kidney Transplant Recipients. Front Rehabilit Sci 2022;3. [DOI: 10.3389/fresc.2022.808476] [Reference Citation Analysis]
|
| 82 |
Kadakia Y, Hwang C, MacConmara M. Rescue of an asymptomatic arterial occlusion after kidney transplant. BMJ Case Rep 2022;15:e247347. [PMID: 35131794 DOI: 10.1136/bcr-2021-247347] [Reference Citation Analysis]
|
| 83 |
Seyahi N, Alagoz S, Atli Z, Ozcan SG, Tripepi G, Bakir A, Trabulus S, Pekmezci S, Zoccali C. Coronary artery calcification progression and long-term cardiovascular outcomes in renal transplant recipients: an analysis by the joint model. Clin Kidney J 2022;15:101-8. [PMID: 35106150 DOI: 10.1093/ckj/sfab174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Evans RDR, Lan JH, Kadatz M, Brar S, Chang DT, McMichael L, Gill J, Gill JS. Use and Outcomes of Induction Therapy in Well-Matched Kidney Transplant Recipients. Clin J Am Soc Nephrol 2022;17:271-9. [PMID: 35131930 DOI: 10.2215/CJN.09170721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 85 |
Alshamsi I. Extended Literature Review of the role of erythropoietin stimulating agents (ESA) use in the management of post renal transplant anaemia. Transplantation Reports 2022. [DOI: 10.1016/j.tpr.2022.100097] [Reference Citation Analysis]
|
| 86 |
Chang DH, Dumanski SM, Ahmed SB. Female Reproductive and Gynecologic Considerations in Chronic Kidney Disease: Adolescence and Young Adulthood. Kidney International Reports 2022;7:152-64. [DOI: 10.1016/j.ekir.2021.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 87 |
Hellemans R, Abramowicz D. Is the failure of recent trials on withdrawal of calcineurin inhibitors due to inadequate mycophenolic acid dosing? J Nephrol 2022. [PMID: 35088366 DOI: 10.1007/s40620-021-01183-y] [Reference Citation Analysis]
|
| 88 |
Rønning M, Hjellvik V, Sakshaug S, Blix HS, Midtvedt K, Reisæter AV, Holdaas H, Åsberg A. Use of Statins in Kidney Transplant Recipients in Norway. Int J Environ Res Public Health 2022;19:1370. [PMID: 35162389 DOI: 10.3390/ijerph19031370] [Reference Citation Analysis]
|
| 89 |
Huang L, Wang J, Yang J, Zhang H, Hu Y, Miao J, Mao J, Fang L. Impact of Sampling Time Variability on Tacrolimus Dosage Regimen in Pediatric Primary Nephrotic Syndrome: Single-Center, Prospective, Observational Study. Front Pharmacol 2021;12:726667. [PMID: 35069185 DOI: 10.3389/fphar.2021.726667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 90 |
Tanabe T, Osawa T, Hotta K, Iwami D, Kikuchi H, Matsumoto R, Abe T, Shinohara N. [TREATMENT OF BLADDER UROTHELIAL CARCINOMA WITH LUNG METASTASIS AFTER RENAL TRANSPLANTATION]. Nihon Hinyokika Gakkai Zasshi 2022;113:37-41. [PMID: 36682811 DOI: 10.5980/jpnjurol.113.37] [Reference Citation Analysis]
|
| 91 |
Pisano A, Mallamaci F, D'Arrigo G, Bolignano D, Wuerzner G, Ortiz A, Burnier M, Kanaan N, Sarafidis P, Persu A, Ferro CJ, Loutradis C, Boletis IN, London G, Halimi JM, Sautenet B, Rossignol P, Vogt L, Zoccali C. Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis. Clin Kidney J 2022;15:31-42. [PMID: 35035934 DOI: 10.1093/ckj/sfab135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 92 |
Brescacin A, Iesari S, Guzzo S, Alfieri CM, Darisi R, Perego M, Puliatti C, Ferraresso M, Favi E. Allograft Vesicoureteral Reflux after Kidney Transplantation. Medicina (Kaunas) 2022;58:81. [PMID: 35056389 DOI: 10.3390/medicina58010081] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 93 |
Fulchiero R, Amaral S. Post-transplant lymphoproliferative disease after pediatric kidney transplant. Front Pediatr 2022;10:1087864. [PMID: 36568415 DOI: 10.3389/fped.2022.1087864] [Reference Citation Analysis]
|
| 94 |
Boey CY, Yee SY, Amir Hassan SZ, Yahya R, Hashim H. Value of Baseline Post-Transplant MAG3 Renal Scintigraphy in the Evaluation of Graft Function. Transplantation Proceedings 2022. [DOI: 10.1016/j.transproceed.2021.12.016] [Reference Citation Analysis]
|
| 95 |
Kouri A, Balani S, Kizilbash S. Anemia in Pediatric Kidney Transplant Recipients-Etiologies and Management. Front Pediatr 2022;10:929504. [PMID: 35795334 DOI: 10.3389/fped.2022.929504] [Reference Citation Analysis]
|
| 96 |
Rohan Dwivedi, K B Shashikiran, Sonu Manuel, Faizan Ahmed Ansari, Ravi Tej Madipalli, Anvesh Golla, Sree Bhushan Raju. Induction with rATG versus No-induction in Deceased Donor Renal Transplantation – A Retrospective Observational Study. Indian J Nephrol 2022;32. [ DOI: 10.4103/ijn.IJN_545_20] [Reference Citation Analysis]
|
| 97 |
Carias Martinez K, Alasfar S. Posttransplant Erythrocytosis in Kidney Transplant Recipients. Complications in Kidney Transplantation 2022. [DOI: 10.1007/978-3-031-13569-9_52] [Reference Citation Analysis]
|
| 98 |
Oomen L, Bootsma-Robroeks C, Cornelissen E, de Wall L, Feitz W. Pearls and Pitfalls in Pediatric Kidney Transplantation After 5 Decades. Front Pediatr 2022;10:856630. [PMID: 35463874 DOI: 10.3389/fped.2022.856630] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Ohashi T, Akazawa C. Content Validity of a Self-Management Behavior Assessment Tool for Adult Post-Renal Transplant Recipients Using a Modified Delphi Method. Health 2022;14:70-95. [DOI: 10.4236/health.2022.141007] [Reference Citation Analysis]
|
| 100 |
Nikolova A, Patel JK. Induction Therapy and Therapeutic Antibodies. Pharmacology of Immunosuppression 2022. [DOI: 10.1007/164_2021_570] [Reference Citation Analysis]
|
| 101 |
Fischereder M. Nierentransplantation (NTX). Therapie-Handbuch - Nephrologie 2022. [DOI: 10.1016/b978-3-437-23854-3.00019-1] [Reference Citation Analysis]
|
| 102 |
Laguna-castro M, Rodríguez-durán A, Cobacho-salmoral O, Crespo-montero R. Embarazo y trasplante renal. Una revisión sistemática. Enferm Nefrol 2021;24:337-50. [DOI: 10.37551/s2254-28842021029] [Reference Citation Analysis]
|
| 103 |
Liu X, Liu K, Gui Z, Feng D, Wang Z, Zheng M, Fei S, Chen H, Sun L, Han Z, Ju X, Zhang H, Tan R, Gu M. Single Nucleotide Polymorphisms of IL-33 Gene Correlated with Renal Allograft Fibrosis in Kidney Transplant Recipients. J Immunol Res 2021;2021:8029180. [PMID: 34950738 DOI: 10.1155/2021/8029180] [Reference Citation Analysis]
|
| 104 |
Paluszkiewicz P, Martuszewski A, Zaręba N, Wala K, Banasik M, Kepinska M. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases. Int J Mol Sci 2021;23:131. [PMID: 35008556 DOI: 10.3390/ijms23010131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 105 |
Ng YH, Litvinovich I, Leyva Y, Ford CG, Zhu Y, Kendall K, Croswell E, Puttarajappa CM, Amanda Dew M, Shapiro R, Unruh ML, Myaskovsky L. Medication, Healthcare Follow-up, and Lifestyle Nonadherence: Do They Share the Same Risk Factors? Transplant Direct 2022;8:e1256. [PMID: 34912945 DOI: 10.1097/TXD.0000000000001256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 106 |
Fadel FI, Bazaraa HM, Abdel Mawla MA, Salah DM. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange. Ital J Pediatr 2021;47:236. [PMID: 34906202 DOI: 10.1186/s13052-021-01188-0] [Reference Citation Analysis]
|
| 107 |
Oblak M, Mlinšek G, Kojc N, Frelih M, Buturović-Ponikvar J, Arnol M. Spot Urine Protein Excretion in the First Year Following Kidney Transplantation Associates With Allograft Rejection Phenotype at 1-Year Surveillance Biopsies: An Observational National-Cohort Study. Front Med (Lausanne) 2021;8:781195. [PMID: 34869503 DOI: 10.3389/fmed.2021.781195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 108 |
Wiebe C, Nickerson PW. Role of HLA molecular mismatch in clinical practice. Hum Immunol 2021:S0198-8859(21)00258-5. [PMID: 34887099 DOI: 10.1016/j.humimm.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 109 |
Hong MS, Lee YH, Kong JM, Kwon OJ, Jung CW, Yang J, Kim MS, Han HW, Nam SM. Kidney Function Decline Prediction and Risk Factor Analysis After Kidney Transplantation: Machine Learning and Network Analysis on Nationwide Cohort Data (Preprint).. [DOI: 10.2196/preprints.35296] [Reference Citation Analysis]
|
| 110 |
Ji J, Wang Q, Huang T, Wang Z, He P, Guo C, Xu W, Cao Y, Dong Z, Wang H. Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients. Infect Drug Resist 2021;14:4913-20. [PMID: 34853519 DOI: 10.2147/IDR.S339622] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 111 |
Stam SP, Sokooti S, Eisenga MF, van der Veen A, Gomes-Neto AW, van Dijk PR, van Zanden JJ, Vos MJ, Kema IP, van Beek AP, Bakker SJL; TransplantLines Investigators. Androgens and Development of Posttransplantation Diabetes Mellitus in Male Kidney Transplant Recipients: A Post Hoc Analysis of a Prospective Study. Diabetes Care 2021;44:2683-90. [PMID: 34610923 DOI: 10.2337/dc21-0237] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 112 |
Fernandez Rivera C, Calvo Rodríguez M, Poveda JL, Pascual J, Crespo M, Gomez G, Cabello Pelegrin S, Paul J, Lauzurica R, Perez Mir M, Moreso F, Perelló M, Andres A, González E, Fernandez A, Mendiluce A, Fernández Carbajo B, Sanchez Fructuoso A, Calvo N, Suarez A, Bernal Blanco G, Osuna A, Ruiz-Fuentes MC, Melilli E, Montero Perez N, Ramos A, Fernández B, López V, Hernandez D; Better study. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study. Clin Transplant 2021;:e14550. [PMID: 34851532 DOI: 10.1111/ctr.14550] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 113 |
Ali H, Soliman K, Mohamed MM, Rahman M, Herberth J, Fülöp T, Elsayed I. Impact of kidney transplantation on functional status. Ann Med 2021;53:1302-8. [PMID: 34387134 DOI: 10.1080/07853890.2021.1962963] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Naylor KL, Kim SJ, McArthur E, Garg AX, Vinegar M, McCallum MK, Knoll GA. Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study. Can J Kidney Health Dis 2021;8:20543581211056234. [PMID: 34777844 DOI: 10.1177/20543581211056234] [Reference Citation Analysis]
|
| 115 |
Taira H, Noguchi H, Ueki K, Kaku K, Tsuchimoto A, Okabe Y, Ohya Y, Nakamura M. Initiation of dialysis for kidney graft failure: A retrospective single-center cohort study. Ther Apher Dial 2021. [PMID: 34779578 DOI: 10.1111/1744-9987.13756] [Reference Citation Analysis]
|
| 116 |
Abou-Jaoudé M, El Hage S, Akiki D, Araman R. Effect of donor-to-recipient HLA matching in low-immunological risk kidney transplant recipients without induction therapy on acute rejection, graft survival, infections, and surgical complications at 3 years: The road towards new recommendations. Transpl Immunol 2021;69:101490. [PMID: 34695578 DOI: 10.1016/j.trim.2021.101490] [Reference Citation Analysis]
|
| 117 |
Park Y, Lee H, Eum SH, Kim HD, Ko EJ, Yang CW, Chung BH. Intrapatient Variability in Tacrolimus Trough Levels Over 2 Years Affects Long-Term Allograft Outcomes of Kidney Transplantation. Front Immunol 2021;12:746013. [PMID: 34659243 DOI: 10.3389/fimmu.2021.746013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 118 |
Hisadome Y, Mei T, Noguchi H, Ohkuma T, Sato Y, Kaku K, Okabe Y, Nakamura M. Safety and Efficacy of Sodium-glucose Cotransporter 2 Inhibitors in Kidney Transplant Recipients With Pretransplant Type 2 Diabetes Mellitus: A Retrospective, Single-center, Inverse Probability of Treatment Weighting Analysis of 85 Transplant Patients. Transplant Direct 2021;7:e772. [PMID: 34646935 DOI: 10.1097/TXD.0000000000001228] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 119 |
Ben-David E, Hull R, Banerjee D. Diabetes mellitus in dialysis and renal transplantation. Ther Adv Endocrinol Metab 2021;12:20420188211048663. [PMID: 34631007 DOI: 10.1177/20420188211048663] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 120 |
Vinson AJ, Agarwal G, Dai R, Anzalone AJ, Lee SB, French E, Olex A, Madhira V, Mannon RB. COVID-19 in Solid Organ Transplantation: Results of the National COVID Cohort Collaborative. Transplant Direct 2021;7:e775. [PMID: 34646938 DOI: 10.1097/TXD.0000000000001234] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 121 |
Gastañaga-Holguera T, Calvo M, Gómez-Irwin L, Gesto IC, González-González V, Vidaurreta M. Successful pregnancy and follow-up after in vitro fertilization of a kidney transplant patient with systemic lupus erythematosus, primary biliary cholangitis, and hypothyroidism. JBRA Assist Reprod 2021;25:657-60. [PMID: 34415135 DOI: 10.5935/1518-0557.20210052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 122 |
Ranjan SK, Mittal A, Kumar S, Kishore S, Narain TA, Mammen KJ. Papillary Renal Cell Carcinoma with Sarcomatoid Differentiation in a Native Kidney of Transplant Recipient: A Case Report and Review of Literature. Indian J Nephrol 2021;31:386-9. [PMID: 34584356 DOI: 10.4103/ijn.IJN_239_20] [Reference Citation Analysis]
|
| 123 |
Nassar M, Nso N, Ariyaratnam J, Sandhu J, Mohamed M, Baraka B, Ibrahim A, Alfishawy M, Zheng D, Bhangoo H, Soliman KM, Li M, Rizzo V, Daoud A. Coronavirus disease 2019 and renal transplantation. World J Clin Cases 2021; 9(27): 7986-7997 [PMID: 34621855 DOI: 10.12998/wjcc.v9.i27.7986] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 124 |
Andrews LM, de Winter BCM, Cornelissen EAM, de Jong H, Hesselink DA, Schreuder MF, Brüggemann RJM, van Gelder T, Cransberg K. A Population Pharmacokinetic Model Does Not Predict the Optimal Starting Dose of Tacrolimus in Pediatric Renal Transplant Recipients in a Prospective Study: Lessons Learned and Model Improvement. Clin Pharmacokinet 2020;59:591-603. [PMID: 31654367 DOI: 10.1007/s40262-019-00831-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 125 |
Tanrısev M, Ayna Kılıçaslan T, Çolak H, Ersan S, Yılmaz B, Alp A, Tuğmen C, Sevgili BE. Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions. Ann Transplant 2021;26:e932434. [PMID: 34531361 DOI: 10.12659/AOT.932434] [Reference Citation Analysis]
|
| 126 |
Lee C, Kim HJ, Chang TI, Kang EW, Joo YS, Kim HW, Park JT, Yoo TH, Kang SW, Han SH. Synergic association of diabetes mellitus and chronic kidney disease with muscle loss and cachexia: results of a 16-year longitudinal follow-up of a community-based prospective cohort study. Aging (Albany NY) 2021;13:21941-61. [PMID: 34528898 DOI: 10.18632/aging.203539] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 127 |
Grupper A, Katchman E, Ben-Yehoyada M, Rabinowich L, Schwartz D, Schwartz IF, Shashar M, Halperin T, Turner D, Goykhman Y, Shibolet O, Levy S, Houri I, Baruch R, Katchman H. Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine. Clin Transplant 2021;:e14478. [PMID: 34506644 DOI: 10.1111/ctr.14478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 128 |
Kwon H, Kim YH, Ko Y, Lim SJ, Jung JH, Baek CH, Kim H, Park SK, Shin S, Cho YP. Pure T-cell mediated rejection following kidney transplant according to response to treatment. PLoS One 2021;16:e0256898. [PMID: 34478461 DOI: 10.1371/journal.pone.0256898] [Reference Citation Analysis]
|
| 129 |
Ahn JB, Bae S, Chu NM, Wang L, Kim J, Schnitzler M, Hess GP, Lentine KL, Segev DL, McAdams-DeMarco MA. The Risk of Postkidney Transplant Outcomes by Induction Choice Differs by Recipient Age. Transplant Direct 2021;7:e715. [PMID: 34476294 DOI: 10.1097/TXD.0000000000001105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 130 |
Nowicka M, Górska M, Nowicka Z, Edyko K, Goździk M, Kurnatowska I. Adherence to Pharmacotherapy and Lifestyle Recommendations Among Hemodialyzed Patients and Kidney Transplant Recipients. Journal of Renal Nutrition 2021;31:503-11. [DOI: 10.1053/j.jrn.2020.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 131 |
Chancharoenthana W, Leelahavanichkul A, Ariyanon W, Vadcharavivad S, Phumratanaprapin W. Comparative Long-Term Renal Allograft Outcomes of Recurrent Immunoglobulin A with Severe Activity in Kidney Transplant Recipients with and without Rituximab: An Observational Cohort Study. J Clin Med 2021;10:3939. [PMID: 34501386 DOI: 10.3390/jcm10173939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 132 |
Srisuwarn P, Sumethkul V. Kidney transplant from donors with hepatitis B: A challenging treatment option. World J Hepatol 2021;13:853-67. [PMID: 34552692 DOI: 10.4254/wjh.v13.i8.853] [Reference Citation Analysis]
|
| 133 |
Ozkok A, Alpay N, Alan S, Bakan ND, Soysal F, Yazici H, Ekşioğlu-Demiralp E, Yildiz A. Immunological parameters associated with the severity of COVID-19 pneumonia in kidney transplant recipients. Int Urol Nephrol 2021. [PMID: 34415473 DOI: 10.1007/s11255-021-02947-y] [Reference Citation Analysis]
|
| 134 |
Loperto I, Scala A, Rossano L, Carrano R, Federico S, Triassi M, Improta G. Use of regression models to predict glomerular filtration rate in kidney transplanted patients. 2021 International Symposium on Biomedical Engineering and Computational Biology 2021. [DOI: 10.1145/3502060.3503627] [Reference Citation Analysis]
|
| 135 |
Suárez Fernández ML, Ridao Cano N, Álvarez Santamarta L, Gago Fraile M, Blake O, Díaz Corte C. A Current Review of the Etiology, Clinical Features, and Diagnosis of Urinary Tract Infection in Renal Transplant Patients. Diagnostics (Basel) 2021;11:1456. [PMID: 34441390 DOI: 10.3390/diagnostics11081456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 136 |
Lentine KL, Cheungpasitporn W, Xiao H, McAdams-DeMarco M, Lam NN, Segev DL, Bae S, Ahn JB, Hess GP, Caliskan Y, Randall HB, Kasiske BL, Schnitzler MA, Axelrod DA. Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis. Transplantation 2021;105:1840-9. [PMID: 33214534 DOI: 10.1097/TP.0000000000003547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 137 |
Hou YC, Lu KC, Kuo KL. The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review. Vaccines (Basel) 2021;9:885. [PMID: 34452010 DOI: 10.3390/vaccines9080885] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 138 |
Thölking G, Filensky B, Jehn U, Schütte-Nütgen K, Koch R, Kurschat C, Pavenstädt H, Suwelack B, Reuter S, Kuypers D. Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation. Sci Rep 2021;11:15606. [PMID: 34341448 DOI: 10.1038/s41598-021-95201-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 139 |
Grupper A, Rabinowich L, Schwartz D, Schwartz IF, Ben-Yehoyada M, Shashar M, Katchman E, Halperin T, Turner D, Goykhman Y, Shibolet O, Levy S, Houri I, Baruch R, Katchman H. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant 2021;21:2719-26. [PMID: 33866672 DOI: 10.1111/ajt.16615] [Cited by in Crossref: 212] [Cited by in F6Publishing: 228] [Article Influence: 106.0] [Reference Citation Analysis]
|
| 140 |
van Gelder T. How cyclosporin reduces mycophenolic acid exposure by 40% while other calcineurin inhibitors do not. Kidney Int 2021:S0085-2538(21)00686-4. [PMID: 34284043 DOI: 10.1016/j.kint.2021.06.036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 141 |
Codina S, Manonelles A, Tormo M, Sola A, Cruzado JM. Chronic Kidney Allograft Disease: New Concepts and Opportunities. Front Med (Lausanne) 2021;8:660334. [PMID: 34336878 DOI: 10.3389/fmed.2021.660334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 142 |
Thölking G, Schulte C, Jehn U, Schütte-Nütgen K, Pavenstädt H, Suwelack B, Reuter S. The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation. J Clin Med 2021;10:3066. [PMID: 34300232 DOI: 10.3390/jcm10143066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 143 |
Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK. Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton) 2021. [PMID: 34240786 DOI: 10.1111/nep.13939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 144 |
Yang Y, Huang X, Shi Y, Yang R, Shi H, Yang X, Hao G, Zheng Y, Wang J, Su L, Li Y, Zhao W. CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients. Front Pharmacol 2021;12:692922. [PMID: 34290611 DOI: 10.3389/fphar.2021.692922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 145 |
Matsuda Y, Watanabe T, Li XK. Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells. Front Immunol 2021;12:682334. [PMID: 34276669 DOI: 10.3389/fimmu.2021.682334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 146 |
Deng J, Lu Y, He L, Ou J, Xie H. A comparison of mycophenolate mofetil and calcineurin inhibitor as maintenance immunosuppression for kidney transplant recipients: A meta-analysis of randomized controlled trials. Turk J Med Sci 2021;51:1080-91. [PMID: 33356028 DOI: 10.3906/sag-1910-156] [Reference Citation Analysis]
|
| 147 |
Alzoubi B, Kharel A, Machhi R, Aziz F, Swanson KJ, Parajuli S. Post-transplant erythrocytosis after kidney transplantation: A review. World J Transplant 2021; 11(6): 220-230 [PMID: 34164297 DOI: 10.5500/wjt.v11.i6.220] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 148 |
Prasad GVR, Bhamidi V. Managing cardiovascular disease risk in South Asian kidney transplant recipients. World J Transplant 2021; 11(6): 147-160 [PMID: 34164291 DOI: 10.5500/wjt.v11.i6.147] [Reference Citation Analysis]
|
| 149 |
Almaimani AO. Asymptomatic Bacteriuria in Post Renal Transplant Patients: To Treat or Not? Cureus 2021;13:e15713. [PMID: 34159042 DOI: 10.7759/cureus.15713] [Reference Citation Analysis]
|
| 150 |
Zwart TC, Guchelaar HJ, van der Boog PJM, Swen JJ, van Gelder T, de Fijter JW, Moes DJAR. Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation. Drug Discov Today 2021:S1359-6446(21)00273-7. [PMID: 34119665 DOI: 10.1016/j.drudis.2021.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 151 |
Chung BH. Biomarker for recurrent immunoglobulin A nephropathy in kidney allografts: promising but still a long way to go. Kidney Res Clin Pract 2021;40:180-2. [PMID: 34162047 DOI: 10.23876/j.krcp.21.106] [Reference Citation Analysis]
|
| 152 |
Tan MSH, Chung SJ, Ho QY, Thangaraju S, Kee TYS. A single-centre observational study comparing the impact of different cytomegalovirus prophylaxis strategies on cytomegalovirus infections in kidney transplant recipients. Proceedings of Singapore Healthcare 2021;30:117-124. [DOI: 10.1177/2010105820953461] [Reference Citation Analysis]
|
| 153 |
Wang X, Patel SA, Haddadin M, Cerny J. Post-allogeneic hematopoietic stem cell transplantation viral reactivations and viremias: a focused review on human herpesvirus-6, BK virus and adenovirus. Ther Adv Infect Dis 2021;8:20499361211018027. [PMID: 34104434 DOI: 10.1177/20499361211018027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 154 |
Buxeda A, Redondo-Pachón D, Pérez-Sáez MJ, Crespo M, Pascual J. Sex differences in cancer risk and outcomes after kidney transplantation. Transplant Rev (Orlando) 2021;35:100625. [PMID: 34020178 DOI: 10.1016/j.trre.2021.100625] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 155 |
Kielar M, Gala-Błądzińska A, Dumnicka P, Ceranowicz P, Kapusta M, Naumnik B, Kubiak G, Kuźniewski M, Kuśnierz-Cabala B. Complement Components in the Diagnosis and Treatment after Kidney Transplantation-Is There a Missing Link? Biomolecules 2021;11:773. [PMID: 34064132 DOI: 10.3390/biom11060773] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 156 |
Sapiertein Silva JF, Ferreira GF, Perosa M, Nga HS, de Andrade LGM. A machine learning prediction model for waiting time to kidney transplant. PLoS One 2021;16:e0252069. [PMID: 34015020 DOI: 10.1371/journal.pone.0252069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 157 |
[DOI: 10.1145/3472813.3472816] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 158 |
Gurgel do Amaral M, Reijneveld SA, Almansa J, Navis G, de Winter AF. Do Uncontrolled Hypertension, Diabetes, Dyslipidemia, and Obesity Mediate the Relationship Between Health Literacy and Chronic Kidney Disease Complications? Int J Environ Res Public Health 2021;18:5235. [PMID: 34069095 DOI: 10.3390/ijerph18105235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 159 |
Zapke SE, Willmann S, Grebe SO, Menke K, Thürmann PA, Schmiedl S. Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring. Front Pharmacol 2021;12:630904. [PMID: 34054518 DOI: 10.3389/fphar.2021.630904] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 160 |
Manickavasagar R, Thuraisingham R. Post renal-transplant malignancy surveillance. Clin Med (Lond) 2020;20:142-5. [PMID: 32188647 DOI: 10.7861/clinmed.2019-0423] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 161 |
Almisfer AK, Qasim SS, Alqahtani MA, Alghafees MA, Alqarni AK, AlNowaiser NM, Altamimi A. Incidence Rate and Predictors of Delayed Graft Function Among Adult Kidney Transplant Recipients at a Tertiary Care Hospital in Riyadh, Saudi Arabia. Cureus 2021;13:e14985. [PMID: 34123677 DOI: 10.7759/cureus.14985] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 162 |
Marinaki S, Vallianou K, Melexopoulou C, Lionaki S, Darema M, Lambrou P, Boletis I. The Changing Landscape of Pneumocystis Jiroveci Infection in Kidney Transplant Recipients: Single-Center Experience of Late-Onset Pneumocystis Pneumonia. Transplant Proc 2021;53:1576-82. [PMID: 33962778 DOI: 10.1016/j.transproceed.2021.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 163 |
Balashova AV, Mustafina VR, Glinkina IV. Interdisciplinary problem of post-transplant diabetes mellitus: literature review. jour 2021;12:60-73. [DOI: 10.47093/2218-7332.2021.12.1.60-73] [Reference Citation Analysis]
|
| 164 |
Perrottet N, Fernández-Ruiz M, Binet I, Dickenmann M, Dahdal S, Hadaya K, Müller T, Schaub S, Koller M, Rotman S, Moll S, Hopfer H, Venetz JP, Aubert V, Bühler L, Steiger J, Manuel O, Pascual M, Golshayan D; and the Swiss Transplant Cohort Study (STCS). Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study. PLoS One 2021;16:e0250829. [PMID: 33930037 DOI: 10.1371/journal.pone.0250829] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 165 |
Hernández D, Vázquez T, Alonso-Titos J, León M, Caballero A, Cobo MA, Sola E, López V, Ruiz-Esteban P, Cruzado JM, Sellarés J, Moreso F, Manonelles A, Torio A, Cabello M, Delgado-Burgos J, Casas C, Gutiérrez E, Jironda C, Kanter J, Serón D, Torres A. Impact of HLA Mismatching on Early Subclinical Inflammation in Low-Immunological-Risk Kidney Transplant Recipients. J Clin Med 2021;10:1934. [PMID: 33947168 DOI: 10.3390/jcm10091934] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 166 |
Krall P, Yañez D, Rojo A, Delucchi Á, Córdova M, Morales J, Boza P, de la Rivera A, Espinoza N, Armijo N, Castañeda LE, Farfán MJ, Salas C. CYP3A5 and UGT1A9 Polymorphisms Influence Immunosuppressive Therapy in Pediatric Kidney Transplant Recipients. Front Pharmacol 2021;12:653525. [PMID: 33967795 DOI: 10.3389/fphar.2021.653525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 167 |
Ali H, Mohamed MM, Sharma A, Fulop T, Halawa A. Outcomes of Interleukin-2 Receptor Antagonist Induction Therapy in Standard-Risk Renal Transplant Recipients Maintained on Tacrolimus: A Systematic Review and Meta-Analysis. Am J Nephrol 2021;52:279-91. [PMID: 33887727 DOI: 10.1159/000514454] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 168 |
Sotomayor CG, Bustos NI, Yepes-Calderon M, Arauna D, de Borst MH, Berger SP, Rodrigo R, Dullaart RPF, Navis GJ, Bakker SJL. Plasma Vitamin C and Risk of Late Graft Failure in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study. Antioxidants (Basel) 2021;10:631. [PMID: 33919075 DOI: 10.3390/antiox10050631] [Reference Citation Analysis]
|
| 169 |
Aref A, Sharma A, Halawa A. Does steroid-free immunosuppression improve the outcome in kidney transplant recipients compared to conventional protocols? World J Transplant 2021; 11(4): 99-113 [PMID: 33954088 DOI: 10.5500/wjt.v11.i4.99] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 170 |
Odler B, Deak AT, Pregartner G, Riedl R, Bozic J, Trummer C, Prenner A, Söllinger L, Krall M, Höflechner L, Hebesberger C, Boxler MS, Berghold A, Schemmer P, Pilz S, Rosenkranz AR. Hypomagnesemia Is a Risk Factor for Infections after Kidney Transplantation: A Retrospective Cohort Analysis. Nutrients 2021;13:1296. [PMID: 33919913 DOI: 10.3390/nu13041296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 171 |
Takahashi K, Kurihara Y, Usui J, Kimura T, Kaneko S, Nishiyama H, Yamagata K, Oda T. Bowel obstruction caused by a colonic mass 2 years after living-donor kidney transplantation. ANZ J Surg 2021. [PMID: 33847071 DOI: 10.1111/ans.16852] [Reference Citation Analysis]
|
| 172 |
Cossart AR, Isbel NM, Scuderi C, Campbell SB, Staatz CE. Pharmacokinetic and Pharmacodynamic Considerations in Relation to Calcineurin Usage in Elderly Kidney Transplant Recipients. Front Pharmacol 2021;12:635165. [PMID: 33912051 DOI: 10.3389/fphar.2021.635165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 173 |
Sharif A, Peracha J, Winter D, Reulen R, Hawkins M. Exploring the Epidemiology of Cancer after Solid Organ Transplantation (EpCOT): an observational cohort study. BMJ Open 2021;11:e043731. [DOI: 10.1136/bmjopen-2020-043731] [Reference Citation Analysis]
|
| 174 |
Yepes-Calderón M, Sotomayor CG, Pena M, Eisenga MF, Gans ROB, Berger SP, Moers C, Sugaya T, Doekharan D, Navis GJ, van den Born J, Bakker SJL. Urinary liver-type fatty acid-binding protein is independently associated with graft failure in outpatient kidney transplant recipients. Am J Transplant 2021;21:1535-44. [PMID: 32946659 DOI: 10.1111/ajt.16312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 175 |
Sahman M, Mugosa S, Rancic N. Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study. Front Public Health 2021;9:671316. [PMID: 33869136 DOI: 10.3389/fpubh.2021.671316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 176 |
Taj SM, Baghaffar H, Alnajjar DK, Almashabi NK, Ismail S. Prevalence of Non-Adherence to Immunosuppressive Medications in Kidney Transplant Recipients: Barriers and Predictors. Ann Transplant 2021;26:e928356. [PMID: 33782377 DOI: 10.12659/AOT.928356] [Reference Citation Analysis]
|
| 177 |
Runyo F, Matignon M, Audureau E, Vindrios W, Boueilh A, Gomart C, Grimbert P, Gallien S, Melica G. Infectious disease consultation is effective in boosting vaccine coverage in patients awaiting kidney transplantation: A French prospective study. Transpl Infect Dis 2021;:e13607. [PMID: 33773002 DOI: 10.1111/tid.13607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 178 |
Rysz J, Franczyk B, Radek M, Ciałkowska-Rysz A, Gluba-Brzózka A. Diabetes and Cardiovascular Risk in Renal Transplant Patients. Int J Mol Sci 2021;22:3422. [PMID: 33810367 DOI: 10.3390/ijms22073422] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 179 |
Rahimishahmirzadi M, Jevnikar AM, House AA, Luke PP, Humar A, Silverman MS, Shalhoub SM, Hosseini-Moghaddam SM. Late-onset allograft rejection, cytomegalovirus infection, and renal allograft loss: Is anti-CMV prophylaxis required following late-onset allograft rejection? Clin Transplant 2021;35:e14285. [PMID: 33713374 DOI: 10.1111/ctr.14285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 180 |
Klangjareonchai T, Eguchi N, Tantisattamo E, Ferrey AJ, Reddy U, Dafoe DC, Ichii H. Current Pharmacological Intervention and Medical Management for Diabetic Kidney Transplant Recipients. Pharmaceutics 2021;13:413. [PMID: 33808901 DOI: 10.3390/pharmaceutics13030413] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 181 |
Shen CL, Wu BS, Lien TJ, Yang AH, Yang CY. BK Polyomavirus Nephropathy in Kidney Transplantation: Balancing Rejection and Infection. Viruses 2021;13:487. [PMID: 33809472 DOI: 10.3390/v13030487] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 182 |
Jahromi M, Al-Otaibi T, Ashry Gheith O, Farouk Othman N, Mahmoud T, Nair P, A-Halim M, Aggarwal P, Messenger G, Chu P, De Serres SA, Azzi JR. Analysis of the frequency of single nucleotide polymorphisms in cytokine genes in patients with New Onset Diabetes After Transplant. Sci Rep 2021;11:6014. [PMID: 33727573 DOI: 10.1038/s41598-021-84400-9] [Reference Citation Analysis]
|
| 183 |
Salehi S, Abedini F, Shahi A, Afzali S, Dashti-khavidaki S, Amirzargar AA. The effect of CYP3A4 genetic polymorphisms on the pharmacokinetics of calcineurin inhibitors in renal transplant recipients: a systematic review and meta-analysis protocol.. [DOI: 10.1101/2021.03.13.21253531] [Reference Citation Analysis]
|
| 184 |
Han F, Sun Q, Huang Z, Li H, Ma M, Liao T, Luo Z, Zheng L, Zhang N, Chen N, Hong L, Na N, Sun Q. Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients. Aging (Albany NY) 2021;13:8440-53. [PMID: 33714205 DOI: 10.18632/aging.202654] [Reference Citation Analysis]
|
| 185 |
Azizzadeh L, Fazeli SA, Hashemian F, Dehghani S, Ahmadi SS, Pourmand G. Early Conversion to Tacrolimus Vs Cyclosporine Continuation in Normally Functioning Kidney Allograft: A Single-Center Study. Iran J Pharm Res 2020;19:556-71. [PMID: 33680051 DOI: 10.22037/ijpr.2020.113220.14174] [Reference Citation Analysis]
|
| 186 |
Arnau A, Benito-Hernández A, Ramos-Barrón MA, García-Unzueta MT, Gómez-Román JJ, Gómez-Ortega JM, López-Hoyos M, San Segundo D, Ruiz JC, Rodrigo E. Urinary C-X-C Motif Chemokine 10 Is Related to Acute Graft Lesions Secondary to T Cell- and Antibody-Mediated Damage. Ann Transplant 2021;26:e929491. [PMID: 33686050 DOI: 10.12659/AOT.929491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 187 |
Mallavarapu RK, Sanoff SL, Howell DN, Roberts JK. BK virus nephropathy in non-renal solid organ transplant recipients: Are we looking hard enough? Clin Transplant 2021;35:e14265. [PMID: 33615555 DOI: 10.1111/ctr.14265] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 188 |
Cherneha M, Korth J, Kaulfuß M, Trilling M, Widera M, Rohn H, Dolff S, Babel N, Hoerning A, Kribben A, Witzke O. Reactivations of Latent Viral Infections Are Associated with an Increased Thr389 p70S6k Phosphorylation in Peripheral Lymphocytes of Renal Transplant Recipients. Viruses 2021;13:424. [PMID: 33800846 DOI: 10.3390/v13030424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 189 |
Boulay H, Mazaud-Guittot S, Supervielle J, Chemouny JM, Dardier V, Lacroix A, Dion L, Vigneau C. Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review. Clin Kidney J 2021;14:1871-8. [PMID: 34345409 DOI: 10.1093/ckj/sfab049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 190 |
Sotomayor CG, Benjamens S, Dijkstra H, Yakar D, Moers C, Bakker SJL, Pol RA. Introduction of the Grayscale Median for Ultrasound Tissue Characterization of the Transplanted Kidney. Diagnostics (Basel) 2021;11:390. [PMID: 33668900 DOI: 10.3390/diagnostics11030390] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 191 |
Zhuang J, Hou J. The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection. Front Immunol 2021;12:625998. [PMID: 33717141 DOI: 10.3389/fimmu.2021.625998] [Reference Citation Analysis]
|
| 192 |
Francke MI, Andrews LM, Le HL, van de Wetering J, Clahsen-van Groningen MC, van Gelder T, van Schaik RHN, van der Holt B, de Winter BCM, Hesselink DA. Avoiding Tacrolimus Underexposure and Overexposure with a Dosing Algorithm for Renal Transplant Recipients: A Single Arm Prospective Intervention Trial. Clin Pharmacol Ther 2021;110:169-78. [PMID: 33452682 DOI: 10.1002/cpt.2163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 193 |
Chancharoenthana W, Leelahavanichkul A. Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)-Positive Living Donors to HBsAg-Negative Recipients: Benefits and Risks. Clin Infect Dis 2021;72:720-1. [PMID: 32492130 DOI: 10.1093/cid/ciaa707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 194 |
Jehn U, Schütte-Nütgen K, Henke U, Pavenstädt H, Suwelack B, Reuter S. Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients. Sci Rep 2021;11:3713. [PMID: 33580120 DOI: 10.1038/s41598-021-83333-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 195 |
Taber DJ, Hirsch J, Keys A, Su Z, McGillicuddy JW. Etiologies and Outcomes Associated With Tacrolimus Levels Out of a Typical Range That Lead to High Variability in Kidney Transplant Recipients. Ther Drug Monit 2021;43:401-7. [PMID: 33560095 DOI: 10.1097/FTD.0000000000000863] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 196 |
Blazquez-Navarro A, Dang-Heine C, Bauer C, Wittenbrink N, Wolk K, Sabat R, Witzke O, Westhoff TH, Sawitzki B, Reinke P, Thomusch O, Hugo C, Babel N, Or-Guil M. Sex-Associated Differences in Cytomegalovirus Prevention: Prophylactic Strategy is Potentially Associated With a Strong Kidney Function Impairment in Female Renal Transplant Patients. Front Pharmacol 2020;11:534681. [PMID: 33519427 DOI: 10.3389/fphar.2020.534681] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 197 |
Massicotte-Azarniouch D, Sood MM, Fergusson DA, Chassé M, Tinmouth A, Knoll GA. Blood Transfusion and Adverse Graft-related Events in Kidney Transplant Patients. Kidney Int Rep 2021;6:1041-9. [PMID: 33912754 DOI: 10.1016/j.ekir.2021.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 198 |
Werbel WA, Bae S, Yu S, Al Ammary F, Segev DL, Durand CM. Early steroid withdrawal in HIV-infected kidney transplant recipients: Utilization and outcomes. Am J Transplant 2021;21:717-26. [PMID: 32681603 DOI: 10.1111/ajt.16195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 199 |
Portoles JM, Jimenez C, Janeiro D, Lopez-Oliva MO, Ortega-Carrion A, Blanquez D, Arribas L, Gomez C, Diez T, Pascual J, Portero I. The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy. Front Immunol 2020;11:618202. [PMID: 33569062 DOI: 10.3389/fimmu.2020.618202] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 200 |
Varnas D, Jankauskienė A. Pneumocystis Jirovecii Pneumonia in a Kidney Transplant Recipient 13 Months after Transplantation: A Case Report and Literature Review. Acta Med Litu 2021;28:136-44. [PMID: 34393636 DOI: 10.15388/Amed.2020.28.1.5] [Reference Citation Analysis]
|
| 201 |
Catić-Đorđević A, Pavlović I, Spasić A, Stefanović N, Pavlović D, Damnjanović I, Mitić B, Veličković-Radovanović R. Assessment of pharmacokinetic mycophenolic acid clearance models using Monte Carlo numerical analysis. Xenobiotica 2021;51:387-93. [PMID: 33416418 DOI: 10.1080/00498254.2020.1871532] [Reference Citation Analysis]
|
| 202 |
Kim HD, Chang JY, Chung BH, Kim CD, Lee SH, Kim YH, Yang CW. Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial. Ann Transplant 2021;26:e927984. [PMID: 33479188 DOI: 10.12659/AOT.927984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 203 |
Yazdi M, Kahwaji JM, Meguerditchian S, Lee R. Belatacept Conversion Protocols and Outcomes in Kidney Transplant Recipients. Transplant Proc 2021;53:976-83. [PMID: 33478745 DOI: 10.1016/j.transproceed.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 204 |
Jarmi T, Khouzam S, Shekhar N, Hosni M, White L, Hodge DO, Mai ML, Wadei HM. The Impact of Different Induction Immunosuppressive Therapy on Long-Term Kidney Transplant Function When Measured by Iothalamate Clearance. J Clin Med Res 2020;12:787-93. [PMID: 33447312 DOI: 10.14740/jocmr4369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 205 |
Alasfar S, Hall IE, Mansour SG, Jia Y, Thiessen-Philbrook HR, Weng FL, Singh P, Schröppel B, Muthukumar T, Mohan S, Malik RF, Harhay MN, Doshi MD, Akalin E, Bromberg JS, Brennan DC, Reese PP, Parikh CR. Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation. BMC Nephrol 2021;22:26. [PMID: 33435916 DOI: 10.1186/s12882-021-02231-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 206 |
Prasoppokakorn T, Vanichanan J, Chaiteerakij R, Jutivorakool K, Udomkarnjananun S, Pongpirul K, Taesombat W, Wattanatorn S, Avihingsanon Y, Tungsanga K, Eiam-Ong S, Praditpornsilpa K, Townamchai N. A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis a vaccine in kidney transplant recipients. Sci Rep 2021;11:50. [PMID: 33420114 DOI: 10.1038/s41598-020-80052-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 207 |
Nobakht E, Jagadeesan M, Paul R, Bromberg J, Dadgar S. Precision Medicine in Kidney Transplantation: Just Hype or a Realistic Hope? Transplant Direct 2021;7:e650. [PMID: 33437865 DOI: 10.1097/TXD.0000000000001102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 208 |
Bae S, McAdams-DeMarco MA, Massie AB, Ahn JB, Werbel WA, Brennan DC, Lentine KL, Durand CM, Segev DL. Early Changes in Kidney Transplant Immunosuppression Regimens During the COVID-19 Pandemic. Transplantation 2021;105:170-6. [PMID: 33093404 DOI: 10.1097/TP.0000000000003502] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 209 |
Zelnick LR, Leca N, Young B, Bansal N. Association of the Estimated Glomerular Filtration Rate With vs Without a Coefficient for Race With Time to Eligibility for Kidney Transplant. JAMA Netw Open 2021;4:e2034004. [PMID: 33443583 DOI: 10.1001/jamanetworkopen.2020.34004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 29.0] [Reference Citation Analysis]
|
| 210 |
Shokeir AA, Hassan S, Shehab T, Ismail W, Saad IR, Badawy AA, Sameh W, Hammouda HM, Elbaz AG, Ali AA, Barsoum R. Egyptian clinical practice guideline for kidney transplantation. Arab J Urol 2021;19:105-22. [PMID: 34104484 DOI: 10.1080/2090598X.2020.1868657] [Reference Citation Analysis]
|
| 211 |
Dahl KG, Wahl AK, Urstad KH, Falk RS, Andersen MH. Changes in Health Literacy during the first year following a kidney transplantation: Using the Health Literacy Questionnaire. Patient Educ Couns 2021;104:1814-22. [PMID: 33454146 DOI: 10.1016/j.pec.2020.12.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 212 |
Buchholz BM, Herden U, Fischer L. Besonderheiten bei Infektionen in der Transplantationschirurgie/Immunsuppression. Infektionen in der Allgemein- und Viszeralchirurgie 2021. [DOI: 10.1007/978-3-662-62508-8_13] [Reference Citation Analysis]
|
| 213 |
Marin EP, Colegio O. Immunosuppressive Pharmacology. Transplantation Surgery 2021. [DOI: 10.1007/978-3-030-55244-2_20] [Reference Citation Analysis]
|
| 214 |
Johnston J, Goldberg A. Ethical Challenges in Pediatric Kidney Transplantation. Challenges in Pediatric Kidney Transplantation 2021. [DOI: 10.1007/978-3-030-74783-1_15] [Reference Citation Analysis]
|
| 215 |
Li Marzi V, Morselli S, Mormile N, Serni S. Defunctionalized Bladder and Kidney Transplantation. Non-Neurogenic Bladder Dysfunctions 2021. [DOI: 10.1007/978-3-030-57393-5_13] [Reference Citation Analysis]
|
| 216 |
Jain SR, Kumar D. Vaccination Strategies in Solid Organ and Stem Cell Transplant. Emerging Transplant Infections 2021. [DOI: 10.1007/978-3-030-25869-6_11] [Reference Citation Analysis]
|
| 217 |
Taha AR. Acute Kidney Injury During Pregnancy. Obstetric Catastrophes 2021. [DOI: 10.1007/978-3-030-70034-8_43] [Reference Citation Analysis]
|
| 218 |
Bock ME, Wall L, Dobrec C, Chandran M, Goebel J. Management of dyslipidemia in pediatric renal transplant recipients. Pediatr Nephrol 2021;36:51-63. [PMID: 31897714 DOI: 10.1007/s00467-019-04428-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 219 |
Literatur. Klinikleitfaden Nephrologie 2021. [DOI: 10.1016/b978-3-437-22931-2.00038-4] [Reference Citation Analysis]
|
| 220 |
Chicco D, Lovejoy CA, Oneto L. A Machine Learning Analysis of Health Records of Patients With Chronic Kidney Disease at Risk of Cardiovascular Disease. IEEE Access 2021;9:165132-165144. [DOI: 10.1109/access.2021.3133700] [Reference Citation Analysis]
|
| 221 |
Savani SI, Gilbert M. Rheumatologic Challenges. Challenges in Pediatric Kidney Transplantation 2021. [DOI: 10.1007/978-3-030-74783-1_7] [Reference Citation Analysis]
|
| 222 |
Thomas-fonseca G, Cano-cervantes H, Hernández-estrada S, Díaz-avendaño O, Alamilla-sánchez M, García-macas V. Variación del peso a los 12 meses postrasplante renal y su efecto en el riesgo cardiovascular. Revista Mexicana de Trasplantes 2021;10:86-94. [DOI: 10.35366/102863] [Reference Citation Analysis]
|
| 223 |
Chengappa M, Herrmann S, Poonacha T. Self-reported Financial Conflict of Interest in Nephrology Clinical Practice Guidelines. Kidney Int Rep 2021;6:768-74. [PMID: 33732991 DOI: 10.1016/j.ekir.2020.12.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 224 |
Ambrosi F, Ricci C, Malvi D, Cillia C, Ravaioli M, Fiorentino M, Cardillo M, Vasuri F, D'Errico A. Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. Kidney Res Clin Pract 2020;39:487-94. [PMID: 32855366 DOI: 10.23876/j.krcp.20.050] [Reference Citation Analysis]
|
| 225 |
Mascitti H. Infections de l’immunodéprimé (hors VIH): Infections (HIV patients excluded) in immunosuppressed patients. Med Mal Infect 2020;50:8S6-8S11. [PMID: 33357973 DOI: 10.1016/S0399-077X(20)30777-0] [Reference Citation Analysis]
|
| 226 |
Kielar M, Dumnicka P, Gala-Błądzińska A, Będkowska-Prokop A, Ignacak E, Maziarz B, Ceranowicz P, Kuśnierz-Cabala B. Urinary NGAL Measured after the First Year Post Kidney Transplantation Predicts Changes in Glomerular Filtration over One-Year Follow-Up. J Clin Med 2020;10:E43. [PMID: 33375581 DOI: 10.3390/jcm10010043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 227 |
Martynov SA, Severina AS, Larina II, Shamhalova MS, Arzumanov SV, Pinchuk AV, Shestakova MV. [Preparation of the dialysis patient with type 1 diabetes mellitus for kidney transplantation]. Probl Endokrinol (Mosk) 2020;66:18-30. [PMID: 33481364 DOI: 10.14341/probl12686] [Reference Citation Analysis]
|
| 228 |
So S, Au EHK, Lim WH, Lee VWS, Wong G. Factors Influencing Long-Term Patient and Allograft Outcomes in Elderly Kidney Transplant Recipients. Kidney Int Rep 2021;6:727-36. [PMID: 33732987 DOI: 10.1016/j.ekir.2020.11.035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 229 |
Bae S, Garonzik-Wang JM, Massie AB, McAdams-DeMarco MA, Coresh J, Segev DL. Inconsistencies in the association of clinical factors with the choice of early steroid withdrawal across kidney transplant centers: A national registry study. Clin Transplant 2021;35:e14176. [PMID: 33259086 DOI: 10.1111/ctr.14176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 230 |
Goh LF, Khoo SR, Tung Y, Lee PH, Kee T. Impact of transiting from fluorescent polarisation immunoassay to high-performance liquid chromatography–tandem mass spectrometry for immunosuppressant levels analysis in kidney transplant patients. Proceedings of Singapore Healthcare 2020;29:228-33. [DOI: 10.1177/2010105820974385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 231 |
VanWagner LB, Aghaulor B, Hussain T, Kosirog M, Campbell P, Pine S, Daud A, Finn DJ, Levitsky J, Lloyd-Jones DM, Holl JL. When evidence is lacking: a mixed-methods approach for the development of practice guidance in liver transplantation. Gastroenterol Rep (Oxf) 2021;9:22-30. [PMID: 33747523 DOI: 10.1093/gastro/goaa068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 232 |
Burek Kamenaric M, Ivkovic V, Kovacevic Vojtusek I, Zunec R. The Role of HLA and KIR Immunogenetics in BK Virus Infection after Kidney Transplantation. Viruses 2020;12:E1417. [PMID: 33317205 DOI: 10.3390/v12121417] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 233 |
Shilova ES, Borovik NV, Yarmolinskaya MI. Diabetic nephropathy in type 1 diabetes and pregnancy. Modern view of the problem. Diabetes mellitus 2020;23:340-348. [DOI: 10.14341/dm12228] [Reference Citation Analysis]
|
| 234 |
Shaddock R, Anderson KV, Beyth R. Renal Repercussions of Medications. Primary Care: Clinics in Office Practice 2020;47:691-702. [DOI: 10.1016/j.pop.2020.08.006] [Reference Citation Analysis]
|
| 235 |
Hecking M, Sharif A, Eller K, Jenssen T. Management of post-transplant diabetes: immunosuppression, early prevention, and novel antidiabetics. Transpl Int. 2021;34:27-48. [PMID: 33135259 DOI: 10.1111/tri.13783] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 236 |
Pan J, Fu Y, Cao Y, Feng G, Zhao J, Shi X, Mo C, Song W, Shen Z. Single-Center Retrospective Analysis of Prophylaxis and Treatment of Pneumocystis carinii Pneumonia in Patients with Renal Dysfunction After Renal Transplantation. Ann Transplant 2020;25:e925126. [PMID: 33184254 DOI: 10.12659/AOT.925126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 237 |
Vincenti F, Kim J, Gouveia D, Pelle G, Mayne TJ, Neylan JF. Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function. Kidney Int Rep 2021;6:296-303. [PMID: 33615054 DOI: 10.1016/j.ekir.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 238 |
Masiero L, Puoti F, Bellis L, Lombardini L, Totti V, Angelini ML, Spazzoli A, Nanni Costa A, Cardillo M, Sella G, Mosconi G. Physical activity and renal function in the Italian kidney transplant population. Ren Fail 2020;42:1192-204. [PMID: 33256487 DOI: 10.1080/0886022X.2020.1847723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 239 |
Fortea JI, Cuadrado A, Puente Á, Álvarez Fernández P, Huelin P, Álvarez Tato C, García Carrera I, Cobreros M, Cagigal Cobo ML, Calvo Montes J, Ruiz de Alegría Puig C, Rodríguez SanJuán JC, Castillo Suescun FJ, Fernández Santiago R, Echeverri Cifuentes JA, Casafont F, Crespo J, Fábrega E. Is Routine Prophylaxis Against Pneumocystis jirovecii Needed in Liver Transplantation? A Retrospective Single-Centre Experience and Current Prophylaxis Strategies in Spain. J Clin Med 2020;9:E3573. [PMID: 33171962 DOI: 10.3390/jcm9113573] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 240 |
Kanigicherla DAK, Bhogal T, Stocking K, Chinnadurai R, Gray S, Javed S, Fortune C, Augustine T, Kalra PA. Non-invasive cardiac stress studies may not offer significant benefit in pre-kidney transplant evaluation: A retrospective cohort study. PLoS One 2020;15:e0240912. [PMID: 33113550 DOI: 10.1371/journal.pone.0240912] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 241 |
Wong G, Marsh J, Howell M, Lim WH, Chadban S, Coates T, Hawley C, Campbell S, Larkins N, Snelling T, Allan L, Teixeira-Pinto A, Reidlinger D, Wyburn K, Craig JC. Screening and Management Practices for Polyoma (BK) Viremia and Nephropathy in Kidney Transplant Recipients From the Lands Down Under: Addressing the Unknowns and Rationale for a Multicenter Clinical Trial. Kidney Int Rep 2020;5:1777-80. [PMID: 33102970 DOI: 10.1016/j.ekir.2020.06.038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 242 |
Gielis EM, Ledeganck KJ, Dendooven A, Meysman P, Beirnaert C, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation. Nephrol Dial Transplant 2020;35:714-21. [PMID: 31106364 DOI: 10.1093/ndt/gfz091] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 243 |
Boucquemont J, Foucher Y, Masset C, Legendre C, Scemla A, Buron F, Morelon E, Garrigue V, Pernin V, Albano L, Sicard A, Girerd S, Ladrière M, Giral M, Dantal J; DIVAT consortium. Induction therapy in kidney transplant recipients: Description of the practices according to the calendar period from the French multicentric DIVAT cohort. PLoS One 2020;15:e0240929. [PMID: 33091057 DOI: 10.1371/journal.pone.0240929] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 244 |
Ferrari C, Lavelli V, Santo G, Frugis MT, Iuele F, Rubini G, Sardaro A. 18F-Fluorocholine PET/CT, Tc-99m-MIBI and TC-99m-MDP SPECT/CT in Tertiary Hyperparathyroidism with Renal Osteodystrophy. Diagnostics (Basel) 2020;10:E851. [PMID: 33092198 DOI: 10.3390/diagnostics10100851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 245 |
Jeong R, Quinn RR, Lentine KL, Ravani P, Ye F, Campbell P, Wen K, Broscheit C, Gourishankar S, Lam NN. Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin. Can J Kidney Health Dis 2020;7:2054358120964061. [PMID: 33117549 DOI: 10.1177/2054358120964061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 246 |
Cohen-Bucay A, Ramirez-Andrade SE, Gordon CE, Francis JM, Chitalia VC. Advances in BK Virus Complications in Organ Transplantation and Beyond. Kidney Med 2020;2:771-86. [PMID: 33319201 DOI: 10.1016/j.xkme.2020.06.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 247 |
Jacoby F, Tim H, Zeier M, Delecluse S. All-cause and cancer-specific overall survival in kidney transplant recipients with pre-transplant malignancies in a German cohort. Journal of Onco-Nephrology 2020;4:171-178. [DOI: 10.1177/2399369320964816] [Reference Citation Analysis]
|
| 248 |
Heimgartner N, Graf N, Frey D, Saleh L, Wüthrich RP, Bonani M. Predictive Power of Bone Turnover Biomarkers to Estimate Bone Mineral Density after Kidney Transplantation with or without Denosumab: A post hoc Analysis of the POSTOP Study. Kidney Blood Press Res 2020;45:758-67. [PMID: 32998144 DOI: 10.1159/000510565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 249 |
Zhu L, Shu H, Li H, Qiu T, Zhou J, Chen G. Slow Recovery from Critical Coronavirus Disease 2019 Pneumonia in an Immunosuppressed Renal Transplant Recipient with Early Acute Cardiorenal Syndrome. Cardiorenal Med 2020;10:470-5. [PMID: 32987381 DOI: 10.1159/000510916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 250 |
Busque S, Scandling JD, Lowsky R, Shizuru J, Jensen K, Waters J, Wu HH, Sheehan K, Shori A, Choi O, Pham T, Fernandez Vina MA, Hoppe R, Tamaresis J, Lavori P, Engleman EG, Meyer E, Strober S. Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal. Sci Transl Med 2020;12:eaax8863. [PMID: 31996467 DOI: 10.1126/scitranslmed.aax8863] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 251 |
Schaenman J, Phonphok K, Spanuchart I, Duong T, Sievers TM, Lum E, Reed EF, Bunnapradist S. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transpl Infect Dis 2021;23:e13457. [PMID: 32892447 DOI: 10.1111/tid.13457] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 252 |
Clari R, Tarella C, Giraudi R, Torazza MC, Gallo E, Lavacca A, Fop F, Mella A, Dolla C, Biancone L. Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome. Clin Kidney J 2021;14:317-24. [PMID: 33564434 DOI: 10.1093/ckj/sfaa105] [Reference Citation Analysis]
|
| 253 |
Arnol M, Naumovic R, Dimitrov EP, Racki S, Bucsa CA, Covic A, Mitic I, Vavic N, Radovanovic RMV, Zibar L, Bizilj S, Erculj V, Missoni TS, Stupica KT, Knotek M. Immunosuppressive regimens following kidney transplantation in five European countries: The observational RECORD study. Transplantation Reports 2020;5:100061. [DOI: 10.1016/j.tpr.2020.100061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 254 |
Niazkhani Z, Fereidoni M, Rashidi Khazaee P, Shiva A, Makhdoomi K, Georgiou A, Pirnejad H. Translation of evidence into kidney transplant clinical practice: managing drug-lab interactions by a context-aware clinical decision support system. BMC Med Inform Decis Mak 2020;20:196. [PMID: 32819359 DOI: 10.1186/s12911-020-01196-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 255 |
Mcevoy CM, Clotet-freixas S, Tokar T, Pastrello C, Reid S, Batruch I, Raopeters AA, Kaths JM, Urbanellis P, Farkona S, Van JA, Urquhart BL, John R, Jurisica I, Robinson LA, Selzner M, Konvalinka A. Normothermic Ex-vivo Kidney Perfusion in a Porcine Auto-Transplantation Model Preserves the Expression of Key Mitochondrial Proteins: An Unbiased Proteomics Analysis.. [DOI: 10.1101/2020.08.17.253252] [Reference Citation Analysis]
|
| 256 |
Imran Ali S, Ali B, Hussain J, Hussain M, Satti FA, Park GH, Lee S. Cost-Sensitive Ensemble Feature Ranking and Automatic Threshold Selection for Chronic Kidney Disease Diagnosis. Applied Sciences 2020;10:5663. [DOI: 10.3390/app10165663] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 257 |
Kamar N, Lepage B, Couzi L, Albano L, Durrbach A, Pernin V, Esposito L, Hebral AL, Darres A, Lequintrec M, Cassuto E, Merville P, Congy N, Del Bello A. A Randomized Prospective Study Comparing Anti-T-Lymphocyte Igs to Basiliximab in Highly Sensitized Kidney Transplant Patients. Kidney Int Rep 2020;5:1207-17. [PMID: 32775820 DOI: 10.1016/j.ekir.2020.05.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 258 |
Korytowska N, Pytlak B, Niemczyk M. PRZEWLEKŁA CHOROBA NEREK ORAZ WYBRANE ASPEKTY MONITOROWANIA STANU BIORCÓW NERKI. pps 2020;18:27-39. [DOI: 10.56782/pps.14] [Reference Citation Analysis]
|
| 259 |
Kinoshita Y, Yagisawa T, Sugihara T, Hara K, Takeshima S, Kubo T, Shinzato T, Shimizu T, Suzuki M, Maeshima A, Kamei J, Fujisaki A, Ando S, Kume H, Fujimura T. Clinical outcomes in donors and recipients of kidney transplantations involving medically complex living donors - a retrospective study.Transpl Int. 2020;33:1417-1423. [PMID: 32654198 DOI: 10.1111/tri.13699] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 260 |
Veenhof H, Schouw HM, Besouw MTP, Touw DJ, Gracchi V. Flucloxacillin decreases tacrolimus blood trough levels: a single-center retrospective cohort study. Eur J Clin Pharmacol 2020;76:1667-73. [PMID: 32712713 DOI: 10.1007/s00228-020-02968-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 261 |
Suwelack B, Bunnapradist S, Meier-Kriesche U, Stevens DR, Procaccianti C, Morganti R, Budde K. Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial. Ann Transplant 2020;25:e923278. [PMID: 32719307 DOI: 10.12659/AOT.923278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 262 |
Shen T, Zhuang L, Sun XD, Qi XS, Wang ZH, Li RD, Chang WX, Yang JY, Yang Y, Zheng SS, Xu X. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol 2020; 26(27): 3851-3864 [PMID: 32774062 DOI: 10.3748/wjg.v26.i27.3851] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 263 |
Lees JS, Mangion K, Rutherford E, Witham MD, Woodward R, Roditi G, Hopkins T, Brooksbank K, Jardine AG, Mark PB. Vitamin K for kidney transplant organ recipients: investigating vessel stiffness (ViKTORIES): study rationale and protocol of a randomised controlled trial. Open Heart 2020;7. [PMID: 32675297 DOI: 10.1136/openhrt-2019-001070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 264 |
van de Kuit A, Benjamens S, Sotomayor CG, Rijkse E, Berger SP, Moers C, Bakker SJL, Minnee RC, Yakar D, Pol RA. Postoperative Ultrasound in Kidney Transplant Recipients: Association Between Intrarenal Resistance Index and Cardiovascular Events. Transplant Direct 2020;6:e581. [PMID: 33134505 DOI: 10.1097/TXD.0000000000001034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 265 |
Low S, Chua HR, Wong R, Goh A, Ng YH, Teo BW, Vathsala A. Myocardial ischemia by radionuclide imaging and long-term outcomes after kidney transplantation. Int Urol Nephrol 2020;52:1995-2003. [PMID: 32661630 DOI: 10.1007/s11255-020-02542-7] [Reference Citation Analysis]
|
| 266 |
Thongprayoon C, Hansrivijit P, Kovvuru K, Kanduri SR, Bathini T, Pivovarova A, Smith JR, Cheungpasitporn W. Impacts of High Intra- and Inter-Individual Variability in Tacrolimus Pharmacokinetics and Fast Tacrolimus Metabolism on Outcomes of Solid Organ Transplant Recipients. J Clin Med 2020;9:E2193. [PMID: 32664531 DOI: 10.3390/jcm9072193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 267 |
Gustavsen MT, Midtvedt K, Robertsen I, Woillard JB, Debord J, Klaasen RA, Vethe NT, Bergan S, Åsberg A. Fasting Status and Circadian Variation Must be Considered When Performing AUC-based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients. Clin Transl Sci 2020;13:1327-35. [PMID: 32652886 DOI: 10.1111/cts.12833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 268 |
Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S, Chen Z, Chen G. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am J Transplant 2020;20:1859-63. [PMID: 32181990 DOI: 10.1111/ajt.15869] [Cited by in Crossref: 223] [Cited by in F6Publishing: 240] [Article Influence: 74.3] [Reference Citation Analysis]
|
| 269 |
Lim CC, Gardner D, Ng RZ, Chin YM, Tan HZ, Mok IY, Choo JC. Synergistic impact of pre-diabetes and immunosuppressants on the risk of diabetes mellitus during treatment of glomerulonephritis and renal vasculitis. Kidney Res Clin Pract 2020;39:172-9. [PMID: 32541094 DOI: 10.23876/j.krcp.20.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 270 |
Hisadome Y, Noguchi H, Nakafusa Y, Sakihama K, Mei T, Kaku K, Okabe Y, Masutani K, Ohara Y, Ikeda K, Oda Y, Nakamura M. Association of Pretransplant BK Polyomavirus Antibody Status with BK Polyomavirus Infection After Kidney Transplantation: A Prospective Cohort Pilot Study of 47 Transplant Recipients. Transplant Proc 2020;52:1762-8. [PMID: 32611487 DOI: 10.1016/j.transproceed.2020.01.164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 271 |
Osako K, Yazawa M, Terashita M, Imai N, Nakazawa R, Sasaki H, Shibagaki Y. Arteriovenous fistulas after ultrasound-guided needle biopsy of kidney allografts and treatment outcomes after transcatheter embolization: A single-center experience in Japan. Clin Exp Nephrol 2020;24:963-70. [PMID: 32594374 DOI: 10.1007/s10157-020-01922-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 272 |
Perri A, Izzo G, Lofaro D, La Vignera S, Brunetti A, Calogero AE, Aversa A. Erectile Dysfunction after Kidney Transplantation. J Clin Med 2020;9:E1991. [PMID: 32630390 DOI: 10.3390/jcm9061991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 273 |
Albitar O, Ballouze R, Harun SN, Mohamed Noor DA, Sheikh Ghadzi SM. Population Pharmacokinetic Modeling of Cyclosporine Among Malaysian Renal Transplant Patients: An Evaluation of Methods to Handle Missing Doses in Conventional Drug-Monitoring Data. J Clin Pharmacol 2020;60:1474-82. [PMID: 32557653 DOI: 10.1002/jcph.1670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 274 |
Kluch M, Kurnatowska I, Matera K, Łokieć K, Puzio T, Czkwianianc E, Grzelak P. Nutrition Trends in Patients Over the Long Term After Kidney Transplantation. Transplant Proc 2020;52:2357-62. [PMID: 32571697 DOI: 10.1016/j.transproceed.2019.12.055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 275 |
Tantisattamo E, Molnar MZ, Ho BT, Reddy UG, Dafoe DC, Ichii H, Ferrey AJ, Hanna RM, Kalantar-Zadeh K, Amin A. Approach and Management of Hypertension After Kidney Transplantation. Front Med (Lausanne) 2020;7:229. [PMID: 32613001 DOI: 10.3389/fmed.2020.00229] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 276 |
Chen J, Perez R, de Mattos AM, Wang C, Li Z, Applegate RL 2nd, Liu H. Perioperative Dexmedetomidine Improves Outcomes of Kidney Transplant. Clin Transl Sci 2020;13:1279-87. [PMID: 32506659 DOI: 10.1111/cts.12826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 277 |
Infante B, Rossini M, Di Lorenzo A, Coviello N, Giuseppe C, Gesualdo L, Giuseppe G, Stallone G. Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy. Clin Kidney J 2020;13:758-67. [PMID: 33123355 DOI: 10.1093/ckj/sfaa060] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 278 |
Ambarsari CG, Hidayati EL, Hasan I, Grace A, Oswari H. Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series. Int J Nephrol Renovasc Dis 2020;13:139-46. [PMID: 32606888 DOI: 10.2147/IJNRD.S248632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 279 |
McGillicuddy JW, Chandler JL, Sox LR, Taber DJ. Exploratory Analysis of the Impact of an mHealth Medication Adherence Intervention on Tacrolimus Trough Concentration Variability: Post Hoc Results of a Randomized Controlled Trial. Ann Pharmacother 2020;54:1185-93. [PMID: 32506922 DOI: 10.1177/1060028020931806] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 280 |
Roháľ T. Patient after kidney transplantation in outpatient internal clinic. Vnitr Lek 2020;66:e17-e21. [DOI: 10.36290/vnl.2020.075] [Reference Citation Analysis]
|
| 281 |
Kim JE, Min SI, Lee H, Ha J, Kim YS, Han SS. Risk of Graft Failure in Kidney Recipients with Cured Post-Transplant Cancer. J Korean Med Sci 2020;35:e166. [PMID: 32449324 DOI: 10.3346/jkms.2020.35.e166] [Reference Citation Analysis]
|
| 282 |
Aleksic S, Eisenberg R, Tsomos E, Zahedpour Anaraki S, Japp E, Upadhyay L, Mowrey WB, Akalin E, Zonszein J. Glycemic management and clinical outcomes in underserved minority kidney transplant recipients with type 2 and posttransplantation diabetes: A single-center retrospective study. Diabetes Res Clin Pract 2020;165:108221. [PMID: 32442553 DOI: 10.1016/j.diabres.2020.108221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 283 |
Selistre LDS, Lemoine S, Dantec A, Buron F, de Souza VC, Bertoldo M, Poli-de-Figueiredo CE, Rimmelé T, Thaunat O, Badet L, Morelon E, Sicard A, Dubourg L. Comparison of creatinine-based equations for estimating glomerular filtration rate in deceased donor renal transplant recipients. PLoS One 2020;15:e0231873. [PMID: 32343691 DOI: 10.1371/journal.pone.0231873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 284 |
Vadcharavivad S, Saengram W, Phupradit A, Poolsup N, Chancharoenthana W. Once-Daily versus Twice-Daily Tacrolimus in Kidney Transplantation: A Systematic Review and Meta-analysis of Observational Studies. Drugs 2019;79:1947-62. [PMID: 31713065 DOI: 10.1007/s40265-019-01217-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 285 |
Byrne A, Bush R, Johns F, Upadhyay K. Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation. Medicines 2020;7:21. [DOI: 10.3390/medicines7040021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 286 |
Bădulescu MR, Socaciu MA, Moisoiu T, Andries A, Iacob G, Badea R. Current status of imaging diagnosis in the transplanted kidney. A review of the literature with a special focus on contrast-enhanced ultrasonography. Med Pharm Rep 2020;93:133-44. [PMID: 32478319 DOI: 10.15386/mpr-1536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 287 |
Thongprayoon C, Hansrivijit P, Leeaphorn N, Acharya P, Torres-Ortiz A, Kaewput W, Kovvuru K, Kanduri SR, Bathini T, Cheungpasitporn W. Recent Advances and Clinical Outcomes of Kidney Transplantation. J Clin Med 2020;9:E1193. [PMID: 32331309 DOI: 10.3390/jcm9041193] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 288 |
Maenaka A, Kenta I, Ota A, Miwa Y, Ohashi W, Horimi K, Matsuoka Y, Ohnishi M, Uchida K, Kobayashi T. Interferon-γ-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase. FEBS Open Bio 2020;10:927-36. [PMID: 32237049 DOI: 10.1002/2211-5463.12854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 289 |
Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transplant 2019;34:914-20. [PMID: 30260424 DOI: 10.1093/ndt/gfy262] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 290 |
Bae H, Na DH, Chang JY, Park KH, Min JW, Ko EJ, Lee H, Yang CW, Chung BH, Oh EJ. Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients. Korean J Intern Med 2021;36:164-74. [PMID: 32241081 DOI: 10.3904/kjim.2019.339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 291 |
Albatati S, Sharma A, Haubrich K, Wright A, Gantt S, Blydt-Hansen TD. Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients. Pediatr Res 2020;87:892-6. [PMID: 31377753 DOI: 10.1038/s41390-019-0523-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 292 |
Werbel WA, Durand CM. Solid Organ Transplantation in HIV-Infected Recipients: History, Progress, and Frontiers. Curr HIV/AIDS Rep 2019;16:191-203. [PMID: 31093920 DOI: 10.1007/s11904-019-00440-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 293 |
Said MY, Post A, Minović I, van Londen M, van Goor H, Postmus D, Heiner-Fokkema MR, van den Berg E, Pasch A, Navis G, Bakker SJL. Urinary sulfate excretion and risk of late graft failure in renal transplant recipients - a prospective cohort study. Transpl Int 2020;33:752-61. [PMID: 32112582 DOI: 10.1111/tri.13600] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 294 |
Ravaioli M, Maroni L, Angeletti A, Fallani G, De Pace V, Germinario G, Odaldi F, Corradetti V, Caraceni P, Baldassarre M, Vasuri F, D'Errico A, Sangiorgi G, Siniscalchi A, Morelli MC, Rossetto A, Ranieri VM, Cescon M, Del Gaudio M, Zanfi C, Bertuzzo V, Comai G, La Manna G. Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Expanded Criteria Donors in Liver and Kidney Transplantation: Protocol for a Single-Center Randomized Controlled Trial. JMIR Res Protoc 2020;9:e13922. [PMID: 32191209 DOI: 10.2196/13922] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 295 |
Sofue T. Renal Rehabilitation in Kidney Transplant Recipients. Jpn J Rehabil Med 2020;57:221-226. [DOI: 10.2490/jjrmc.57.221] [Reference Citation Analysis]
|
| 296 |
de Lucena DD, de Sá JR, Medina-Pestana JO, Rangel ÉB. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. J Diabetes Res 2020;2020:1938703. [PMID: 32258163 DOI: 10.1155/2020/1938703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 297 |
Зыблев С, Зыблева С. Induction Immunosupression with Anti-CD Antibodies and Immune Status of Kidney Transplant Recipients. Рецепт 2020. [DOI: 10.34883/pi.2020.23.1.004] [Reference Citation Analysis]
|
| 298 |
Okada M, Okada K, Kubo Y, Nakamura R, Fujiwara T, Matsuura M. A case of pulmonary cryptococcosis diagnosed by excisional biopsy in a renal transplant recipient. The Journal of the Japanese Association for Chest Surgery 2020;34:130-136. [DOI: 10.2995/jacsurg.34.130] [Reference Citation Analysis]
|
| 299 |
Ali H, Soliman KM, Shaheen I, Kim JJ, Kossi ME, Sharma A, Pararajasingam R, Halawa A. Rabbit anti-thymocyte globulin (rATG) vs IL-2 receptor antagonist induction therapies in tacrolimus-based immunosuppression era: a meta-analysis.Int Urol Nephrolog. 2020;52: 791-802. [PMID: 32170593 DOI: 10.1007/s11255-020-02418-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 300 |
Kim YH, Kim JY, Kim DH, Ko Y, Choi JY, Shin S, Jung JH, Park SK, Kim SH, Kwon H, Han DJ. Pneumocystis pneumonia occurrence and prophylaxis duration in kidney transplant recipients according to perioperative treatment with rituximab. BMC Nephrol 2020;21:93. [PMID: 32160881 DOI: 10.1186/s12882-020-01750-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 301 |
Capiau S, Veenhof H, Koster RA, Bergqvist Y, Boettcher M, Halmingh O, Keevil BG, Koch BCP, Linden R, Pistos C, Stolk LM, Touw DJ, Stove CP, Alffenaar JC. Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug Monitoring. Ther Drug Monit 2019;41:409-30. [PMID: 31268966 DOI: 10.1097/FTD.0000000000000643] [Cited by in Crossref: 108] [Cited by in F6Publishing: 93] [Article Influence: 36.0] [Reference Citation Analysis]
|
| 302 |
Chen YX, Li R, Gu L, Xu KY, Liu YZ, Zhang RW. Prognostic Performance of SOFA, qSOFA, and SIRS in Kidney Transplant Recipients Suffering from Infection: A Retrospective Observational Study. Adv Ther 2020;37:1100-13. [PMID: 31981104 DOI: 10.1007/s12325-020-01225-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 303 |
Arabi Z, Ghalib B, Asmari I, Gafar M, Alam S, Abdulgadir M, AlShareef A, Rashidi A, Alruwaymi M, Altheaby A. Instructions for kidney recipients and donors (In English for medical providers and in Arabic for patients and donors). Avicenna J Med 2020;10:41-53. [PMID: 32110549 DOI: 10.4103/ajm.ajm_120_19] [Reference Citation Analysis]
|
| 304 |
Haninger-Vacariu N, Herkner H, Lorenz M, Säemann M, Vychytil A, Jansen M, Marculescu R, Kramar R, Sunder-Plassmann G, Schmidt A. Exclusion of pregnancy in dialysis patients: diagnostic performance of human chorionic gonadotropin. BMC Nephrol 2020;21:70. [PMID: 32111190 DOI: 10.1186/s12882-020-01729-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 305 |
Veenhof H, van Boven JFM, van der Voort A, Berger SP, Bakker SJL, Touw DJ. Effects, costs and implementation of monitoring kidney transplant patients' tacrolimus levels with dried blood spot sampling: A randomized controlled hybrid implementation trial. Br J Clin Pharmacol 2020;86:1357-66. [PMID: 32077134 DOI: 10.1111/bcp.14249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 306 |
Krajewski W, Kamińska D, Poterek A, Małkiewicz B, Kłak J, Zdrojowy R, Janczak D. Pathogenicity of BK virus on the urinary system. Cent European J Urol 2020;73:94-103. [PMID: 32395331 DOI: 10.5173/ceju.2020.0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 307 |
Hennes AJ, Holdener KE, Burlingham WJ, Mandelbrot DA, Parajuli S, Mohamed MA, Garg N, Aziz F, Astor BC, Djamali A. Mycophenolate Monotherapy in HLA-Matched Kidney Transplant Recipients: A Case Series of 20 Patients. Transplant Direct 2020;6:e526. [PMID: 32095512 DOI: 10.1097/TXD.0000000000000961] [Reference Citation Analysis]
|
| 308 |
Jänigen BM, Gehrmann S, Glatz T, Seidl M, Thomusch O, Prager EP, Zschiedrich S, Fichtner-Feigl S, Pisarski P, Schneider J. Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot Study. Transplant Proc 2020;52:780-4. [PMID: 32111386 DOI: 10.1016/j.transproceed.2020.01.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 309 |
Schmid-Mohler G, Zala P, Graf N, Witschi P, Mueller TF, Peter Wüthrich R, Huber L, Fehr T, Spirig R. Comparison of a Behavioral Versus an Educational Weight Management Intervention After Renal Transplantation: A Randomized Controlled Trial. Transplant Direct 2019;5:e507. [PMID: 32095502 DOI: 10.1097/TXD.0000000000000936] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 310 |
Ahmed SH, Biddle K, Augustine T, Azmi S. Post-Transplantation Diabetes Mellitus. Diabetes Ther. 2020;11:779-801. [PMID: 32095994 DOI: 10.1007/s13300-020-00790-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 311 |
Cooper JE. Evaluation and Treatment of Acute Rejection in Kidney Allografts. Clin J Am Soc Nephrol 2020;15:430-8. [PMID: 32066593 DOI: 10.2215/CJN.11991019] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 312 |
Zuziela MA, Vidal J, Knorr JP. Evaluating Factors Associated With Blood Pressure Control in the Early Post-Kidney Transplant Period. Hosp Pharm 2021;56:359-67. [PMID: 34381275 DOI: 10.1177/0018578720906614] [Reference Citation Analysis]
|
| 313 |
Osté MCJ, Flores-Guerrero JL, Gruppen EG, Kieneker LM, Connelly MA, Otvos JD, Dullaart RPF, Bakker SJL. High Plasma Branched-Chain Amino Acids Are Associated with Higher Risk of Post-Transplant Diabetes Mellitus in Renal Transplant Recipients. J Clin Med 2020;9:E511. [PMID: 32069900 DOI: 10.3390/jcm9020511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 314 |
Warren H, Olsburgh J. Management of Renal Cell Carcinoma and Other Renal Masses in the Kidney Graft. Curr Urol Rep 2020;21:8. [PMID: 32048068 DOI: 10.1007/s11934-020-0959-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 315 |
Ni X, Wang W, Li X, Li Y, Chen J, Shi D, Wen J. Utility of Diffusion-Weighted Imaging for Guiding Clinical Management of Patients With Kidney Transplant: A Prospective Study. J Magn Reson Imaging 2020;52:565-74. [PMID: 32030832 DOI: 10.1002/jmri.27071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 316 |
Zheng H, Bu S, Song Y, Wang M, Wu J, Chen J. To Ligate or Not to Ligate: A Meta-analysis of Cardiac Effects and Allograft Function following Arteriovenous Fistula Closure in Renal Transplant Recipients. Annals of Vascular Surgery 2020;63:287-92. [DOI: 10.1016/j.avsg.2019.06.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 317 |
Lim C, Wong M, Koh H, Mok I, Chin Y, Choo J. Methylprednisolone and greater proteinuria predispose older adults with glomerulonephritis to new onset diabetes mellitus. Diabetes & Metabolism 2020;46:70-72. [DOI: 10.1016/j.diabet.2018.02.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 318 |
Garofalo M, Pisani F, Lai Q, Montali F, Nudo F, Gaeta A, Russo G, Natilli A, Poli L, Martinelli C, Binda B, Pretagostini R. Viremia Negativization After BK Virus Infection in Kidney Transplantation: A National Bicentric Study. Transplant Proc 2019;51:2936-8. [PMID: 31711578 DOI: 10.1016/j.transproceed.2019.04.091] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 319 |
Bover J, Ureña-Torres P, Mateu S, DaSilva I, Gràcia S, Sánchez-Baya M, Arana C, Fayos L, Guirado L, Cozzolino M. Evidence in chronic kidney disease-mineral and bone disorder guidelines: is it time to treat or time to wait? Clin Kidney J 2020;13:513-21. [PMID: 32905295 DOI: 10.1093/ckj/sfz187] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 320 |
Kaviani A, Ince D, Axelrod DA. Management of Antimicrobial Agents in Abdominal Organ Transplant Patients in Intensive Care Unit. Curr Transplant Rep 2020;7:1-11. [PMID: 32432022 DOI: 10.1007/s40472-020-00268-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 321 |
Thölking G, Gillhaus NH, Schütte-Nütgen K, Pavenstädt H, Koch R, Suwelack B, Reuter S. Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers After Renal Transplantation. J Clin Med 2020;9:E328. [PMID: 31979381 DOI: 10.3390/jcm9020328] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 322 |
Flothow DJG, Suwelack B, Pavenstädt H, Schütte-Nütgen K, Reuter S. The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients. J Clin Med 2020;9:E258. [PMID: 31963650 DOI: 10.3390/jcm9010258] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 323 |
Jehn U, Schütte-Nütgen K, Bautz J, Pavenstädt H, Suwelack B, Thölking G, Heinzow H, Reuter S. Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation. J Clin Med 2020;9:E252. [PMID: 31963515 DOI: 10.3390/jcm9010252] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 324 |
Oberbauer R, Bestard O, Furian L, Maggiore U, Pascual J, Rostaing L, Budde K. Optimization of tacrolimus in kidney transplantation: New pharmacokinetic perspectives. Transplant Rev (Orlando) 2020;34:100531. [PMID: 31955920 DOI: 10.1016/j.trre.2020.100531] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 325 |
Van Laecke S, Abramowicz D. Cardiovascular disease in kidney transplant recipients: leave no stone unturned. Nephrol Dial Transplant 2019;34:727-30. [PMID: 31062030 DOI: 10.1093/ndt/gfz084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 326 |
Gomes-Neto AW, Osté MCJ, Sotomayor CG, van den Berg E, Geleijnse JM, Berger SP, Gans ROB, Bakker SJL, Navis GJ. Mediterranean Style Diet and Kidney Function Loss in Kidney Transplant Recipients. Clin J Am Soc Nephrol 2020;15:238-46. [PMID: 31896540 DOI: 10.2215/CJN.06710619] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 327 |
Pieloch D. Kidney Transplantation. Nutrition in Kidney Disease 2020. [DOI: 10.1007/978-3-030-44858-5_18] [Reference Citation Analysis]
|
| 328 |
Delecluse S. Maligne Erkrankungen bei chronischer Niereninsuffizienz. Onko-Nephrologie 2020. [DOI: 10.1007/978-3-662-59911-2_23] [Reference Citation Analysis]
|
| 329 |
Jain SR, Kumar D. Vaccination Strategies in Solid Organ and Stem Cell Transplant. Emerging Transplant Infections 2020. [DOI: 10.1007/978-3-030-01751-4_11-1] [Reference Citation Analysis]
|
| 330 |
Schlosser M, Foller S, Grimm M, Wolf G. Nierentransplantation. Elsevier Essentials Nephrologie 2020. [DOI: 10.1016/b978-3-437-21691-6.00011-6] [Reference Citation Analysis]
|
| 331 |
Marcotte LM, Powell H. Preventive Health in the Adult Solid Organ Transplant Recipient. Primary Care of the Solid Organ Transplant Recipient 2020. [DOI: 10.1007/978-3-030-50629-2_12] [Reference Citation Analysis]
|
| 332 |
Baek CH. Postoperative Management. Kidney Transplantation in Sensitized Patients 2020. [DOI: 10.1007/978-981-10-7046-4_5] [Reference Citation Analysis]
|
| 333 |
Delecluse S. Tumorerkrankungen nach solider Organtransplantation. Onko-Nephrologie 2020. [DOI: 10.1007/978-3-662-59911-2_24] [Reference Citation Analysis]
|
| 334 |
Hernández-estrada S. Nivel de la tasa de filtrado glomerular para iniciar el protocolo de trasplante, evaluación de urolitiasis, proteinuria y hematuria en el receptor de trasplante renal. Revista Mexicana de Trasplantes 2020;9:35-40. [DOI: 10.35366/93483] [Reference Citation Analysis]
|
| 335 |
Ban TH, Park WY, Jin K, Han S, Chung BH, Park SC, Choi BS, Park CW, Yun SS, Kim YS, Yang CW. Changing pattern and safety of pretransplant malignancy in kidney transplant recipients. Kidney Res Clin Pract 2019;38:509-16. [PMID: 31640307 DOI: 10.23876/j.krcp.19.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 336 |
de Ferranti SD, Steinberger J, Ameduri R, Baker A, Gooding H, Kelly AS, Mietus-Snyder M, Mitsnefes MM, Peterson AL, St-Pierre J, Urbina EM, Zachariah JP, Zaidi AN. Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association. Circulation 2019;139:e603-34. [PMID: 30798614 DOI: 10.1161/CIR.0000000000000618] [Cited by in Crossref: 141] [Cited by in F6Publishing: 149] [Article Influence: 35.3] [Reference Citation Analysis]
|
| 337 |
Olenski S, Scuderi C, Choo A, Bhagat Singh AK, Way M, Jeyaseelan L, John G. Urinary tract infections in renal transplant recipients at a quaternary care centre in Australia. BMC Nephrol 2019;20:479. [PMID: 31881863 DOI: 10.1186/s12882-019-1666-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 338 |
Bae S, Garonzik Wang JM, Massie AB, Jackson KR, McAdams-DeMarco MA, Brennan DC, Lentine KL, Coresh J, Segev DL. Early Steroid Withdrawal in Deceased-Donor Kidney Transplant Recipients with Delayed Graft Function. J Am Soc Nephrol 2020;31:175-85. [PMID: 31852720 DOI: 10.1681/ASN.2019040416] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 339 |
Hahn D, Hodson EM, Hamiwka LA, Lee VW, Chapman JR, Craig JC, Webster AC. Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients. Cochrane Database Syst Rev 2019;12:CD004290. [PMID: 31840244 DOI: 10.1002/14651858.CD004290.pub3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 340 |
Maldonado AQ, Hall RC, Pilch NA, Ensor CR, Anders S, Gilarde JA, Tichy EM. ASHP Guidelines on Pharmacy Services in Solid Organ Transplantation. American Journal of Health-System Pharmacy 2020;77:222-32. [DOI: 10.1093/ajhp/zxz291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 341 |
Zhang J, Chen GD, Qiu J, Liu GC, Chen LZ, Fu K, Wu ZX. Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies. BMC Nephrol 2019;20:446. [PMID: 31796001 DOI: 10.1186/s12882-019-1628-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 342 |
Kincaide E, Hitchman K, Hall R, Yamaguchi I, Ding Y, Crowther B. Impact of active antibody-mediated rejection treatment on donor-specific antibodies in pediatric kidney transplant recipients. Pediatr Transplant 2019;23:e13590. [PMID: 31617318 DOI: 10.1111/petr.13590] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 343 |
Bittermann T, Hubbard RA, Lewis JD, Goldberg DS. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes. Am J Transplant 2019;19:3319-27. [PMID: 31243887 DOI: 10.1111/ajt.15513] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 344 |
Larpparisuth N, Skulratanasak P, Premasathian N, Vongwiwatana A. Efficacy of Bortezomib as an Adjunctive Therapy for Refractory Chronic Active Antibody-Mediated Rejection in Kidney Transplant Patients: A Single-Center Experience. Transplantation Proceedings 2019;51:3293-6. [DOI: 10.1016/j.transproceed.2019.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 345 |
Yao J, Jiang L, Xue D, Sun Y. Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients. Exp Ther Med 2019;18:4603-8. [PMID: 31777558 DOI: 10.3892/etm.2019.8113] [Reference Citation Analysis]
|
| 346 |
Favi E, James A, Puliatti C, Whatling P, Ferraresso M, Rui C, Cacciola R. Utility and safety of early allograft biopsy in adult deceased donor kidney transplant recipients. Clin Exp Nephrol 2020;24:356-68. [PMID: 31768863 DOI: 10.1007/s10157-019-01821-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 347 |
Zheng X, Gong L, Xue W, Zeng S, Xu Y, Zhang Y, Hu X. Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis. AIDS Res Ther 2019;16:37. [PMID: 31747972 DOI: 10.1186/s12981-019-0253-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 348 |
Arreola-Guerra JM, Alberú J, Chew-Wong A, Macias DM, Hernández-Rosales J, Zuñiga-Macías L, Delgadillo-Castañeda R, Ricalde-Ríos G, Haro-Alcalde F, Villafán-Bernal JR, Ramos-Medellín CL, Reyes-Acevedo R. Changes in the commercial brand of tacrolimus lead to subtherapeutic trough levels and acute rejection in renal transplant recipients. Clin Transplant 2019;33:e13749. [PMID: 31691354 DOI: 10.1111/ctr.13749] [Reference Citation Analysis]
|
| 349 |
Usta M, Ersoy A, Ayar Y. Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients. Turkish Journal of Internal Medicine 2019;1:21-25. [DOI: 10.46310/tjim.632066] [Reference Citation Analysis]
|
| 350 |
Palmer SC, Chung EY, McGregor DO, Bachmann F, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev 2019;10:CD005015. [PMID: 31637698 DOI: 10.1002/14651858.CD005015.pub4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 351 |
Ghareeb M, Gohh RY, Akhlaghi F. Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations. Clin Pharmacokinet 2018;57:1199-210. [PMID: 29330784 DOI: 10.1007/s40262-017-0626-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 352 |
Le Gal S, Toubas D, Totet A, Dalle F, Abou Bacar A, Le Meur Y, Nevez G, Accoceberry I, Bailly E, Bellanger AP, Bonhomme J, Cateau E, Candolfi E, Damiani C, Dannaoui E, Dardé M, Debourgogne A, Delhaes L, Desoubeaux G, Favennec L, Flori P, Gabriel F, Iriart X, Lachaud L, Leterrier M, Le Pape P, Machouard M, Marty P, Maubon D, Millon L, Pomares C, Pons D, Rodier M; Anofel Association. Pneumocystis Infection Outbreaks in Organ Transplantation Units in France: A Nation-Wide Survey. Clinical Infectious Diseases 2020;70:2216-20. [DOI: 10.1093/cid/ciz901] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 353 |
Dakroub F, Touzé A, Akl H, Brochot E. Pre-Transplantation Assessment of BK Virus Serostatus: Significance, Current Methods, and Obstacles. Viruses 2019;11:E945. [PMID: 31615131 DOI: 10.3390/v11100945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 354 |
Liu W, Wang K, Zhao YH, Song GP, Gao W, Li DH. Clinical relevance of a CD4+ T cell immune function assay in the diagnosis of infection in pediatric living-donor liver transplantation. Exp Ther Med 2019;18:3823-8. [PMID: 31602249 DOI: 10.3892/etm.2019.8003] [Reference Citation Analysis]
|
| 355 |
Hultin S, M. Hawley C, W. Johnson D, S. Francis R. Perioperative Care for Kidney Transplant Recipients. Perioperative Care for Organ Transplant Recipient 2019. [DOI: 10.5772/intechopen.84388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 356 |
Reigner B, Grange S, Bentley D, Banken L, Abt M, Hughes R, Scheubel E, Guentert TW. Generics in transplantation medicine: Randomized comparison of innovator and substitution products containing mycophenolate mofetil
. Int J Clin Pharmacol Ther 2019;57:506-19. [PMID: 31397274 DOI: 10.5414/CP203487] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 357 |
Montero N, Quero M, Arcos E, Comas J, Rama I, Lloberas N, Coloma A, Meneghini M, Manonelles A, Melilli E, Bestard O, Tort J, Cruzado JM. Effects of body weight variation in obese kidney recipients: a retrospective cohort study. Clin Kidney J 2020;13:1068-76. [PMID: 33391751 DOI: 10.1093/ckj/sfz124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 358 |
Gagnon MF, Cardinal H, Emond JP, Latour M, Lemieux B. The Evolution of Monoclonal Gammopathy of Undetermined Significance in Kidney Transplant Recipients. Transplant Direct 2019;5:e489. [PMID: 31723584 DOI: 10.1097/TXD.0000000000000937] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 359 |
Gokoel SRM, Gombert-Handoko KB, Zwart TC, van der Boog PJM, Moes DJAR, de Fijter JW. Medication non-adherence after kidney transplantation: A critical appraisal and systematic review. Transplant Rev (Orlando) 2020;34:100511. [PMID: 31627978 DOI: 10.1016/j.trre.2019.100511] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 360 |
Whelan AM, Ku E. Use of ambulatory blood pressure monitoring in kidney transplant recipients. Nephrol Dial Transplant 2019;34:1437-9. [PMID: 30838404 DOI: 10.1093/ndt/gfz010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 361 |
Larpparisuth N, Pinpaiboon S, Ratchawang N, Promraj R, Skulratanasak P, Vongwiwatana A, Premasathian N. A Study of the Pharmacokinetic Comparison between the Generic and Original Form of Mycophenolate Mofetil Among Thai Renal Transplant Patients. Transplant Proc 2019;51:2629-32. [PMID: 31471014 DOI: 10.1016/j.transproceed.2019.03.063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 362 |
Toan PQ, Bao Quyen LT, Thu Hang DT, My Anh TT, Cuong LM, Lanh NS, Su HX. Identification of BK Virus Genotypes in Recipients of Renal Transplant in Vietnam. Transplant Proc 2019;51:2683-8. [PMID: 31477425 DOI: 10.1016/j.transproceed.2019.03.072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 363 |
Ong SC, Kumar V. Pregnancy in a Kidney Transplant Patient. Clin J Am Soc Nephrol 2020;15:120-2. [PMID: 31451514 DOI: 10.2215/CJN.03910319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 364 |
Migliozzi DR, Asal NJ. Clinical Controversy in Transplantation: Tacrolimus Versus Cyclosporine in Statin Drug Interactions. Ann Pharmacother 2020;54:171-7. [DOI: 10.1177/1060028019871891] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 365 |
Malhotra R, Katz R, Weiner DE, Levey AS, Cheung AK, Bostom AG, Ix JH. Blood Pressure, Chronic Kidney Disease Progression, and Kidney Allograft Failure in Kidney Transplant Recipients: A Secondary Analysis of the FAVORIT Trial. Am J Hypertens 2019;32:816-23. [PMID: 31179500 DOI: 10.1093/ajh/hpz095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 366 |
Fischman C, Fribourg M, Fabrizio G, Cioni M, Comoli P, Nocera A, Cardillo M, Cantarelli C, Gallon L, Petrosyan A, Da Sacco S, Perin L, Cravedi P. Circulating B Cells With Memory and Antibody-Secreting Phenotypes Are Detectable in Pediatric Kidney Transplant Recipients Before the Development of Antibody-Mediated Rejection. Transplant Direct 2019;5:e481. [PMID: 31579809 DOI: 10.1097/TXD.0000000000000914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 367 |
Ali H, Mohiuddin A, Sharma A, Shaheen I, Kim JJ, El Kosi M, Halawa A. Implication of interleukin-2 receptor antibody induction therapy in standard risk renal transplant in the tacrolimus era: a meta-analysis. Clin Kidney J 2019;12:592-9. [PMID: 31384453 DOI: 10.1093/ckj/sfy132] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 368 |
Blazquez-navarro A, Dang-heine C, Bauer C, Wittenbrink N, Wolk K, Sabat R, Witzke O, Westhoff TH, Sawitzki B, Reinke P, Thomusch O, Hugo C, Babel N, Or-guil M. Sex-associated differences in cytomegalovirus prevention: Prophylactic strategy is associated with a strong kidney function impairment in female renal transplant patients.. [DOI: 10.1101/726968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 369 |
Hyun H, Park E, Cho M, Min SI, Ha J, Kang HJ, Shin HY, Ha IS, Cheong HI, Ahn YH, Kang HG. Post-Transplant Lymphoproliferative Diseases in Pediatric Kidney Allograft Recipients with Epstein-Barr Virus Viremia. J Korean Med Sci 2019;34:e203. [PMID: 31373185 DOI: 10.3346/jkms.2019.34.e203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 370 |
Horie K, Tsuchiya T, Iinuma K, Maekawa Y, Nakane K, Kato T, Mizutani K, Koie T. Risk factors and incidence of malignant neoplasms after kidney transplantation at a single institution in Japan. Clin Exp Nephrol 2019;23:1323-30. [PMID: 31372795 DOI: 10.1007/s10157-019-01769-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 371 |
Alloway RR, Woodle ES, Abramowicz D, Segev DL, Castan R, Ilsley JN, Jeschke K, Somerville KT, Brennan DC. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation. Am J Transplant 2019;19:2252-61. [PMID: 30838775 DOI: 10.1111/ajt.15342] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 372 |
Cobos Jiménez V, Rabacal W, Rayens E, Norris KA. Immunization with Pneumocystis recombinant KEX1 induces robust and durable humoral responses in immunocompromised non-human primates. Hum Vaccin Immunother 2019;15:2075-80. [PMID: 31348719 DOI: 10.1080/21645515.2019.1631135] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 373 |
Pascual J, Berger SP, Chadban SJ, Citterio F, Kamar N, Hesselink DA, Legendre C, Eisenberger U, Oppenheimer F, Russ GR, Sommerer C, Rigotti P, Srinivas TR, Watarai Y, Henry ML, Vincenti F, Tedesco-Silva H. Evidence-based practice: Guidance for using everolimus in combination with low-exposure calcineurin inhibitors as initial immunosuppression in kidney transplant patients. Transplant Rev (Orlando) 2019;33:191-9. [PMID: 31377099 DOI: 10.1016/j.trre.2019.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 374 |
Muñoz-gallego I, Moral N, Pascual C, Alonso Y, Folgueira L. BK virus viral load: analysis of the requests received by the microbiology laboratory and clinical involvement of the issued results. Eur J Clin Microbiol Infect Dis 2019;38:1969-73. [DOI: 10.1007/s10096-019-03632-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 375 |
Paquot F, Weekers L, Bonvoisin C, Pottel H, Jouret F. "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation. BMC Nephrol 2019;20:249. [PMID: 31288762 DOI: 10.1186/s12882-019-1444-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 376 |
Lam E, Bashir B, Chaballa M, Kraft WK. Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy. Expert Rev Clin Pharmacol. 2019;12:781-790. [PMID: 31242782 DOI: 10.1080/17512433.2019.1637733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 377 |
Scaggs Huang FA, Danziger-Isakov L. Infectious disease risks in pediatric renal transplantation. Pediatr Nephrol 2019;34:1155-66. [PMID: 29626241 DOI: 10.1007/s00467-018-3951-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 378 |
Schulte K, Püchel J, Schüssel K, Borzikowsky C, Kunzendorf U, Feldkamp T. Effect of Sodium Bicarbonate in Kidney Transplant Recipients With Chronic Metabolic Acidosis. Transplant Direct 2019;5:e464. [PMID: 31334338 DOI: 10.1097/TXD.0000000000000910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 379 |
Moroni G, Belingheri M, Frontini G, Tamborini F, Messa P. Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation. Front Immunol 2019;10:1332. [PMID: 31275309 DOI: 10.3389/fimmu.2019.01332] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 380 |
Yamagata K, Hoshino J, Sugiyama H, Hanafusa N, Shibagaki Y, Komatsu Y, Konta T, Fujii N, Kanda E, Sofue T, Ishizuka K, Kitagawa M, Kono K, Hinamoto N, Miyai T, Koike K, Toda S, Hasegawa J, Yamanouchi M, Yoshimura R, Ishii R, Goto S, Kawarazaki H, Takase K, Taki F, Matsumura M, Raita Y, Sakurai S, Shimizu T, Yamanoto S, Kawaguchi T, Oguchi H, Tsujita M, Yazawa M, Uchida A, Ando Y, Kaneko S, Matsunaga A, Harada T, Ito O, Kohzuki M. Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases. Ren Replace Ther 2019;5. [DOI: 10.1186/s41100-019-0209-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 381 |
Kim JE, Han A, Lee H, Ha J, Kim YS, Han SS. Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. BMC Nephrol 2019;20:212. [PMID: 31182046 DOI: 10.1186/s12882-019-1407-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 382 |
DiBrito SR, Bowring MG, Holscher CM, Haugen CE, Rasmussen SV, Duncan MD, Efron DT, Stevens K, Segev DL, Garonzik-Wang J, Haut ER. Acute Care Surgery for Transplant Recipients: A National Survey of Surgeon Perspectives and Practices. J Surg Res 2019;243:114-22. [PMID: 31170553 DOI: 10.1016/j.jss.2019.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 383 |
Hall K, Uy CP, Bright R, Willicombe M, Webster P. Improving the quality of kidney transplant recipient discharge summaries. Clin Med 2019;19:52-53. [DOI: 10.7861/clinmedicine.19-3-s52] [Reference Citation Analysis]
|
| 384 |
Wiebe C, Kosmoliaptsis V, Pochinco D, Gibson IW, Ho J, Birk PE, Goldberg A, Karpinski M, Shaw J, Rush DN, Nickerson PW. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Am J Transplant 2019;19:1708-19. [PMID: 30414349 DOI: 10.1111/ajt.15177] [Cited by in Crossref: 95] [Cited by in F6Publishing: 96] [Article Influence: 23.8] [Reference Citation Analysis]
|
| 385 |
Hall K, Uy CP, Bright R, Willicombe M, Webster P. Improving the quality of kidney transplant recipient discharge summaries. Clin Med 2019;19:s52-s53. [DOI: 10.7861/clinmedicine.19-3s-s52] [Reference Citation Analysis]
|
| 386 |
Liu SY, Liu C, Nehus E, Macaluso M, Lu B, Kim MO. Propensity score analysis for correlated subgroup effects. Stat Methods Med Res 2020;29:1067-80. [PMID: 31144601 DOI: 10.1177/0962280219850595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 387 |
Pisano A, Bolignano D, Mallamaci F, D’arrigo G, Halimi J, Persu A, Wuerzner G, Sarafidis P, Watschinger B, Burnier M, Zoccali C. Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis. Nephrology Dialysis Transplantation 2020;35:878-87. [DOI: 10.1093/ndt/gfz092] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 388 |
Carminatti M, Tedesco-Silva H, Silva Fernandes NM, Sanders-Pinheiro H. Chronic kidney disease progression in kidney transplant recipients: A focus on traditional risk factors. Nephrology (Carlton) 2019;24:141-7. [PMID: 30159972 DOI: 10.1111/nep.13483] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 389 |
Kulabusaya B, Vadcharavivad S, Avihingsanon Y, van Gelder T, Praditpornsilpa K. Early pharmacokinetics of low dosage mycophenolate exposure in Thai kidney transplant recipients. Int J Clin Pharm 2019;41:1047-55. [PMID: 31129889 DOI: 10.1007/s11096-019-00848-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 390 |
Sabé N, Oriol I, Melilli E, Manonelles A, Bestard O, Polo C, Los Arcos I, Perelló M, Garcia D, Riera L, Tebé C, Len Ò, Moreso F, Cruzado JM, Carratalà J. Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial. Open Forum Infect Dis 2019;6:ofz243. [PMID: 31214630 DOI: 10.1093/ofid/ofz243] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 391 |
Jahromi M, Al-Otaibi T, Othman N, Gheith O, Mahmoud T, Nair P, Halim MA, Nampoory N. Immunogenetics of new onset diabetes after transplantation in Kuwait. Diabetes Metab Syndr Obes 2019;12:731-42. [PMID: 31190933 DOI: 10.2147/DMSO.S195859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 392 |
van der Zwan M, Baan CC, van Gelder T, Hesselink DA. Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation. Clin Pharmacokinet 2018;57:191-207. [PMID: 28669130 DOI: 10.1007/s40262-017-0573-x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 393 |
Llinàs-Mallol L, Redondo-Pachón D, Pérez-Sáez MJ, Raïch-Regué D, Mir M, Yélamos J, López-Botet M, Pascual J, Crespo M. Peripheral blood lymphocyte subsets change after steroid withdrawal in renal allograft recipients: a prospective study. Sci Rep 2019;9:7453. [PMID: 31092833 DOI: 10.1038/s41598-019-42913-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 394 |
Peabody J, Billings P, Valdenor C, Demko Z, Moshkevich S, Paculdo D, Tran M. Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice. Int J Nephrol 2019;2019:5303284. [PMID: 31214362 DOI: 10.1155/2019/5303284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 395 |
Isnard P, Kula T, Avettand Fenoel V, Anglicheau D, Terzi F, Legendre C, Elledge SJ, Canaud G. Temporal virus serological profiling of kidney graft recipients using VirScan. Proc Natl Acad Sci U S A 2019;116:10899-904. [PMID: 31085644 DOI: 10.1073/pnas.1821166116] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 396 |
Sonnenberg EM, Cohen JB, Hsu JY, Potluri VS, Levine MH, Abt PL, Reese PP. Association of Kidney Transplant Center Volume With 3-Year Clinical Outcomes. Am J Kidney Dis 2019;74:441-51. [PMID: 31076173 DOI: 10.1053/j.ajkd.2019.02.019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 397 |
Wu CY, Yu TM, Wu MJ, Chuang YW. Prognostic Value of Effective Renal Plasma Flow for First-year Renal Outcome in Kidney Allograft Recipients. Transplant Proc 2019;51:1353-6. [PMID: 31056247 DOI: 10.1016/j.transproceed.2019.02.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 398 |
Paulsen G, Cumagun P, Mixon E, Fowler K, Feig D, Shimamura M. Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis. Pediatr Transplant 2019;23:e13382. [PMID: 30786115 DOI: 10.1111/petr.13382] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 399 |
Khishigsuren B, Demir E, Akgul S, Temurhan S, Ucar A, Dirim A, Catikkas N, Bayraktar A, Caliskan Y, Yazici H, Oguz F, Turkmen A, Sever M. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients. Transplantation Proceedings 2019;51:1115-7. [DOI: 10.1016/j.transproceed.2019.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 400 |
Attias P, Melica G, Boutboul D, De Castro N, Audard V, Stehlé T, Gaube G, Fourati S, Botterel F, Fihman V, Audureau E, Grimbert P, Matignon M. Epidemiology, Risk Factors, and Outcomes of Opportunistic Infections after Kidney Allograft Transplantation in the Era of Modern Immunosuppression: A Monocentric Cohort Study. J Clin Med 2019;8:E594. [PMID: 31052269 DOI: 10.3390/jcm8050594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 401 |
Phupradit A, Vadcharavivad S, Ingsathit A, Kantachuvesiri S, Areepium N, Sra-Ium S, Auamnoy T, Sukasem C, Sumethkul V, Kitiyakara C. Impact of POR and CYP3A5 Polymorphisms on Trough Concentration to Dose Ratio of Tacrolimus in the Early Post-operative Period Following Kidney Transplantation. Ther Drug Monit 2018;40:549-57. [PMID: 29878980 DOI: 10.1097/FTD.0000000000000542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 402 |
Rajkumar T, Mazid S, Vucak‐dzumhur M, Sykes TM, Elder GJ. Health‐related quality of life following kidney and simultaneous pancreas kidney transplantation. Nephrology 2019. [DOI: 10.1111/nep.13523] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 403 |
Schütte-Nütgen K, Thölking G, Steinke J, Pavenstädt H, Schmidt R, Suwelack B, Reuter S. Fast Tac Metabolizers at Risk ⁻ It is Time for a C/D Ratio Calculation. J Clin Med 2019;8:E587. [PMID: 31035422 DOI: 10.3390/jcm8050587] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 404 |
Spasić A, Catić-Đorđević A, Veličković-Radovanović R, Stefanović N, Džodić P, Cvetković T. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. Int J Clin Pharm 2019;41:776-84. [PMID: 31028595 DOI: 10.1007/s11096-019-00837-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 405 |
Abeysekera N, Graver A, Cooley L, Kirkland G, Jose MD. Infectious complications in the Southern Tasmanian kidney transplant population. Nephrology (Carlton) 2019;24:849-54. [PMID: 30152077 DOI: 10.1111/nep.13482] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 406 |
Cai G, Zheng H, Luo L, Wang Z, Jiang Z, Xu S, Lv H, Chen Y, Zhou B, Hu C. Factors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis Patients-Findings Mainly from Asiatic Populations: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health 2019;16:E1453. [PMID: 31022900 DOI: 10.3390/ijerph16081453] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 407 |
Dendle C, Polkinghorne KR, Mulley WR, Gan PY, Kanellis J, Stuart RL, Thursky K, Holdsworth SR. A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years. Transpl Infect Dis 2019;21:e13076. [PMID: 30875147 DOI: 10.1111/tid.13076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 408 |
Chewcharat A, Thongprayoon C, Bathini T, Aeddula NR, Boonpheng B, Kaewput W, Watthanasuntorn K, Lertjitbanjong P, Sharma K, Torres-Ortiz A, Leeaphorn N, Mao MA, Khoury NJ, Cheungpasitporn W. Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis. J Clin Med. 2019;8:530. [PMID: 30999706 DOI: 10.3390/jcm8040530] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 409 |
Fernando ME, Jayanivash J, Srinivasaprasad ND, Suren S, Thirumalvalavan K. Post-Renal Transplant Metabolic Acidosis: A Neglected Entity. Indian J Nephrol 2019;29:116-21. [PMID: 30983752 DOI: 10.4103/ijn.IJN_93_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 410 |
Uffing A, Hidalgo LG, McMullan C, Perry J, Milford EL, Murakami N, Yeung MY, Guleria I, Wood IG, Akalin E, Azzi J, Chandraker AK, Riella LV. Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation. Transplant Direct 2019;5:e446. [PMID: 31165081 DOI: 10.1097/TXD.0000000000000893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 411 |
Xie J, Liu J, Liu M, Yan J, Ding S, Ma K. Self-management and Related Psychosocial Variables Among Renal Transplant Patients. Transplant Proc 2019;51:734-41. [PMID: 30979458 DOI: 10.1016/j.transproceed.2019.01.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 412 |
Goumard A, Sautenet B, Bailly E, Miquelestorena-Standley E, Proust B, Longuet H, Binet L, Baron C, Halimi JM, Büchler M, Gatault P. Increased risk of rejection after basiliximab induction in sensitized kidney transplant recipients without pre-existing donor-specific antibodies - a retrospective study. Transpl Int 2019;32:820-30. [PMID: 30903722 DOI: 10.1111/tri.13428] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 413 |
Cho YH, Hyun HS, Park E, Moon KC, Min SI, Ha J, Ha IS, Cheong HI, Ahn YH, Kang HG. Higher Incidence of BK Virus Nephropathy in Pediatric Kidney Allograft Recipients with Alport Syndrome. J Clin Med 2019;8:E491. [PMID: 30978953 DOI: 10.3390/jcm8040491] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 414 |
Ralph AF, Butow P, Craig JC, Wong G, Chadban SJ, Luxton G, Gutman T, Hanson CS, Ju A, Tong A. Living kidney donor and recipient perspectives on their relationship: longitudinal semi-structured interviews. BMJ Open 2019;9:e026629. [PMID: 30948607 DOI: 10.1136/bmjopen-2018-026629] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 415 |
Yepes-Calderón M, Sotomayor CG, Gomes-Neto AW, Gans ROB, Berger SP, Rimbach G, Esatbeyoglu T, Rodrigo R, Geleijnse JM, Navis GJ, Bakker SJL. Plasma Malondialdehyde and Risk of New-Onset Diabetes after Transplantation in Renal Transplant Recipients: A Prospective Cohort Study. J Clin Med 2019;8:E453. [PMID: 30987358 DOI: 10.3390/jcm8040453] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 416 |
Veenhof H, Koster RA, Alffenaar JC, van den Berg AP, de Groot MR, Verschuuren EA, Berger SP, Bakker SJ, Touw DJ. Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:1854-62. [DOI: 10.1515/cclm-2019-0053] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 417 |
Fox TG, Nailescu C. Vaccinations in pediatric kidney transplant recipients. Pediatr Nephrol 2019;34:579-91. [PMID: 29671067 DOI: 10.1007/s00467-018-3953-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 418 |
Huh S, Han N, Sohn M, Ryu J, Yang J, Oh JM. Formulation of the Scope and Key Questions of the Guideline Recommendations for Immunosuppressive Treatment in Kidney Transplantation. Korean J Clin Pharm 2019;29:18-24. [DOI: 10.24304/kjcp.2019.29.1.18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 419 |
Fung SKS, Chau KF, Chow KM. Clinical practice guidelines for the provision of renal service in Hong Kong: Potential Kidney Transplant Recipient Wait-listing and Evaluation, Deceased Kidney Donor Evaluation, and Kidney Transplant Postoperative Care. Nephrology (Carlton) 2019;24 Suppl 1:60-76. [PMID: 30900332 DOI: 10.1111/nep.13502] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 420 |
Qiu J, Li J, Chen G, Huang G, Fu Q, Wang C, Chen L. Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study. BMC Nephrol 2019;20:101. [PMID: 30902050 DOI: 10.1186/s12882-019-1293-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 421 |
Kong I, Law MC, Ng GS. Clinical practice guidelines for the provision of renal service in Hong Kong: Renal Nursing Practice. Nephrology 2019;24:77-97. [DOI: 10.1111/nep.13504] [Reference Citation Analysis]
|
| 422 |
Aloufi M, Alzahrany G, Abdulmajeed N, Alzahrani S, Alghwery S, Zahid R, Alghamdi A. Viral Infections After Kidney Transplantation in a Cohort of Children: A Retrospective Single-Center Study. Transplantation Proceedings 2019;51:522-5. [DOI: 10.1016/j.transproceed.2019.01.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 423 |
Cohen-Bucay A, Gordon CE, Francis JM. Non-immunological complications following kidney transplantation. F1000Res. 2019;8. [PMID: 30828430 DOI: 10.12688/f1000research.16627.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 424 |
Rahamimov R, Tifti-Orbach H, Zingerman B, Green H, Schneider S, Chagnac A, Mor E, Fox BD, Rozen-Zvi B. Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation. Eur J Clin Pharmacol 2019;75:951-8. [PMID: 30762079 DOI: 10.1007/s00228-019-02643-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 425 |
Kaya Aksoy G, Comak E, Koyun M, Akbaş H, Akkaya B, Aydınlı B, Uçar F, Akman S. Tacrolimus Variability: A Cause of Donor-Specific Anti-HLA Antibody Formation in Children. Eur J Drug Metab Pharmacokinet 2019;44:539-48. [DOI: 10.1007/s13318-019-00544-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 426 |
Dahdal S, Saison C, Valette M, Bachy E, Pallet N, Lina B, Koenig A, Monneret G, Defrance T, Morelon E, Thaunat O. Residual Activatability of Circulating Tfh17 Predicts Humoral Response to Thymodependent Antigens in Patients on Therapeutic Immunosuppression. Front Immunol 2018;9:3178. [PMID: 30804950 DOI: 10.3389/fimmu.2018.03178] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 427 |
Kamar N, Cassuto E, Piotti G, Govoni M, Ciurlia G, Geraci S, Poli G, Nicolini G, Mariat C, Essig M, Malvezzi P, Le Meur Y, Garrigue V, Del Bello A, Rostaing L. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study. Adv Ther 2019;36:462-77. [PMID: 30552587 DOI: 10.1007/s12325-018-0855-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 428 |
Fiorentino M, Pesce F, Schena A, Simone S, Castellano G, Gesualdo L. Updates on urinary tract infections in kidney transplantation. J Nephrol 2019;32:751-61. [PMID: 30689126 DOI: 10.1007/s40620-019-00585-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 429 |
Andrews LM, Hesselink DA, van Schaik RHN, van Gelder T, de Fijter JW, Lloberas N, Elens L, Moes DJAR, de Winter BCM. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients. Br J Clin Pharmacol 2019;85:601-15. [PMID: 30552703 DOI: 10.1111/bcp.13838] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 430 |
Thibaud V, Rioux-Leclercq N, Vigneau C, Morice S. Recurrence of Goodpasture syndrome without circulating anti-glomerular basement membrane antibodies after kidney transplant, a case report. BMC Nephrol 2019;20:6. [PMID: 30621605 DOI: 10.1186/s12882-018-1197-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 431 |
Campagne O, Mager DE, Brazeau D, Venuto RC, Tornatore KM. The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients. Br J Clin Pharmacol 2019;85:516-29. [PMID: 30414331 DOI: 10.1111/bcp.13811] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 432 |
Sprangers B, Pirenne J, Mathieu C, Waer M. Other Forms of Immunosuppression. Kidney Transplantation - Principles and Practice 2019. [DOI: 10.1016/b978-0-323-53186-3.00020-6] [Reference Citation Analysis]
|
| 433 |
Brubaker A, Stoltz D, Gallo A. Medical Course and Complications After Renal Transplantation. Psychosocial Care of End-Stage Organ Disease and Transplant Patients 2019. [DOI: 10.1007/978-3-319-94914-7_9] [Reference Citation Analysis]
|
| 434 |
Klewitz F, Nöhre M, Bauer-Hohmann M, Tegtbur U, Schiffer L, Pape L, Schiffer M, de Zwaan M. Information Needs of Patients About Immunosuppressive Medication in a German Kidney Transplant Sample: Prevalence and Correlates. Front Psychiatry 2019;10:444. [PMID: 31316406 DOI: 10.3389/fpsyt.2019.00444] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 435 |
Brochot E, Descamps V, Handala L, Faucher J, Choukroun G, Helle F, Castelain S, François C, Duverlie G, Touzé A. BK polyomavirus in the urine for follow-up of kidney transplant recipients. Clinical Microbiology and Infection 2019;25:112.e1-5. [DOI: 10.1016/j.cmi.2018.07.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 436 |
Lim MA, Bloom RD. Immunosuppressive Therapy. Chronic Kidney Disease, Dialysis, and Transplantation 2019. [DOI: 10.1016/b978-0-323-52978-5.00038-0] [Reference Citation Analysis]
|
| 437 |
Riccardi N, Rotulo GA, Castagnola E. Definition of Opportunistic Infections in Immunocompromised Children on the Basis of Etiologies and Clinical Features: A Summary for Practical Purposes. Curr Pediatr Rev 2019;15:197-206. [PMID: 31242834 DOI: 10.2174/1573396315666190617151745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 438 |
Schaenman J, Sabrina Tan C. Prevention and Treatment of Polyomavirus-Associated Diseases. Infectious Diseases in Solid-Organ Transplant Recipients 2019. [DOI: 10.1007/978-3-030-15394-6_8] [Reference Citation Analysis]
|
| 439 |
Ben-Porat T, Weiss-Sadan A, Rottenstreich A, Sherf-Dagan S, Schweiger C, Yosef-Levi IM, Weiner D, Azulay O, Sakran N, Harari R, Elazary R. Nutritional Management for Chronic Kidney Disease Patients who Undergo Bariatric Surgery: A Narrative Review. Adv Nutr 2019;10:122-32. [PMID: 30753268 DOI: 10.1093/advances/nmy112] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 440 |
Ryu JH, Choi S, Lee HJ, Kim YT, Kim YW, Yang J. Low early posttransplant serum tacrolimus levels are associated with poor patient survival in lung transplant patients. Ann Thorac Med 2019;14:186-91. [PMID: 31333768 DOI: 10.4103/atm.ATM_160_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 441 |
Chancharoenthana W, Leelahavanichkul A, Wattanatorn S, Avihingsanon Y, Praditpornsilpa K, Eiam-Ong S, Townamchai N. Alteration of urinary neutrophil gelatinase-associated lipocalin as a predictor of tacrolimus-induced chronic renal allograft fibrosis in tacrolimus dose adjustments following kidney transplantation. PLoS One 2018;13:e0209708. [PMID: 30576367 DOI: 10.1371/journal.pone.0209708] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 442 |
Mendonça L, Diniz H, Silvano J, Marques S, Sampaio S, Pestana M. Early Versus Late Conversion From Immediate to Prolonged-Release Tacrolimus After Renal Transplantation: Clinical Effects and Treatment Costs. Transplant Direct 2019;5:e417. [PMID: 30656215 DOI: 10.1097/TXD.0000000000000853] [Reference Citation Analysis]
|
| 443 |
Daviet F, Rouby F, Poullin P, Moussi-Francès J, Sallée M, Burtey S, Mancini J, Duffaud F, Sabatier R, Pourroy B, Grandvuillemin A, Grange S, Frémeaux-Bacchi V, Coppo P, Micallef J, Jourde-Chiche N. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort. Br J Clin Pharmacol 2019;85:403-12. [PMID: 30394581 DOI: 10.1111/bcp.13808] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 444 |
Chancharoenthana W, Leelahavanichkul A, Udomkarnjananun S, Wattanatorn S, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, Eiam-Ong S, Townamchai N. Durability of Antibody Response Against the Hepatitis B Virus in Kidney Transplant Recipients: A Proposed Immunization Guideline From a 3-Year Follow-up Clinical Study. Open Forum Infect Dis 2019;6:ofy342. [PMID: 30697573 DOI: 10.1093/ofid/ofy342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 445 |
Gielis EM, Beirnaert C, Dendooven A, Meysman P, Laukens K, De Schrijver J, Van Laecke S, Van Biesen W, Emonds MP, De Winter BY, Bosmans JL, Del Favero J, Abramowicz D, Ledeganck KJ. Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay. PLoS One. 2018;13:e0208207. [PMID: 30521549 DOI: 10.1371/journal.pone.0208207] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 446 |
Sherif MF, Abu Alghar MI, Alshafe MH, Badra AG. Assessment of acute renal allograft dysfunction by MRI diffusion techniques. The Egyptian Journal of Radiology and Nuclear Medicine 2018;49:1131-9. [DOI: 10.1016/j.ejrnm.2018.06.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 447 |
Aguirre LE, Guzman ME, Lopes G, Hurley J. Immune Checkpoint Inhibitors and the Risk of Allograft Rejection: A Comprehensive Analysis on an Emerging Issue. Oncologist 2019;24:394-401. [PMID: 30413665 DOI: 10.1634/theoncologist.2018-0195] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 448 |
Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. 2019;32:389-399. [PMID: 30406606 DOI: 10.1007/s40620-018-0549-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 449 |
Piccoli GB, Zakharova E, Attini R, Ibarra Hernandez M, Orozco Guillien A, Alrukhaimi M, Liu ZH, Ashuntantang G, Covella B, Cabiddu G, Li PKT, Garcia-Garcia G, Levin A. Pregnancy in Chronic Kidney Disease: Need for Higher Awareness. A Pragmatic Review Focused on What Could Be Improved in the Different CKD Stages and Phases. J Clin Med 2018;7:E415. [PMID: 30400594 DOI: 10.3390/jcm7110415] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 450 |
Szydłowicz M, Jakuszko K, Szymczak A, Piesiak P, Kowal A, Kopacz Ż, Wesołowska M, Lobo ML, Matos O, Hendrich AB, Kicia M. Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report. Parasitol Res 2019;118:181-9. [PMID: 30392033 DOI: 10.1007/s00436-018-6131-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 451 |
Nolte Fong JV, Moore LW. Nutrition Trends in Kidney Transplant Recipients: the Importance of Dietary Monitoring and Need for Evidence-Based Recommendations. Front Med (Lausanne). 2018;5:302. [PMID: 30430111 DOI: 10.3389/fmed.2018.00302] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 452 |
Sofue T, Suzuki H, Ueda N, Kushida Y, Minamino T. Post-transplant immunoglobulin A deposition and nephropathy in allografts. Nephrology (Carlton) 2018;23 Suppl 2:4-9. [PMID: 29968406 DOI: 10.1111/nep.13281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 453 |
Matsukuma Y, Masutani K, Tsuchimoto A, Okabe Y, Nakamura M, Kitazono T, Tsuruya K. Effect of steroid pulse therapy on post-transplant immunoglobulin A nephropathy. Nephrology (Carlton) 2018;23 Suppl 2:10-6. [PMID: 29968415 DOI: 10.1111/nep.13272] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 454 |
Lee IK, Huang CH, Huang WC, Chen YC, Tsai CY, Chang K, Chen YH. Prognostic Factors in Adult Patients with Dengue: Developing Risk Scoring Models and Emphasizing Factors Associated with Death ≤7 Days after Illness Onset and ≤3 Days after Presentation. J Clin Med 2018;7:E396. [PMID: 30373324 DOI: 10.3390/jcm7110396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 455 |
You J, Kim M, Lee J, Han DJ, Park YS, Lee JH. Epstein-Barr virus infection in children with renal transplantation: A single-centre experience. Nephrology 2018;23:1039-45. [DOI: 10.1111/nep.13162] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 456 |
Dagenais R, Leung M, Poinen K, Landsberg D. Common Questions and Misconceptions in the Management of Renal Transplant Patients: A Guide for Health Care Providers in the Posttransplant Setting. Ann Pharmacother 2019;53:419-29. [PMID: 30345802 DOI: 10.1177/1060028018809318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 457 |
Zwart TC, Gokoel SRM, van der Boog PJM, de Fijter JW, Kweekel DM, Swen JJ, Guchelaar HJ, Moes DJAR. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device. Br J Clin Pharmacol 2018;84:2889-902. [PMID: 30176064 DOI: 10.1111/bcp.13755] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 458 |
Dendle C, Mulley WR, Holdsworth S. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Transplant Rev (Orlando) 2019;33:87-98. [PMID: 30551846 DOI: 10.1016/j.trre.2018.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 459 |
Rahimifard N, Mahmoudi S, Mamishi S, Pourakbari B. Prevalence of latent tuberculosis infection in transplant candidates: A systematic review and meta-analysis. Microb Pathog 2018;125:401-10. [PMID: 30291870 DOI: 10.1016/j.micpath.2018.09.040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 460 |
Karaahmet F, Arıcı M. The relationship between vitamin D levels and 24-hour ambulatory blood pressure in renal transplantation patients. Ortadogu Tıp Derg 2018;10:302-306. [DOI: 10.21601/ortadogutipdergisi.449335] [Reference Citation Analysis]
|
| 461 |
Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group. KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl (2011) 2018;8:91-165. [PMID: 30675443 DOI: 10.1016/j.kisu.2018.06.001] [Cited by in Crossref: 87] [Cited by in F6Publishing: 107] [Article Influence: 17.4] [Reference Citation Analysis]
|
| 462 |
Kim HJ, Lu B, Nehus EJ, Kim MO. Estimating heterogeneous treatment effects for latent subgroups in observational studies. Stat Med 2019;38:339-53. [PMID: 30232820 DOI: 10.1002/sim.7970] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 463 |
Zhang J, Qiu J, Chen GD, Wang CX, Wang C, Yu SJ, Chen LZ. Etiological analysis of graft dysfunction following living kidney transplantation: a report of 366 biopsies. Ren Fail 2018;40:219-25. [PMID: 29619905 DOI: 10.1080/0886022X.2018.1455592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 464 |
Babenko NN, Goryainov VA, Kaabak MM, Nikoda VV, Lishova EA. The use of belatacept in kidney transplantation. Transplantologiâ (Mosk ) 2018;10:222-231. [DOI: 10.23873/2074-0506-2018-10-3-222-231] [Reference Citation Analysis]
|
| 465 |
Girerd S, Schikowski J, Girerd N, Duarte K, Busby H, Gambier N, Ladrière M, Kessler M, Frimat L, Aarnink A. Impact of reduced exposure to calcineurin inhibitors on the development of de novo DSA: a cohort of non-immunized first kidney graft recipients between 2007 and 2014. BMC Nephrol 2018;19:232. [PMID: 30219043 DOI: 10.1186/s12882-018-1014-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 466 |
Hasan T, Au E, Chen S, Tong A, Wong G. Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines. BMJ Open 2018;8:e022445. [PMID: 30209157 DOI: 10.1136/bmjopen-2018-022445] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 467 |
Bath RM, Doering BE, Nailor MD, Goodlet KJ. Pharmacotherapy-Induced Hepatitis B Reactivation Among Patients With Prior Functional Cure: A Systematic Review. Ann Pharmacother 2019;53:294-310. [PMID: 30203666 DOI: 10.1177/1060028018800501] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 468 |
Arreola-guerra JM, Rosado-canto R, Alberú J, Maravilla E, Torres-gonzález P, Criollo E, Pérez M, Mancilla E, Arvizu M, Morales-buenrostro LE, Vilatobá-chapa M, Sifuentes-osornio J. Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial. Transpl Infect Dis 2018;20:e12980. [DOI: 10.1111/tid.12980] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 469 |
Lam NN, Klarenbach S, Quinn RR, Hemmelgarn B, Tonelli M, Ye F, Ravani P, Bello AK, Brennan DC, Lentine KL. Renal Function, Albuminuria, and the Risk of Cardiovascular Events After Kidney Transplantation. Transplant Direct 2018;4:e389. [PMID: 30498766 DOI: 10.1097/TXD.0000000000000828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 470 |
Marticorena Garcia SR, Guo J, Dürr M, Denecke T, Hamm B, Sack I, Fischer T. Comparison of ultrasound shear wave elastography with magnetic resonance elastography and renal microvascular flow in the assessment of chronic renal allograft dysfunction. Acta Radiol 2018;59:1139-45. [PMID: 29249167 DOI: 10.1177/0284185117748488] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 471 |
Hosseini-moghaddam SM, Shokoohi M, Singh G, Dufresne SF, Boucher A, Jevnikar A, Prasad GVR, Shoker A, Kabbani D, Hebert MJ, Cardinal H, Houde I, Humar A, Kumar D. A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients. Clinical Infectious Diseases 2019;68:1320-6. [DOI: 10.1093/cid/ciy682] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 472 |
Strohbehn GW, Pan WW, Petrilli CM, Heidemann L, Larson S, Aaronson KD, Johnson M, Ellies T, Heung M. Large-Scale Variability of Inpatient Tacrolimus Therapeutic Drug Monitoring at an Academic Transplant Center: A Retrospective Study. Therapeutic Drug Monitoring 2018;40:394-400. [DOI: 10.1097/ftd.0000000000000526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 473 |
Conte C, Secchi A. Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention. Acta Diabetol 2018;55:763-79. [PMID: 29619563 DOI: 10.1007/s00592-018-1137-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 474 |
Vangala C, Pan J, Cotton RT, Ramanathan V. Mineral and Bone Disorders After Kidney Transplantation. Front Med (Lausanne) 2018;5:211. [PMID: 30109232 DOI: 10.3389/fmed.2018.00211] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 475 |
Gandolfini I, Crespo E, Baweja M, Jarque M, Donadei C, Luque S, Montero N, Allesina A, Perin L, Maggiore U, Cravedi P, Bestard O. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation. PLoS One 2018;13:e0200696. [PMID: 30059561 DOI: 10.1371/journal.pone.0200696] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 476 |
Bunniran S, Lee E, Kamble P, Suehs B, Franks B, Schwartz J, Thal G, Spalding J. Healthcare utilization and costs with fixed-source versus variable-source tacrolimus in patients receiving a kidney transplant. J Med Econ 2018;21:1067-74. [PMID: 30032686 DOI: 10.1080/13696998.2018.1503596] [Reference Citation Analysis]
|
| 477 |
Kim KW, Kim BM, Doh KC, Kim CD, Jeong KH, Lee SH, Yang CW, Chung BH. Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients. PLoS One 2018;13:e0200631. [PMID: 30011312 DOI: 10.1371/journal.pone.0200631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 478 |
Malyszko J, Dryl-Rydzynska T, Marcinkowski W, Prystacki T, Malyszko JS. Comorbidities on kidney transplantation waiting list relative to the status of the potential recipient. Arch Med Sci 2018;14:941-4. [PMID: 30002713 DOI: 10.5114/aoms.2016.60337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 479 |
Ng JCY, Leung M, Wright AJ, Ensom MHH. Clinical Pharmacokinetic Monitoring of Leflunomide in Renal Transplant Recipients with BK Virus Reactivation: A Review of the Literature. Clin Pharmacokinet 2017;56:1015-31. [PMID: 28247238 DOI: 10.1007/s40262-017-0521-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 480 |
Sagasaki M, Nakada Y, Yamamoto I, Kawabe M, Yamakawa T, Katsumata H, Mafune A, Katsuma A, Kobayashi A, Koike K, Koike Y, Miki J, Yamada H, Kimura T, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Yokoo T. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient: ABMR after pregnancy and delivery. Nephrology 2018;23:81-4. [DOI: 10.1111/nep.13279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 481 |
Saengram W, Vadcharavivad S, Poolsup N, Chancharoenthana W. Extended release versus immediate release tacrolimus in kidney transplant recipients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74:1249-1260. [PMID: 29961086 DOI: 10.1007/s00228-018-2512-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 482 |
Okada M, Kamei K, Matsuoka K, Ito S. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient. CEN Case Rep 2018;7:288-91. [PMID: 29949115 DOI: 10.1007/s13730-018-0344-z] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 483 |
Gunawansa N, Rathore R, Sharma A, Halawa A. Vaccination practices in End Stage Renal Failure and Renal Transplantation; Review of current guidelines and recommendations. World J Transplant 2018; 8(3): 68-74 [PMID: 29988933 DOI: 10.5500/wjt.v8.i3.68] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 484 |
Madden K, Janitell C, Sower D, Yang S. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples. Transpl Infect Dis 2018;20:e12952. [DOI: 10.1111/tid.12952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 485 |
Varga AN, Johnson D, Sawinski DL, Lim MA, Bloom RD, Abt PL, Goral S, Bleicher M, Levine MH, Naji A, Nazarian S, Porrett P, Trofe-clark J. Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients. Pharmacotherapy 2018;38:620-7. [DOI: 10.1002/phar.2116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 486 |
Cabiddu G, Spotti D, Gernone G, Santoro D, Moroni G, Gregorini G, Giacchino F, Attini R, Limardo M, Gammaro L, Todros T, Piccoli GB; Kidney and Pregnancy Study Group of the Italian Society of Nephrology. A best-practice position statement on pregnancy after kidney transplantation: focusing on the unsolved questions. The Kidney and Pregnancy Study Group of the Italian Society of Nephrology. J Nephrol 2018;31:665-81. [PMID: 29949013 DOI: 10.1007/s40620-018-0499-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 487 |
Wang F, He K, Wang J, Zhao MH, Li Y, Zhang L, Saran R, Bragg-Gresham JL. Prevalence and Risk Factors for CKD: A Comparison Between the Adult Populations in China and the United States. Kidney Int Rep 2018;3:1135-43. [PMID: 30197980 DOI: 10.1016/j.ekir.2018.05.011] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 488 |
Adams SM, Crisamore KR, Empey PE. Clinical Pharmacogenomics: Applications in Nephrology. Clin J Am Soc Nephrol 2018;13:1561-71. [PMID: 29793969 DOI: 10.2215/CJN.02730218] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 489 |
Shi X, Lv J, Han W, Zhong X, Xie X, Su B, Ding J. What is the impact of human leukocyte antigen mismatching on graft survival and mortality in renal transplantation? A meta-analysis of 23 cohort studies involving 486,608 recipients. BMC Nephrol 2018;19:116. [PMID: 29776389 DOI: 10.1186/s12882-018-0908-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 490 |
Lim CC, Wong MWY, Koh HL, Chin YM, Mok IYJ, Choo JCJ. New-onset diabetes mellitus among patients with glomerular diseases. Intern Med J 2019;49:101-8. [PMID: 29741271 DOI: 10.1111/imj.13964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 491 |
Tang JT, Yan L, Wang LL, Bai YJ, Li YM, Zou YG, Li Y, van Gelder T, Shi YY. A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. Ann Transplant 2018;23:300-9. [PMID: 29735966 DOI: 10.12659/AOT.907666] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 492 |
Höcker B, Aguilar M, Schnitzler P, Pape L, Bald M, König J, Marks SD, Genc G, Büscher A, Kemper MJ, Billing H, Pohl M, Dello Strologo L, Webb NJA, Rieger S, Mankertz A, Krupka K, Bruckner T, Fichtner A, Tönshoff B. Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy. Pediatr Nephrol 2018;33:897-910. [PMID: 29322328 DOI: 10.1007/s00467-017-3868-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 493 |
Nissaisorakarn V, Lee JR, Lubetzky M, Suthanthiran M. Urine biomarkers informative of human kidney allograft rejection and tolerance. Human Immunology 2018;79:343-55. [DOI: 10.1016/j.humimm.2018.01.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 494 |
Chong HJ, Kim HK, Lee MH, Lee S. Influenza vaccine acceptance and health beliefs among Korean kidney transplant patients. Psychology, Health & Medicine 2018;23:1113-24. [DOI: 10.1080/13548506.2018.1467023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 495 |
Halawa A. Steroid withdrawal protocols in Renal Transplantation. Arch Clin Nephrol 2018. [DOI: 10.17352/acn.000029] [Reference Citation Analysis]
|
| 496 |
Han A, Ahn S, Min SK, Ha J, Kim YS, Ahn C, Min SI. Value of perioperative genitourinary screening culture and colonization status in predicting early urinary tract infection after renal transplantation. PLoS One 2018;13:e0196115. [PMID: 29672580 DOI: 10.1371/journal.pone.0196115] [Reference Citation Analysis]
|
| 497 |
Kim YC, Shin N, Lee S, Hyuk H, Kim YH, Kim H, Park SK, Cho JH, Kim CD, Ha J, Chae DW, Lee JP, Kim YS. Effect of post-transplant glycemic control on long-term clinical outcomes in kidney transplant recipients with diabetic nephropathy: A multicenter cohort study in Korea. PLoS One 2018;13:e0195566. [PMID: 29668755 DOI: 10.1371/journal.pone.0195566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 498 |
Saida K, Kamei K, Ogura M, Matsumura S, Kano Y, Sato M, Andoh A, Ishikura K. Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report. Transplant Proc 2018;50:3925-7. [PMID: 30577288 DOI: 10.1016/j.transproceed.2018.04.039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 499 |
Dew MA, Posluszny DM, DiMartini AF, Myaskovsky L, Steel JL, DeVito Dabbs AJ. Posttransplant Medical Adherence: What Have We Learned and Can We Do Better? Curr Transplant Rep 2018;5:174-88. [PMID: 30416933 DOI: 10.1007/s40472-018-0195-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 500 |
Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol 2018;36:1341-53. [PMID: 29610964 DOI: 10.1007/s00345-018-2286-7] [Cited by in Crossref: 114] [Cited by in F6Publishing: 133] [Article Influence: 22.8] [Reference Citation Analysis]
|
| 501 |
Benjamens S, Berger S, Glaudemans A, Sanders J, Pol R, Slart R. Renal scintigraphy for post-transplant monitoring after kidney transplantation. Transplantation Reviews 2018;32:102-9. [DOI: 10.1016/j.trre.2017.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 502 |
Panah F, Ghorbanihaghjo A, Argani H, Asadi Zarmehri M, Nazari Soltan Ahmad S. Ischemic acute kidney injury and klotho in renal transplantation. Clin Biochem 2018;55:3-8. [PMID: 29608890 DOI: 10.1016/j.clinbiochem.2018.03.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 503 |
Snowsill TM, Moore J, Mujica Mota RE, Peters JL, Jones-Hughes TL, Huxley NJ, Coelho HF, Haasova M, Cooper C, Lowe JA, Varley-Campbell JL, Crathorne L, Allwood MJ, Anderson R. Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation. Nephrol Dial Transplant 2017;32:1251-9. [PMID: 28873970 DOI: 10.1093/ndt/gfx074] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 504 |
Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother 2018;14:1311-22. [PMID: 29485353 DOI: 10.1080/21645515.2018.1445446] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 505 |
Law N, Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging 2017;34:743-54. [PMID: 28965331 DOI: 10.1007/s40266-017-0491-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 506 |
Benjamens S, Glaudemans AWJM, Berger SP, Slart RHJA, Pol RA. Have we forgotten imaging prior to and after kidney transplantation? Eur Radiol 2018;28:3263-7. [PMID: 29516166 DOI: 10.1007/s00330-018-5358-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 507 |
Nehus EJ, Liu C, Lu B, Macaluso M, Kim MO. Graft survival of pediatric kidney transplant recipients selected for de novo steroid avoidance-a propensity score-matched study. Nephrol Dial Transplant 2017;32:1424-31. [PMID: 28810723 DOI: 10.1093/ndt/gfx193] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 508 |
Bamoulid J, Staeck O, Crépin T, Halleck F, Saas P, Brakemeier S, Ducloux D, Budde K. Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects. Nephrol Dial Transplant 2017;32:1601-8. [PMID: 27798202 DOI: 10.1093/ndt/gfw368] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 509 |
Ying L, Tian L, Xie Y, Wang Q, Che X, Yan J, Shen L, Huang H, Chen F, Zhang M, Ni Z, Mou S. A case of ureteral myeloid sarcoma post-renal transplantation. BMC Nephrol 2018;19:46. [PMID: 29486724 DOI: 10.1186/s12882-018-0838-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 510 |
Kato S, Miura M. Risk of new-onset diabetes mellitus during treatment with low-dose statins in Japan: A retrospective cohort study. J Clin Pharm Ther 2018;43:536-42. [PMID: 29484697 DOI: 10.1111/jcpt.12675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 511 |
Jones-Hughes T, Snowsill T, Haasova M, Coelho H, Crathorne L, Cooper C, Mujica-Mota R, Peters J, Varley-Campbell J, Huxley N, Moore J, Allwood M, Lowe J, Hyde C, Hoyle M, Bond M, Anderson R. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Health Technol Assess 2016;20:1-594. [PMID: 27578428 DOI: 10.3310/hta20620] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 512 |
Haasova M, Snowsill T, Jones-Hughes T, Crathorne L, Cooper C, Varley-Campbell J, Mujica-Mota R, Coelho H, Huxley N, Lowe J, Dudley J, Marks S, Hyde C, Bond M, Anderson R. Immunosuppressive therapy for kidney transplantation in children and adolescents: systematic review and economic evaluation. Health Technol Assess 2016;20:1-324. [PMID: 27557331 DOI: 10.3310/hta20610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 513 |
Paoletti M, Cattadori B, Gregorini M, Viglio A, Gentile G, D'Armini AM, Pellegrini C, La Fianza A. Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report. CEN Case Rep 2018;7:132-6. [PMID: 29388168 DOI: 10.1007/s13730-018-0310-9] [Reference Citation Analysis]
|
| 514 |
Yamada Y, Tsuchiya T, Inagaki I, Seishima M, Deguchi T. Prediction of Early BK Virus Infection in Kidney Transplant Recipients by the Number of Cells With Intranuclear Inclusion Bodies (Decoy Cells). Transplant Direct 2018;4:e340. [PMID: 29464201 DOI: 10.1097/TXD.0000000000000759] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 515 |
Coussement J, Scemla A, Abramowicz D, Nagler EV, Webster AC. Antibiotics for asymptomatic bacteriuria in kidney transplant recipients. Cochrane Database Syst Rev 2018;2:CD011357. [PMID: 29390169 DOI: 10.1002/14651858.CD011357.pub2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 516 |
Krzyżowska K, Kolonko A, Giza P, Chudek J, Więcek A. Which Kidney Transplant Recipients Can Benefit from the Initial Tacrolimus Dose Reduction? Biomed Res Int 2018;2018:4573452. [PMID: 29651435 DOI: 10.1155/2018/4573452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 517 |
Kim JH, Han N, Kim MG, Yun HY, Lee S, Bae E, Kim YS, Kim IW, Oh JM. Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers. Sci Rep 2018;8:1687. [PMID: 29374217 DOI: 10.1038/s41598-018-20071-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 518 |
Rissling O, Naik M, Brakemeier S, Schmidt D, Staeck O, Hohberger A, Neumayer HH, Budde K. High frequency of valganciclovir underdosing for cytomegalovirus prophylaxis after renal transplantation. Clin Kidney J 2018;11:564-73. [PMID: 30094022 DOI: 10.1093/ckj/sfx145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 519 |
Chan EYH, Warady BA. Acquired cystic kidney disease: an under-recognized condition in children with end-stage renal disease. Pediatr Nephrol 2018;33:41-51. [PMID: 28444445 DOI: 10.1007/s00467-017-3649-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 520 |
Newland DM, Edwards AR, Hall RC, Maxwell PR. Positive Impact of a Pilot Pharmacist-Run Diabetes Pharmacotherapy Clinic in Solid-Organ Transplant Recipients. Diabetes Spectr 2018;31:167-76. [PMID: 29773937 DOI: 10.2337/ds17-0029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 521 |
Taber DJ, Su Z, Fleming JN, McGillicuddy JW, Posadas-Salas MA, Treiber FA, Dubay D, Srinivas TR, Mauldin PD, Moran WP. Tacrolimus Trough Concentration Variability and Disparities in African American Kidney Transplantation. Transplantation. 2017;101:2931-2938. [PMID: 28658199 DOI: 10.1097/tp.0000000000001840] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 522 |
Salcido-Ochoa F, Allen Jr JC. Biomarkers and a tailored approach for immune monitoring in kidney transplantation. World J Transplant 2017; 7(6): 276-284 [PMID: 29312857 DOI: 10.5500/wjt.v7.i6.276] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 523 |
Leal R, Pinto H, Galvão A, Rodrigues L, Santos L, Romãozinho C, Macário F, Alves R, Campos M, Mota A, Figueiredo A. Early Rehospitalization Post-Kidney Transplant Due to Infectious Complications: Can We Predict the Patients at Risk? Transplant Proc 2017;49:783-6. [PMID: 28457394 DOI: 10.1016/j.transproceed.2017.01.062] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 524 |
Mitić B, Paunović G, Dimitrijević Z, Veličković-radovanović R. PREVALENCE OF NEW ONSET DIABETES IN PATIENTS AFTER KIDNEY TRANSPLANTATION – THE PROSPECTIVE STUDY. amm 2017;56:94-99. [DOI: 10.5633/amm.2017.0415] [Reference Citation Analysis]
|
| 525 |
Santeusanio AD, Lukens BE, Eun J. Antiviral treatment of BK virus viremia after kidney transplantation. American Journal of Health-System Pharmacy 2017;74:2037-45. [DOI: 10.2146/ajhp160585] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 526 |
Foster BJ, Mitsnefes MM, Dahhou M, Zhang X, Laskin BL. Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013. Clin J Am Soc Nephrol. 2018;13:91-99. [PMID: 29242373 DOI: 10.2215/cjn.04330417] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 527 |
Sun IO, Jin L, Jin J, Lim SW, Chung BH, Yang CW. The effects of addition of coenzyme Q10 to metformin on sirolimus-induced diabetes mellitus. Korean J Intern Med 2019;34:365-74. [PMID: 29228766 DOI: 10.3904/kjim.2017.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 528 |
Moinuddin Z, Augustine T. Recent Advances in Kidney Transplantation. Annals of SBV 2017;6:7-10. [DOI: 10.5005/jp-journals-10085-6202] [Reference Citation Analysis]
|
| 529 |
Benzimra M, Calligaro GL, Glanville AR. Acute rejection. J Thorac Dis 2017;9:5440-57. [PMID: 29312755 DOI: 10.21037/jtd.2017.11.83] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 530 |
Patel KS, Stephany BR, Barnes JF, Bauer SR, Spinner ML. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists. Pharmacotherapy. 2017;37:1507-1515. [PMID: 28976570 DOI: 10.1002/phar.2037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 531 |
Melilli E, Manonelles A, Montero N, Grinyo J, Martinez-Castelao A, Bestard O, Cruzado J. Impact of immunosuppressive therapy on arterial stiffness in kidney transplantation: are all treatments the same? Clin Kidney J 2018;11:413-21. [PMID: 29988241 DOI: 10.1093/ckj/sfx120] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 532 |
Rancic N, Vavic N, Obrencevic K, Pilipovic F, Dragojevic-Simic V. Tacrolimus Utilization and Expenditure in Serbia. Front Public Health 2017;5:291. [PMID: 29164097 DOI: 10.3389/fpubh.2017.00291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 533 |
Ascha M, Ascha MS, Tanenbaum J, Bordeaux JS. Risk Factors for Melanoma in Renal Transplant Recipients. JAMA Dermatol 2017;153:1130-6. [PMID: 28746700 DOI: 10.1001/jamadermatol.2017.2291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 534 |
Weissenbacher A, Loupy A, Chandraker A, Schneeberger S. Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantation. Curr Opin Organ Transplant 2016;21:510-5. [PMID: 27517505 DOI: 10.1097/MOT.0000000000000349] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 535 |
Bushljetikj IR, Selim G, Taneva OS, Dohchev S, Stankov O, Stavridis S, Saidi S, Dimitrovski K, Ivanovska BZ, Jukic NB, Spasovski G. Monitoring of Renal Allograft Function with Different Equations: What are the Differences? BANTAO Journal 2017;15:24-8. [DOI: 10.1515/bj-2017-0006] [Reference Citation Analysis]
|
| 536 |
Dharnidharka VR, Naik AS, Axelrod DA, Schnitzler MA, Zhang Z, Bae S, Segev DL, Brennan DC, Alhamad T, Ouseph R, Lam NN, Nazzal M, Randall H, Kasiske BL, McAdams-Demarco M, Lentine KL. Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice. Transpl Int 2018;31:198-211. [PMID: 28987015 DOI: 10.1111/tri.13079] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 537 |
Naicker D, Reed PW, Ronaldson J, Kara T, Wong W, Prestidge C. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients. Pediatr Nephrol 2017;32:2125-31. [PMID: 28660366 DOI: 10.1007/s00467-017-3707-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 538 |
Arns W, Huppertz A, Rath T, Ziefle S, Rump LC, Hansen A, Budde K, Lehner LJ, Shipkova M, Baeumer D, Kroeger I, Sieder C, Klein T, Schenker P. Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial. Transplantation 2017;101:2780-8. [DOI: 10.1097/tp.0000000000001843] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 539 |
Molecular Study of Cytomegalovirus Infection among Children with End Stage Renal Diseases Undergoing Dialysis, Pilot Study. Medical & Clinical Research 2017;2. [DOI: 10.33140/mcr.02.04.02] [Reference Citation Analysis]
|
| 540 |
Leal R, Tsapepas D, Crew RJ, Dube GK, Ratner L, Batal I. Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation. Kidney Int Rep 2018;3:281-90. [PMID: 30276344 DOI: 10.1016/j.ekir.2017.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 541 |
Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Clin Kidney J. 2018;11:315-329. [PMID: 29942495 DOI: 10.1093/ckj/sfx122] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 542 |
Obi Y, Kalantar-Zadeh K, Streja E, Rhee CM, Reddy UG, Soohoo M, Wang Y, Ravel V, You AS, Jing J, Sim JJ, Nguyen DV, Gillen DL, Saran R, Robinson B, Kovesdy CP. Seasonal variations in transition, mortality and kidney transplantation among patients with end-stage renal disease in the USA. Nephrol Dial Transplant 2017;32:ii99-ii105. [PMID: 28201764 DOI: 10.1093/ndt/gfw379] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 543 |
van Sloten TT, de Klaver PAG, van den Wall Bake AWL. Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man. Br J Clin Pharmacol 2018;84:208-10. [PMID: 28891590 DOI: 10.1111/bcp.13433] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 544 |
Bia MJ. Slow Rise in Serum Creatinine Level in a Kidney Transplant Recipient 3 Years Post-Transplant. Clin J Am Soc Nephrol 2017;12:1692-4. [PMID: 28336817 DOI: 10.2215/CJN.12691216] [Reference Citation Analysis]
|
| 545 |
Gunawansa N. Tailor-Made Induction Therapy in ‘Low Risk’ Renal Transplants; A South Asian Perspective. Arch Clin Nephrol 2017. [DOI: 10.17352/acn.000024] [Reference Citation Analysis]
|
| 546 |
Hong YA, Hwang HS, Sul HJ, Kim SY, Chang YK. Transitional cell carcinoma involving graft kidney in a kidney transplant recipient: a case report. BMC Nephrol 2017;18:299. [PMID: 28934936 DOI: 10.1186/s12882-017-0715-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 547 |
Ravaioli M, De Pace V, Comai G, Busutti M, Del Gaudio M, Amaduzzi A, Cucchetti A, Siniscalchi A, La Manna G, D'Errico AAD, Pinna AD. Successful Dual Kidney Transplantation After Hypothermic Oxygenated Perfusion of Discarded Human Kidneys. Am J Case Rep 2017;18:1009-13. [PMID: 28928357 DOI: 10.12659/ajcr.905377] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 548 |
Dujardin A, Le Fur A, Cantarovich D. Aortic Dissection and Severe Renal Failure 6 Years After Kidney Transplantation. Transplant Direct 2017;3:e202. [PMID: 28894790 DOI: 10.1097/TXD.0000000000000723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 549 |
Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, Mourad M, Lõhmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ; Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients (ADVANCE) study investigators. Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial. Transplantation 2017;101:1924-34. [PMID: 27547871 DOI: 10.1097/TP.0000000000001453] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 550 |
Ashimov Z, Gaibyldaev Z. Types and Structure of Complications, and Causes of Mortality with Different Combinations of Immunosuppressants in Patients of Undergoing Organ Transplantation. HVT 2017;1:61. [DOI: 10.24969/hvt.2017.21] [Reference Citation Analysis]
|
| 551 |
Marinaki S, Kolovou K, Sakellariou S, Boletis JN, Delladetsima IK. Hepatitis B in renal transplant patients. World J Hepatol 2017;9:1054-63. [PMID: 28951777 DOI: 10.4254/wjh.v9.i25.1054] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 552 |
Li J, Chen S, Qin X, Fu Q, Bi H, Zhang Y, Wang X, Liu L, Wang C, Huang M. Wuzhi Tablet ( Schisandra sphenanthera Extract) Is a Promising Tacrolimus-Sparing Agent for Renal Transplant Recipients Who Are CYP3A5 Expressers: a Two-Phase Prospective Study. Drug Metab Dispos 2017;45:1114-9. [DOI: 10.1124/dmd.117.076737] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 553 |
Gharibi Z, Ayvaci MUS, Hahsler M, Giacoma T, Gaston RS, Tanriover B. Cost-Effectiveness of Antibody-Based Induction Therapy in Deceased Donor Kidney Transplantation in the United States. Transplantation 2017;101:1234-41. [PMID: 27379555 DOI: 10.1097/TP.0000000000001310] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 554 |
Amkreutz J, Koch A, Buendgens L, Muehlfeld A, Trautwein C, Eisert A. Prevalence and nature of potential drug–drug interactions among kidney transplant patients in a German intensive care unit. Int J Clin Pharm 2017;39:1128-39. [DOI: 10.1007/s11096-017-0525-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 555 |
Liu FC, Lin HT, Lin JR, Yu HP. Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients. Ther Clin Risk Manag 2017;13:1043-51. [PMID: 28860788 DOI: 10.2147/TCRM.S142348] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 556 |
Ersan S, Ertilav S, Celik A, Sifil A, Cavdar C, Unlu M, Sarioglu S, Gulay H, Camsari T. Prevalence and Causes of Proteinuria in Kidney Transplant Recipients: Data from a Single Center. BANTAO Journal 2016;14:20-2. [DOI: 10.1515/bj-2016-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 557 |
Wiebe C, Rush DN, Nevins TE, Birk PE, Blydt-Hansen T, Gibson IW, Goldberg A, Ho J, Karpinski M, Pochinco D, Sharma A, Storsley L, Matas AJ, Nickerson PW. Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development. J Am Soc Nephrol 2017;28:3353-62. [PMID: 28729289 DOI: 10.1681/ASN.2017030287] [Cited by in Crossref: 156] [Cited by in F6Publishing: 158] [Article Influence: 26.0] [Reference Citation Analysis]
|
| 558 |
Peters FS, Peeters AMA, Hofland LJ, Betjes MGH, Boer K, Baan CC. Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. Front Immunol 2017;8:822. [PMID: 28747916 DOI: 10.3389/fimmu.2017.00822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 559 |
Goodall DL, Willicombe M, McLean AG, Taube D. High Intrapatient Variability of Tacrolimus Levels and Outpatient Clinic Nonattendance Are Associated With Inferior Outcomes in Renal Transplant Patients. Transplant Direct 2017;3:e192. [PMID: 28795143 DOI: 10.1097/TXD.0000000000000710] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 560 |
Zheng J, Song W. Alemtuzumab versus antithymocyte globulin induction therapies in kidney transplantation patients: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore) 2017;96:e7151. [PMID: 28700465 DOI: 10.1097/MD.0000000000007151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 561 |
Pankhurst L, Hudson A, Mumford L, Willicombe M, Galliford J, Shaw O, Thuraisingham R, Puliatti C, Talbot D, Griffin S, Torpey N, Ball S, Clark B, Briggs D, Fuggle SV, Higgins RM. The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants. Transplant Direct. 2017;3:e181. [PMID: 28706984 DOI: 10.1097/txd.0000000000000695] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 562 |
Franceschini E, Plessi J, Zona S, Santoro A, Digaetano M, Fontana F, Alfano G, Guaraldi G, Comoli P, Facchini F, Potenza L, Gennari W, Codeluppi M, Luppi M, Cappelli G, Gyssens IC, Mussini C. Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study. Transplant Direct 2017;3:e182. [PMID: 28706985 DOI: 10.1097/TXD.0000000000000703] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 563 |
Ling J, Anderson T, Warren S, Kirkland G, Jose M, Yu R, Yew S, Mcfadyen S, Graver A, Johnson W, Jeffs L. Hypercalcaemia preceding diagnosis of Pneumocystis jirovecii pneumonia in renal transplant recipients. Clin Kidney J 2017;10:845-51. [PMID: 29225815 DOI: 10.1093/ckj/sfx044] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 564 |
Ballesteros F, Allard J, Durand C, Cardinal H, Lalonde L, Fortin MC. Kidney Transplant Recipients' Perspectives on Cardiovascular Disease and Related Risk Factors After Transplantation: A Qualitative Study. Transplant Direct 2017;3:e162. [PMID: 28620646 DOI: 10.1097/TXD.0000000000000679] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 565 |
Rosina KTC, Menna Barreto APM, Pontes KSS, Martins CJM, Souza E, Bregman R, Barreto Silva MI, Klein MRST. Vitamin D status in renal transplant recipients living in a low-latitude city: association with body fat, cardiovascular risk factors, estimated glomerular filtration rate and proteinuria. Br J Nutr 2017;117:1279-90. [DOI: 10.1017/s000711451700112x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 566 |
Bia MJ. Diarrhea in a Long-Term Kidney-Pancreas Recipient. Clin J Am Soc Nephrol 2017;12:998-1000. [PMID: 28341775 DOI: 10.2215/CJN.12671216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 567 |
Dantal J, Campone M. Daunting but Worthy Goal: Reducing the De Novo Cancer Incidence After Transplantation. Transplantation 2016;100:2569-83. [PMID: 27861286 DOI: 10.1097/TP.0000000000001428] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 568 |
Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, Akl EA, Azzi JR. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clin J Am Soc Nephrol. 2017;12:1321-1336. [PMID: 28576905 DOI: 10.2215/cjn.13221216] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 569 |
Baker RJ, Mark PB, Patel RK, Stevens KK, Palmer N. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 2017;18:174. [PMID: 28571571 DOI: 10.1186/s12882-017-0553-2] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 570 |
Daloul R, Gupta S, Brennan DC. Biologics in Transplantation (Anti-thymocyte Globulin, Belatacept, Alemtuzumab): How Should We Use Them? Curr Transpl Rep 2017;4:82-90. [DOI: 10.1007/s40472-017-0147-8] [Reference Citation Analysis]
|
| 571 |
Zhang W, Zhong H, Zhuang L, Yu J, Xu X, Wang W, Zhang M, Zhou L, Zheng S. Peripheral blood CD4(+) cell ATP activity measurement to predict HCC recurrence post-DCD liver transplant. Int J Clin Pract 2016;70 Suppl 185:11-6. [PMID: 27197999 DOI: 10.1111/ijcp.12811] [Reference Citation Analysis]
|
| 572 |
Laskin BL, Singh HK, Beier UH, Moatz T, Furth SL, Bunin N, Witte D, Goebel J, Davies SM, Dandoy C. The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot Study. Transplantation. 2016; Feb 18; Epub ahead of print. [PMID: 26895217 DOI: 10.1097/tp.0000000000001085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 573 |
Lamarche C, Orio J, Collette S, Senécal L, Hébert MJ, Renoult É, Tibbles LA, Delisle JS. BK Polyomavirus and the Transplanted Kidney: Immunopathology and Therapeutic Approaches. Transplantation 2016;100:2276-87. [PMID: 27391196 DOI: 10.1097/TP.0000000000001333] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 574 |
Shen CL, Yang AH, Lien TJ, Tarng DC, Yang CY. Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection. Sci Rep 2017;7:1986. [PMID: 28512328 DOI: 10.1038/s41598-017-02140-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 575 |
Galle J, Floege J. [Choosing wisely recommendations in nephrology]. Internist (Berl) 2017;58:568-74. [PMID: 28488055 DOI: 10.1007/s00108-017-0248-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 576 |
Leyssens A, Dierickx D, Verbeken EK, Tousseyn T, Verleden SE, Vanaudenaerde BM, Dupont LJ, Yserbyt J, Verleden GM, Van Raemdonck DE, Vos R. Post-transplant lymphoproliferative disease in lung transplantation: A nested case-control study. Clin Transplant 2017;31:e12983. [DOI: 10.1111/ctr.12983] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 577 |
Brocklebank V, Kavanagh D. Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea. Clin Kidney J 2017;10:600-24. [PMID: 28980670 DOI: 10.1093/ckj/sfx081] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 578 |
Bamoulid J, Crépin T, Courivaud C, Rebibou JM, Saas P, Ducloux D. Antithymocyte globulins in renal transplantation-from lymphocyte depletion to lymphocyte activation: The doubled-edged sword. Transplant Rev (Orlando) 2017;31:180-7. [PMID: 28456447 DOI: 10.1016/j.trre.2017.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 579 |
Long CM. Solid Organ Transplant. PharmacotherapyFirst: A Multimedia Learning Resource 2017. [DOI: 10.21019/pharmacotherapyfirst.sot_overview] [Reference Citation Analysis]
|
| 580 |
Leal R, Pinto H, Galvão A, Santos L, Romãozinho C, Macário F, Alves R, Pratas J, Sousa V, Marinho C, Prado e Castro L, Campos M, Mota A, Figueiredo A. Nephrotic Range Proteinuria in Renal Transplantation: Clinical and Histologic Correlates in a 10-year Retrospective Study. Transplantation Proceedings 2017;49:792-4. [DOI: 10.1016/j.transproceed.2017.01.066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 581 |
Majernikova M, Rosenberger J, Prihodova L, Jarcuskova M, Roland R, Groothoff JW, van Dijk JP. Posttransplant Anemia as a Prognostic Factor of Mortality in Kidney-Transplant Recipients. Biomed Res Int 2017;2017:6987240. [PMID: 28401160 DOI: 10.1155/2017/6987240] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 582 |
Kapoor TM, Mahadeshwar P, Nguyen S, Li J, Kapoor S, Bathon J, Giles J, Askanase A. Low prevalence of Pneumocystis pneumonia in hospitalized patients with systemic lupus erythematosus: review of a clinical data warehouse. Lupus 2017;26:1473-82. [PMID: 28399687 DOI: 10.1177/0961203317703494] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 583 |
Halawa A. Low Dose Rabbit Anti-Thymocyte Globulin as an Induction immunosuppression in High-Risk Renal Transplant Recipients. UNOAJ 2017;4. [DOI: 10.15406/unoaj.2017.04.00134] [Reference Citation Analysis]
|
| 584 |
Jambaldorj E, Han M, Jeong JC, Koo TY, Min SI, Song EY, Ha J, Ahn C, Yang J. Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country. BMC Nephrol 2017;18:88. [PMID: 28292277 DOI: 10.1186/s12882-017-0506-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 585 |
Seoane-Pillado MT, Pita-Fernández S, Valdés-Cañedo F, Seijo-Bestilleiro R, Pértega-Díaz S, Fernández-Rivera C, Alonso-Hernández Á, González-Martín C, Balboa-Barreiro V. Incidence of cardiovascular events and associated risk factors in kidney transplant patients: a competing risks survival analysis. BMC Cardiovasc Disord 2017;17:72. [PMID: 28270107 DOI: 10.1186/s12872-017-0505-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 586 |
Ayubi E, Doosti-Irani A, Sanjari Moghaddam A, Khazaei S, Mansori K, Safiri S, Sani M, Mostafavi E. Comparison of QuantiFERON-TB Gold In-Tube (QFT-GIT) and tuberculin skin test (TST) for diagnosis of latent tuberculosis in haemodialysis (HD) patients: a meta-analysis of κ estimates. Epidemiol Infect 2017;145:1824-33. [PMID: 28249638 DOI: 10.1017/S0950268817000334] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 587 |
Noreikaitė A, Saint-Marcoux F, Marquet P, Kaduševičius E, Stankevičius E. Influence of cyclosporine and everolimus on the main mycophenolate mofetil pharmacokinetic parameters: Cross-sectional study. Medicine (Baltimore) 2017;96:e6469. [PMID: 28353583 DOI: 10.1097/MD.0000000000006469] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 588 |
Lo C, Jun M, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients. Cochrane Database Syst Rev. 2017;2:CD009966. [PMID: 28238223 DOI: 10.1002/14651858.cd009966.pub2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 589 |
Thölking G, Gerth HU, Schuette-Nuetgen K, Reuter S. Influence of tacrolimus metabolism rate on renal function after solid organ transplantation. World J Transplant 2017; 7(1): 26-33 [PMID: 28280692 DOI: 10.5500/wjt.v7.i1.26] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 590 |
Liao R, Lyu X, Tang W, Gao K. Short- and long-term outcomes with renin-angiotensin-aldosterone inhibitors in renal transplant recipients: A meta-analysis of randomized controlled trials. Clin Transplant 2017;31:e12917. [DOI: 10.1111/ctr.12917] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 591 |
Ponticelli C, Cucchiari D. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment. J Nephrol 2017;30:155-7. [PMID: 28211033 DOI: 10.1007/s40620-017-0378-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 592 |
Walker K, Gardner K, Law A, Hawkins N, Hull P. Photoprotection Knowledge and Behaviours Among Organ Transplant Recipients. J Cutan Med Surg 2017;21:217-20. [PMID: 28300448 DOI: 10.1177/1203475417692728] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 593 |
Lionaki S, Panagiotellis K, Melexopoulou C, Boletis JN. The clinical course of IgA nephropathy after kidney transplantation and its management. Transplant Rev (Orlando) 2017;31:106-14. [PMID: 28209246 DOI: 10.1016/j.trre.2017.01.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 594 |
Singh AG, Jai SJ, Ganpule AP, VijayKumar M, Sabnis RB, Desai MR. Critical appraisal of consecutive 36 cases of post renal transplant lymphocele: a proposed algorithm. World J Urol 2017;35:1443-50. [PMID: 28138768 DOI: 10.1007/s00345-016-1997-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 595 |
Schlott F, Steubl D, Hoffmann D, Matevossian E, Lutz J, Heemann U, Hösel V, Busch DH, Renders L, Neuenhahn M. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs. PLoS One 2017;12:e0171035. [PMID: 28129395 DOI: 10.1371/journal.pone.0171035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 596 |
Kannegieter NM, Hesselink DA, Dieterich M, Kraaijeveld R, Rowshani AT, Leenen PJ, Baan CC. The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function. PLoS One 2017;12:e0170806. [PMID: 28122021 DOI: 10.1371/journal.pone.0170806] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 597 |
Liu J, Liu D, Li J, Zhu L, Zhang C, Lei K, Xu Q, You R. Efficacy and Safety of Everolimus for Maintenance Immunosuppression of Kidney Transplantation: A Meta-Analysis of Randomized Controlled Trials. PLoS One 2017;12:e0170246. [PMID: 28107397 DOI: 10.1371/journal.pone.0170246] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 598 |
Andrews LM, de Winter BC, Tang JT, Shuker N, Bouamar R, van Schaik RH, Koch BC, van Gelder T, Hesselink DA. Overweight Kidney Transplant Recipients Are at Risk of Being Overdosed Following Standard Bodyweight-Based Tacrolimus Starting Dose. Transplant Direct 2017;3:e129. [PMID: 28361113 DOI: 10.1097/TXD.0000000000000644] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 599 |
Westhoff TH. Belatacept in renal transplantation-quo vadis? Transl Androl Urol 2016;5:953-5. [PMID: 28078228 DOI: 10.21037/tau.2016.11.11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 600 |
Mak SK, Sin HK, Lo KY, Lo MW, Chan SF, Lo KC, Wong YY, Ho LY, Wong PN, Wong AKM. Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up. Clin Exp Nephrol 2017;21:764-70. [PMID: 28083764 DOI: 10.1007/s10157-016-1364-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 601 |
Haller MC, Kammer M, Kainz A, Baer HJ, Heinze G, Oberbauer R. Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med 2017;15:8. [PMID: 28077142 DOI: 10.1186/s12916-016-0772-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 602 |
Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC. Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients. Cochrane Database Syst Rev 2017;1:CD004759. [PMID: 28073178 DOI: 10.1002/14651858.CD004759.pub2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 603 |
Lai Q, Melandro F, Pisani F. De Novo and Recurrence of Renal Disease. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00042-4] [Reference Citation Analysis]
|
| 604 |
Charnaya O, Moudgil A. Hypertension in the Pediatric Kidney Transplant Recipient. Front Pediatr 2017;5:86. [PMID: 28507980 DOI: 10.3389/fped.2017.00086] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 605 |
Lai Q, Pisani F. Metabolic Disorders Following Kidney Transplantation. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00036-9] [Reference Citation Analysis]
|
| 606 |
Hinten F, Hilbrands LB, Meeuwis KA, van Bergen-verkuyten MC, Slangen BF, van Rossum MM, Rahamat-langendoen J, Massuger LF, de Hullu JA, Melchers WJ. Improvement of Gynecological Screening of Female Renal Transplant Recipients by Self-Sampling for Human Papillomavirus Detection. J Low Genit Tract Dis 2017;21:33-6. [DOI: 10.1097/lgt.0000000000000270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 607 |
Hellemans R, Bosmans JL, Abramowicz D. Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies? Am J Transplant 2017;17:22-7. [PMID: 27223882 DOI: 10.1111/ajt.13884] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 608 |
Rahbar M, Poormand G, Mahmoodi MK, Jazayeri A, Jazayeri SM. Asymptomatic Epstein-Barr Virus Shedding in the Urine of Kidney Transplant Recipients: Case Reports and Review of the Literature. Infect Dis Rep 2016;8:6817. [PMID: 28191298 DOI: 10.4081/idr.2016.6817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 609 |
Kraaij T, Bredewold OW, Trompet S, Huizinga TW, Rabelink TJ, de Craen AJ, Teng YK. TAC-TIC use of tacrolimus-based regimens in lupus nephritis. Lupus Sci Med 2016;3:e000169. [PMID: 28123768 DOI: 10.1136/lupus-2016-000169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 610 |
Maliakkal JG, Brennan DC, Goss C, Horwedel TA, Chen H, Fong DK, Agarwal N, Zheng J, Schechtman KB, Dharnidharka VR. Ureteral stent placement and immediate graft function are associated with increased risk of BK viremia in the first year after kidney transplantation. Transpl Int 2017;30:153-61. [PMID: 27862417 DOI: 10.1111/tri.12888] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 611 |
Vlachopanos G, Bridson JM, Sharma A, Halawa A. Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility. World J Transplant 2016; 6(4): 759-766 [PMID: 28058228 DOI: 10.5500/wjt.v6.i4.759] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 612 |
Tariciotti L, Manzia TM, Sforza D, Anselmo A, Tisone G. Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report. Transplant Proc 2016;48:3109-11. [PMID: 27932158 DOI: 10.1016/j.transproceed.2016.07.021] [Reference Citation Analysis]
|
| 613 |
Wang MK, White C, Akbari A, Brown P, Hussain N, Hiremath S, Knoll G. Utilizing Estimated Creatinine Excretion to Improve the Performance of Spot Urine Samples for the Determination of Proteinuria in Kidney Transplant Recipients. PLoS One 2016;11:e0166547. [PMID: 27911917 DOI: 10.1371/journal.pone.0166547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 614 |
Rebollo-Mesa I, Nova-Lamperti E, Mobillo P, Runglall M, Christakoudi S, Norris S, Smallcombe N, Kamra Y, Hilton R, Bhandari S, Baker R, Berglund D, Carr S, Game D, Griffin S, Kalra PA, Lewis R, Mark PB, Marks S, Macphee I, McKane W, Mohaupt MG, Pararajasingam R, Kon SP, Serón D, Sinha MD, Tucker B, Viklický O, Lechler RI, Lord GM, Hernandez-Fuentes MP; Indices of Tolerance EU Consortium. Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment? Am J Transplant 2016;16:3443-57. [PMID: 27328267 DOI: 10.1111/ajt.13932] [Cited by in Crossref: 78] [Cited by in F6Publishing: 79] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 615 |
Miao B, Lao XM, Lin GL. Post-transplant withdrawal of lamivudine results in fatal hepatitis flares in kidney transplant recipients, under immune suppression, with inactive hepatitis B infection. Afr Health Sci 2016;16:1094-100. [PMID: 28479903 DOI: 10.4314/ahs.v16i4.27] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 616 |
Bamoulid J, Staeck O, Halleck F, Khadzhynov D, Paliege A, Brakemeier S, Dürr M, Budde K. Immunosuppression and Results in Renal Transplantation. European Urology Supplements 2016;15:415-29. [DOI: 10.1016/j.eursup.2016.04.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 617 |
Carrillo-Ibarra S, Cerrillos-Gutiérrez JI, Escalante-Núñez A, Rojas-Campos E, Gómez-Navarro B, Sifuentes-Franco S, Cardona-Muñoz EG, Miranda-Díaz AG. The Oxidative and Inflammatory State in Patients with Acute Renal Graft Dysfunction Treated with Tacrolimus. Oxid Med Cell Longev 2016;2016:5405847. [PMID: 27872679 DOI: 10.1155/2016/5405847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 618 |
Akagun T, Yazici H, Caliskan Y, Ozluk Y, Sahin S, Turkmen A, Kılıcaslan I, Sever MS. The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection. Ren Fail 2017;39:19-25. [PMID: 27776435 DOI: 10.1080/0886022X.2016.1244073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 619 |
Holdaas H, De Simone P, Zuckermann A. Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update. J Transplant 2016;2016:4369574. [PMID: 27807479 DOI: 10.1155/2016/4369574] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 620 |
Lim MA, Kohli J, Bloom RD. Immunosuppression for kidney transplantation: Where are we now and where are we going? Transplant Rev (Orlando). 2017;31:10-17. [PMID: 28340885 DOI: 10.1016/j.trre.2016.10.006] [Cited by in Crossref: 76] [Cited by in F6Publishing: 60] [Article Influence: 10.9] [Reference Citation Analysis]
|
| 621 |
Ma TK, Chow KM, Cheng PM, Kwan BC, Leung CB, Li PK, Szeto CC. Pharmacokinetic study of once-daily formulation of tacrolimus (Advagraf) in stable Chinese kidney transplant recipients. Hong Kong Journal of Nephrology 2016;19:1-6. [DOI: 10.1016/j.hkjn.2016.03.002] [Reference Citation Analysis]
|
| 622 |
Hooper DK, Mitsnefes M. A systems-based approach to managing blood pressure in children following kidney transplantation. Pediatr Nephrol 2016;31:1593-604. [PMID: 26482251 DOI: 10.1007/s00467-015-3192-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 623 |
Ooka K, Lim JK. Treatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug Therapy. J Clin Transl Hepatol 2016;4:206-27. [PMID: 27777889 DOI: 10.14218/JCTH.2016.00017] [Reference Citation Analysis]
|
| 624 |
Kim YS. Open the black box; is urine valuable for screening BK virus-associated nephropathy? Kidney Res Clin Pract 2016;35:131-2. [PMID: 27668154 DOI: 10.1016/j.krcp.2016.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 625 |
L'Huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review. Hum Vaccin Immunother 2015;11:2852-63. [PMID: 26291740 DOI: 10.1080/21645515.2015.1078043] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 626 |
Rancic N, Dragojevic-Simic V, Vavic N, Kovacevic A, Segrt Z, Djordjevic N. Economic Evaluation of Pharmacogenetic Tests in Patients Subjected to Renal Transplantation: A Review of Literature. Front Public Health 2016;4:189. [PMID: 27630984 DOI: 10.3389/fpubh.2016.00189] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 627 |
Størset E, Åsberg A, Hartmann A, Reisaeter AV, Holdaas H, Skauby M, Bergan S, Midtvedt K. Low-target tacrolimus in de novo standard risk renal transplant recipients: A single-centre experience: Low-target tacrolimus in renal transplantation. Nephrology 2016;21:821-7. [DOI: 10.1111/nep.12738] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 628 |
Pallet N, Etienne I, Buchler M, Bailly E, Hurault de Ligny B, Choukroun G, Colosio C, Thierry A, Vigneau C, Moulin B, Le Meur Y, Heng AE, Legendre C, Beaune P, Loriot MA, Thervet E. Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype. Am J Transplant 2016;16:2670-5. [PMID: 26990694 DOI: 10.1111/ajt.13788] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
|
| 629 |
Malone K, Clark S, Palmer JA, Lopez S, Pradhan M, Furth S, Kim J, Fisher B, Laskin B. A quality improvement initiative to increase pneumococcal vaccination coverage among children after kidney transplant. Pediatr Transplant 2016;20:783-9. [PMID: 27334506 DOI: 10.1111/petr.12742] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 630 |
Unagami K, Ishida H, Okumi M, Hirai T, Toki D, Omoto K, Shimizu T, Inui M, Nitta K, Tanabe K. Assessment of 4 Cases of Kidney Transplantation from Hepatitis C Virus Antibody-Positive and RNA-Negative Donors to Antibody-Negative Recipients. Transplant Direct 2016;2:e102. [PMID: 27795994 DOI: 10.1097/TXD.0000000000000614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 631 |
Luscalov S, Loga L, Dican L, Junie LM. Cytomegalovirus infection in immunosuppressed patients after kidney transplantation. Clujul Med 2016;89:343-6. [PMID: 27547053 DOI: 10.15386/cjmed-587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 632 |
Kucirka LM, Durand CM, Bae S, Avery RK, Locke JE, Orandi BJ, McAdams-DeMarco M, Grams ME, Segev DL. Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. Am J Transplant 2016;16:2368-76. [PMID: 27111897 DOI: 10.1111/ajt.13840] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
|
| 633 |
Kashgary A, Sontrop JM, Li L, Al-Jaishi AA, Habibullah ZN, Alsolaimani R, Clark WF. The role of plasma exchange in treating post-transplant focal segmental glomerulosclerosis: A systematic review and meta-analysis of 77 case-reports and case-series. BMC Nephrol. 2016;17:104. [PMID: 27473582 DOI: 10.1186/s12882-016-0322-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
|
| 634 |
Kim YJ, Kim SI. Vaccination strategies in patients with solid organ transplant: evidences and future perspectives. Clin Exp Vaccine Res 2016;5:125-31. [PMID: 27489802 DOI: 10.7774/cevr.2016.5.2.125] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 635 |
White CA, Akbari A, Talreja H, Lalani N, Knoll GA. Classification of Kidney Transplant Recipients Using a Combination of Estimated GFR and Albuminuria Reflects Risk. Transplant Direct 2016;2:e96. [PMID: 27819037 DOI: 10.1097/TXD.0000000000000606] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 636 |
Boan P, Hewison C, Swaminathan R, Irish A, Warr K, Sinniah R, Pryce TM, Flexman J. Optimal use of plasma and urine BK viral loads for screening and predicting BK nephropathy. BMC Infect Dis. 2016;16:342. [PMID: 27448566 DOI: 10.1186/s12879-016-1652-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 637 |
Fitzpatrick A, Mohammadi F, Jesudason S. Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby. Int J Womens Health 2016;8:273-85. [PMID: 27471410 DOI: 10.2147/IJWH.S76819] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 638 |
Taber DJ, Hunt KJ, Fominaya CE, Payne EH, Gebregziabher M, Srinivas TR, Baliga PK, Egede LE. Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension 2016;68:715-25. [PMID: 27402921 DOI: 10.1161/HYPERTENSIONAHA.116.07775] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 639 |
Tanriover B, Jaikaransingh V, MacConmara MP, Parekh JR, Levea SL, Ariyamuthu VK, Zhang S, Gao A, Ayvaci MU, Sandikci B, Rajora N, Ahmed V, Lu CY, Mohan S, Vazquez MA. Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. Clin J Am Soc Nephrol 2016;11:1650-61. [PMID: 27364616 DOI: 10.2215/CJN.13171215] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 640 |
Sautenet B, Blancho G, Büchler M, Morelon E, Toupance O, Barrou B, Ducloux D, Chatelet V, Moulin B, Freguin C, Hazzan M, Lang P, Legendre C, Merville P, Mourad G, Mousson C, Pouteil-Noble C, Purgus R, Rerolle JP, Sayegh J, Westeel PF, Zaoui P, Boivin H, Le Gouge A, Lebranchu Y. One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Double-blind Randomized Placebo-controlled Trial. Transplantation 2016;100:391-9. [PMID: 26555944 DOI: 10.1097/TP.0000000000000958] [Cited by in Crossref: 122] [Cited by in F6Publishing: 132] [Article Influence: 17.4] [Reference Citation Analysis]
|
| 641 |
Dugo M, Mangino M, Meola M, Petrucci I, Valente ML, Laurino L, Stella M, Mastrosimone S, Brunello A, Virgilio B. Ultrasound findings of BK polyomavirus-associated nephropathy in renal transplant patients. J Nephrol. 2016; Jun 24; Epub ahead of print. [PMID: 27342655 DOI: 10.1007/s40620-16-0327-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 642 |
Hardinger KL, Sunderland D, Wiederrich JA. Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy. Int J Nephrol Renovasc Dis 2016;9:139-50. [PMID: 27307759 DOI: 10.2147/IJNRD.S88816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 643 |
Dobrowolski LC, van Huis M, van der Lee JH, Peters Sengers H, Liliën MR, Cransberg K, Cornelissen M, Bouts AH, de Fijter JW, Berger SP, van Zuilen A, Nurmohamed SA, Betjes MH, Hilbrands L, Hoitsma AJ, Bemelman FJ, Krediet P, Groothoff JW. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands. Nephrol Dial Transplant 2016;31:1947-56. [DOI: 10.1093/ndt/gfw225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 644 |
Khorvash F, Mortazavi M, Hakamifard A, Ataei B. Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients. Adv Biomed Res 2016;5:108. [PMID: 27376047 DOI: 10.4103/2277-9175.183669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 645 |
Foster R, Ferguson TW, Rigatto C, Lerner B, Tangri N, Komenda P. A retrospective review of the two-step tuberculin skin test in dialysis patients. Can J Kidney Health Dis 2016;3:28. [PMID: 27274397 DOI: 10.1186/s40697-016-0119-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 646 |
Lee PH, Fan PYW, Kee TYS. Medication therapy management by pharmacists in a kidney transplant ambulatory clinic. Proceedings of Singapore Healthcare 2016;25:117-121. [DOI: 10.1177/2010105816630026] [Reference Citation Analysis]
|
| 647 |
Piotti G, Cremaschi E, Maggiore U. Once-daily prolonged-release tacrolimus formulations for kidney transplantation: what the nephrologist needs to know. J Nephrol 2017;30:53-61. [DOI: 10.1007/s40620-016-0316-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 648 |
Opelz G, Unterrainer C, Süsal C, Döhler B. Efficacy and safety of antibody induction therapy in the current era of kidney transplantation. Nephrol Dial Transplant 2016;31:1730-8. [PMID: 27190386 DOI: 10.1093/ndt/gfw086] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 649 |
Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hernández D, Fernández C, Esforzado N, Paschoalin R, Pérez N, García AI, Del Amo M, Pomés J, González Rinne A, Marrero D, Pérez E, Henríquez F, Díaz JM, Silva I, López V, Perello M, Ramos D, Beneyto I, Cruzado JM, Martínez Castelao A, Bravo J, Rodríguez M, Díaz C, Crespo J, Anaya F, Rodríguez ML, Cubero JJ, Pascual P, Romero R, Andrés Belmonte A, Checa MD, Jiménez C, Escuin F, Crespo M, Mir M, Gómez G, Bayes B, González MJ, Gutiérrez A, Cuberes M, Rodríguez Benoit A, García T, Llamas F, Ortega A, Conde JL, Gómez Alamillo C. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study). Nefrología (English Edition) 2016;36:255-67. [DOI: 10.1016/j.nefroe.2016.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 650 |
Torres A, Torregrosa V, Marcen R, Campistol JM, Arias M, Hernández D, Fernández C, Esforzado N, Paschoalin R, Pérez N, García AI, Del Amo M, Pomés J, González Rinne A, Marrero D, Pérez E, Henríquez F, Díaz JM, Silva I, López V, Perello M, Ramos D, Beneyto I, Cruzado JM, Martínez Castelao A, Bravo J, Rodríguez M, Díaz C, Crespo J, Anaya F, Rodríguez ML, Cubero JJ, Pascual P, Romero R, Andrés Belmonte A, Checa MD, Jiménez C, Escuin F, Crespo M, Mir M, Gómez G, Bayes B, González MJ, Gutiérrez A, Cuberes M, Rodríguez Benoit A, García T, Llamas F, Ortega A, Conde JL, Gómez Alamillo C. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study). Nefrologia 2016;36:255-67. [PMID: 27133898 DOI: 10.1016/j.nefro.2016.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 651 |
Yazbek DC, de Carvalho AB, Barros CS, Medina Pestana JO, Canziani ME. Effect of Statins on the Progression of Coronary Calcification in Kidney Transplant Recipients. PLoS One 2016;11:e0151797. [PMID: 27100788 DOI: 10.1371/journal.pone.0151797] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 652 |
Han SS, Yang SH, Kim MC, Cho JY, Min SI, Lee JP, Kim DK, Ha J, Kim YS. Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function. PLoS One 2016;11:e0153491. [PMID: 27082871 DOI: 10.1371/journal.pone.0153491] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 653 |
Cho H, Yu H, Shin E, Kim YH, Park SK, Jo MW. Risk Factors for Graft Failure and Death following Geriatric Renal Transplantation. PLoS One 2016;11:e0153410. [PMID: 27074003 DOI: 10.1371/journal.pone.0153410] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 654 |
Umber A, Killackey M, Paramesh A, Liu Y, Qin H, Atiq M, Lee B, Alper AB, Simon E, Buell J, Zhang R. A comparison of three induction therapies on patients with delayed graft function after kidney transplantation. J Nephrol 2017;30:289-95. [PMID: 27062485 DOI: 10.1007/s40620-016-0304-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 655 |
Cioni M, Leboeuf C, Comoli P, Ginevri F, Hirsch HH. Characterization of Immunodominant BK Polyomavirus 9mer Epitope T Cell Responses. Am J Transplant 2016;16:1193-206. [PMID: 26663765 DOI: 10.1111/ajt.13598] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 656 |
Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, Treleaven D, Holland D, White C, Muirhead N, Cantarovich M, Paquet M, Kiberd B, Gourishankar S, Shapiro J, Prasad R, Cole E, Pilmore H, Cronin V, Hogan D, Ramsay T, Gill J. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 2016;4:318-26. [PMID: 26608067 DOI: 10.1016/S2213-8587(15)00368-X] [Cited by in Crossref: 85] [Cited by in F6Publishing: 83] [Article Influence: 12.1] [Reference Citation Analysis]
|
| 657 |
Webster AC, Cross NB. When evidence doesn't generalise: the case of ACE inhibition. Lancet Diabetes Endocrinol 2016;4:290-2. [PMID: 26608068 DOI: 10.1016/S2213-8587(15)00415-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 658 |
Bamgbola O. Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Ther Adv Endocrinol Metab 2016;7:110-27. [PMID: 27293540 DOI: 10.1177/2042018816641580] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 659 |
Lee J, Lee JG, Kim S, Song SH, Kim BS, Kim HO, Kim MS, Kim SI, Kim YS, Huh KH. The effect of rituximab dose on infectious complications in ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2016;31:1013-21. [DOI: 10.1093/ndt/gfw017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 660 |
Filiopoulos V, Boletis JN. Renal transplantation with expanded criteria donors: Which is the optimal immunosuppression? World J Transplant 2016; 6(1): 103-114 [PMID: 27011908 DOI: 10.5500/wjt.v6.i1.103] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 661 |
Khan A, Nasr P, El-Charabaty E, El-Sayegh S. An Insight Into the Immunologic Events and Risk Assessment in Renal Transplantation. J Clin Med Res 2016;8:367-72. [PMID: 27081421 DOI: 10.14740/jocmr2411w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 662 |
Niioka T, Kagaya H, Saito M, Inoue T, Numakura K, Yamamoto R, Akamine Y, Habuchi T, Satoh S, Miura M. Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients. Int J Urol. 2016;23:484-490. [PMID: 26990259 DOI: 10.1111/iju.13081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 663 |
Cabiddu G, Castellino S, Gernone G, Santoro D, Moroni G, Giannattasio M, Gregorini G, Giacchino F, Attini R, Loi V, Limardo M, Gammaro L, Todros T, Piccoli GB. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy. J Nephrol 2016;29:277-303. [PMID: 26988973 DOI: 10.1007/s40620-016-0285-6] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 10.4] [Reference Citation Analysis]
|
| 664 |
Ham JY, Jung H, Choi J, Park S, Kim Y, Kim H, Huh S, Kim C, Won DI, Song KE, Cho J. Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients. Scandinavian Journal of Clinical and Laboratory Investigation 2016;76:296-303. [DOI: 10.3109/00365513.2016.1149879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 665 |
McKee RA, Wingert RA. Repopulating Decellularized Kidney Scaffolds: An Avenue for Ex Vivo Organ Generation. Materials (Basel) 2016;9:190. [PMID: 27375844 DOI: 10.3390/ma9030190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 666 |
Pencheva VP, Petrova DS, Genov DK, Georgiev OB. Risk factors for lung diseases after renal transplantation. J Res Med Sci 2015;20:1127-32. [PMID: 26958045 DOI: 10.4103/1735-1995.172978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 667 |
Ryosaka M, Ishida H, Takagi T, Shimizu T, Tanabe K, Kondo T. Solid-type RCC originating from native kidneys in renal transplant recipients should be monitored cautiously. Transpl Int 2015;28:813-9. [PMID: 25809285 DOI: 10.1111/tri.12571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 668 |
Dad T, Tighiouart H, Joseph A, Bostom A, Carpenter M, Hunsicker L, Kusek JW, Pfeffer M, Levey AS, Weiner DE. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. Am J Kidney Dis 2016;68:277-86. [PMID: 26947217 DOI: 10.1053/j.ajkd.2016.01.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 669 |
Safaeian M, Robbins HA, Berndt SI, Lynch CF, Fraumeni JF Jr, Engels EA. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant 2016;16:960-7. [PMID: 26731613 DOI: 10.1111/ajt.13549] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 670 |
Zelle DM, Corpeleijn E, Klaassen G, Schutte E, Navis G, Bakker SJ. Fear of Movement and Low Self-Efficacy Are Important Barriers in Physical Activity after Renal Transplantation. PLoS One 2016;11:e0147609. [PMID: 26844883 DOI: 10.1371/journal.pone.0147609] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
|
| 671 |
Olsburgh J, Zakri RH, Horsfield C, Collins R, Fairweather J, O'Donnell P, Koffman G. TCC in Transplant Ureter--When and When Not to Preserve the Transplant Kidney. Am J Transplant 2016;16:704-11. [PMID: 26731492 DOI: 10.1111/ajt.13533] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 672 |
Krenzien F, ElKhal A, Quante M, Rodriguez Cetina Biefer H, Hirofumi U, Gabardi S, Tullius SG. A Rationale for Age-Adapted Immunosuppression in Organ Transplantation. Transplantation 2015;99:2258-68. [PMID: 26244716 DOI: 10.1097/TP.0000000000000842] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 673 |
Anders HJ, Jayne DR, Rovin BH. Hurdles to the introduction of new therapies for immune-mediated kidney diseases. Nat Rev Nephrol 2016;12:205-16. [PMID: 26804020 DOI: 10.1038/nrneph.2015.206] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 674 |
Varas S, Vella J. Hypertension in the Kidney Transplant Recipient. Core Concepts in Hypertension in Kidney Disease 2016. [DOI: 10.1007/978-1-4939-6436-9_8] [Reference Citation Analysis]
|
| 675 |
Stewart H, Waite E. Solid Organ Transplantation. Care of Adults with Chronic Childhood Conditions 2016. [DOI: 10.1007/978-3-319-43827-6_17] [Reference Citation Analysis]
|
| 676 |
Maxwell H, Webb NJA. Chronic Renal Transplant Dysfunction. Pediatric Kidney Disease 2016. [DOI: 10.1007/978-3-662-52972-0_69] [Reference Citation Analysis]
|
| 677 |
Hardinger KL, Agha IA, Brennan DC. Immunosuppressive Agents. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_3] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 678 |
Surendra M, Raju SB, Raju N, Chandragiri S, Mukku KK, Uppin MS. Rituximab in the treatment of refractory late acute antibody-mediated rejection: Our initial experience. Indian J Nephrol 2016;26:317-21. [PMID: 27795623 DOI: 10.4103/0971-4065.177207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 679 |
Ten Brinke A, Hilkens CM, Cools N, Geissler EK, Hutchinson JA, Lombardi G, Lord P, Sawitzki B, Trzonkowski P, Van Ham SM, Martinez-Caceres EM. Clinical Use of Tolerogenic Dendritic Cells-Harmonization Approach in European Collaborative Effort. Mediators Inflamm 2015;2015:471719. [PMID: 26819498 DOI: 10.1155/2015/471719] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 680 |
Neale J, Smith AC. Cardiovascular risk factors following renal transplant. World J Transplant 2015; 5(4): 183-195 [PMID: 26722646 DOI: 10.5500/wjt.v5.i4.183] [Cited by in CrossRef: 93] [Cited by in F6Publishing: 94] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 681 |
Diekmann F, Campistol JM. Practical considerations for the use of mTOR inhibitors. Transplant Res 2015;4:5. [PMID: 27293552 DOI: 10.1186/s13737-015-0029-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 682 |
Kato T, Kakuta Y, Abe T, Yamanaka K, Imamura R, Okumi M, Ichimaru N, Takahara S, Nonomura N. The benefits of cancer screening in kidney transplant recipients: a single-center experience. Cancer Med 2016;5:153-8. [PMID: 26686199 DOI: 10.1002/cam4.568] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 683 |
Naik AS, Dharnidharka VR, Schnitzler MA, Brennan DC, Segev DL, Axelrod D, Xiao H, Kucirka L, Chen J, Lentine KL. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transpl Int 2016;29:241-52. [PMID: 26563524 DOI: 10.1111/tri.12711] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 684 |
Guerra CM, Formica RN, Kulkarni S, Asch WS, Tichy EM. Duration of Prophylaxis against Fungal Infection in Kidney Transplant Recipients. Prog Transpl 2015;25:311-5. [DOI: 10.7182/pit2015929] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 685 |
Frascà GM, D'Errico A, Malvi D, Porta C, Cosmai L, Santoni M, Sandrini S, Salviani C, Gallieni M, Balestra E. Transplantation of kidneys with tumors. J Nephrol 2016;29:163-8. [PMID: 26588915 DOI: 10.1007/s40620-015-0249-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 686 |
Goto N, Futamura K, Okada M, Yamamoto T, Tsujita M, Hiramitsu T, Narumi S, Watarai Y. Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak. Clin Med Insights Circ Respir Pulm Med 2015;9:81-90. [PMID: 26609250 DOI: 10.4137/CCRPM.S23317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 687 |
Billups K, Neal J, Salyer J. Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant. 2015;25:182-188. [PMID: 26107280 DOI: 10.7182/pit2015826] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 688 |
Pipili C, Cholongitas E. Pharmaceutical management of hepatitis B and C in liver and kidney transplant recipients. World J Gastrointest Pharmacol Ther 2015; 6(4): 105-110 [PMID: 26558143 DOI: 10.4292/wjgpt.v6.i4.105] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 689 |
Yang B, Chen S, Yang G, Mei C, Ong A, Mao Z. New onset diabetes after kidney transplantation in patients with autosomal dominant polycystic kidney disease: systematic review protocol. BMJ Open 2015;5:e008440. [PMID: 26546139 DOI: 10.1136/bmjopen-2015-008440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 690 |
Farragher JF, Elliott MJ, Silver SA, Lichner Z, Tsampalieros A. Translational research in kidney transplantation and the role of patient engagement. Can J Kidney Health Dis 2015;2:42. [PMID: 26543564 DOI: 10.1186/s40697-015-0077-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 691 |
Lim SW, Jin JZ, Jin L, Jin J, Li C. Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantation. Korean J Intern Med. 2015;30:759-770. [PMID: 26552451 DOI: 10.3904/kjim.2015.30.6.759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 692 |
Tillmann FP, Schmitz M, Jäger M, Krauspe R, Rump LC. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up. Int Urol Nephrol 2016;48:279-86. [PMID: 26498632 DOI: 10.1007/s11255-015-1133-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 693 |
Early C, Stuckey L, Tischer S. Osteoporosis in the adult solid organ transplant population: underlying mechanisms and available treatment options. Osteoporos Int 2016;27:1425-40. [PMID: 26475288 DOI: 10.1007/s00198-015-3367-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 694 |
Crawford K, Low JK, Manias E, Walker R, Toussaint ND, Mulley W, Dooley M, Ierino FL, Hughes P, Goodman DJ, Williams A. Nephrologists' management of patient medications in kidney transplantation: results of an online survey. J Eval Clin Pract 2015;21:879-85. [PMID: 26371625 DOI: 10.1111/jep.12394] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 695 |
Gielis EM, Ledeganck KJ, De Winter BY, Del Favero J, Bosmans JL, Claas FH, Abramowicz D, Eikmans M. Cell-Free DNA: An Upcoming Biomarker in Transplantation. Am J Transplant 2015;15:2541-51. [PMID: 26184824 DOI: 10.1111/ajt.13387] [Cited by in Crossref: 116] [Cited by in F6Publishing: 116] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 696 |
Lehner L, Staeck O, Halleck F, Liefeldt L, Bamoulid J, Budde K. Need for optimized immunosuppression in elderly kidney transplant recipients. Transplantation Reviews 2015;29:237-9. [DOI: 10.1016/j.trre.2015.08.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 697 |
Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators. Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 2015;11:656-66. [PMID: 26416497 DOI: 10.1038/nrneph.2015.153] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 698 |
Sureshkumar KK, Marcus RJ, Chopra B. Role of steroid maintenance in sensitized kidney transplant recipients. World J Transplant 2015; 5(3): 102-109 [PMID: 26421263 DOI: 10.5500/wjt.v5.i3.102] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 699 |
Garcia MF, Bravin AM, Garcia PD, Contti MM, Nga HS, Takase HM, de Andrade LG. Behavioral measures to reduce non-adherence in renal transplant recipients: a prospective randomized controlled trial. Int Urol Nephrol 2015;47:1899-905. [PMID: 26377496 DOI: 10.1007/s11255-015-1104-z] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 700 |
O'Regan JA, Canney M, Connaughton DM, O'Kelly P, Williams Y, Collier G, deFreitas DG, O'Seaghdha CM, Conlon PJ. Tacrolimus trough-level variability predicts long-term allograft survival following kidney transplantation. J Nephrol 2016;29:269-76. [PMID: 26374111 DOI: 10.1007/s40620-015-0230-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 701 |
Georgiou GK, Dounousi E, Harissis HV. Calcineurin inhibitors and male fertility after renal transplantation - a review. Andrologia 2016;48:483-90. [DOI: 10.1111/and.12477] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 702 |
Babayev R, Nickolas TL. Bone Disorders in Chronic Kidney Disease: An Update in Diagnosis and Management. Semin Dial 2015;28:645-53. [DOI: 10.1111/sdi.12423] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 703 |
Basu G. Infections After Kidney Transplantation: The Bug Bear Of Kidney Transplantation In Tropics. TOUNJ 2015;8:76-87. [DOI: 10.2174/1874303x01508010076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 704 |
Langsford D, Dwyer K. Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management. World J Diabetes 2015; 6(10): 1132-1151 [PMID: 26322159 DOI: 10.4239/wjd.v6.i10.1132] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 705 |
Boran M, Yıldırım T, Boran E, Boran M, Kilic H. Late-Onset BK Viruria in Renal Transplant Recipients. Transplant Proc 2015;47:1786-9. [PMID: 26293051 DOI: 10.1016/j.transproceed.2015.06.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 706 |
Krepsova E, Tycova I, Sekerkova A, Wohlfahrt P, Hruba P, Striz I, Sawitzki B, Viklicky O. Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance. BMC Nephrol 2015;16:146. [PMID: 26286066 DOI: 10.1186/s12882-015-0141-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 707 |
Nehus E, Liu C, Hooper DK, Macaluso M, Kim MO. Clinical Practice of Steroid Avoidance in Pediatric Kidney Transplantation. Am J Transplant 2015;15:2203-10. [PMID: 25908489 DOI: 10.1111/ajt.13270] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 708 |
Song L, Xie XB, Peng LK, Yu SJ, Peng YT. Mechanism and Treatment Strategy of Osteoporosis after Transplantation. Int J Endocrinol 2015;2015:280164. [PMID: 26273295 DOI: 10.1155/2015/280164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 709 |
Frascà GM, Sandrini S, Cosmai L, Porta C, Asch W, Santoni M, Salviani C, D'Errico A, Malvi D, Balestra E, Gallieni M. Renal cancer in kidney transplanted patients. J Nephrol 2015;28:659-68. [PMID: 26202137 DOI: 10.1007/s40620-015-0219-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 710 |
Hamilton AJ, Webb LH, Williams JK, D'Souza RJ, Ngu LS, Moore J. Autoimmune haemolytic anaemia associated with Epstein Barr virus infection as a severe late complication after kidney transplantation and successful treatment with rituximab: case report. BMC Nephrol 2015;16:108. [PMID: 26187383 DOI: 10.1186/s12882-015-0096-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 711 |
Majernikova M, Rosenberger J, Prihodova L, Marcelli D, Roland R, Groothoff JW, van Dijk JP. Anemia has a negative impact on self-rated health in kidney transplant recipients with well-functioning grafts: findings from an 8-year follow-up study. Qual Life Res 2016;25:183-92. [PMID: 26169231 DOI: 10.1007/s11136-015-1067-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 712 |
Naesens M, Lerut E, Emonds MP, Herelixka A, Evenepoel P, Claes K, Bammens B, Sprangers B, Meijers B, Jochmans I, Monbaliu D, Pirenne J, Kuypers DR. Proteinuria as a Noninvasive Marker for Renal Allograft Histology and Failure: An Observational Cohort Study. J Am Soc Nephrol 2016;27:281-92. [PMID: 26152270 DOI: 10.1681/ASN.2015010062] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 713 |
Gagneux-Brunon A, Pillet S, Laurent B, Mariat C, Michalet M, Lucht F, Botelho-Nevers E. A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury. Med Mal Infect 2015;45:331-4. [PMID: 26144286 DOI: 10.1016/j.medmal.2015.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 714 |
Santos J, Martins LS. Estimating glomerular filtration rate in kidney transplantation: Still searching for the best marker. World J Nephrol 2015; 4(3): 345-353 [PMID: 26167457 DOI: 10.5527/wjn.v4.i3.345] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 715 |
Zeltzer SM, Taylor DO, Tang WH. Long-term dietary habits and interventions in solid-organ transplantation. J Heart Lung Transplant 2015;34:1357-65. [PMID: 26250965 DOI: 10.1016/j.healun.2015.06.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 716 |
Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Noël C, Abramowicz D. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. Am J Transplant 2015;15:1923-32. [PMID: 25707875 DOI: 10.1111/ajt.13191] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 717 |
Molnar AO, Fergusson D, Tsampalieros AK, Bennett A, Fergusson N, Ramsay T, Knoll GA. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ 2015;350:h3163. [PMID: 26101226 DOI: 10.1136/bmj.h3163] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 718 |
Tufton N, Ahmad S, Rolfe C, Rajkariar R, Byrne C, Chowdhury TA. New-onset diabetes after renal transplantation. Diabet Med 2014;31:1284-92. [PMID: 24975051 DOI: 10.1111/dme.12534] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 719 |
Shi WL, Tang HL, Zhai SD. Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis. PLoS One. 2015;10:e0127995. [PMID: 26039043 DOI: 10.1371/journal.pone.0127995] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 720 |
Taber DJ, Gebregziabher MG, Srinivas TR, Chavin KD, Baliga PK, Egede LE. African-American race modifies the influence of tacrolimus concentrations on acute rejection and toxicity in kidney transplant recipients. Pharmacotherapy 2015;35:569-77. [PMID: 26011276 DOI: 10.1002/phar.1591] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
|
| 721 |
Wiseman AC. Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know. Clin J Am Soc Nephrol 2015;10:923-5. [PMID: 25979977 DOI: 10.2215/CJN.03800415] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 722 |
Tanriover B, Zhang S, MacConmara M, Gao A, Sandikci B, Ayvaci MU, Mete M, Tsapepas D, Rajora N, Mohan P, Lakhia R, Lu CY, Vazquez M. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Clin J Am Soc Nephrol 2015;10:1041-9. [PMID: 25979971 DOI: 10.2215/CJN.08710814] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 723 |
Gigliotti P, Lofaro D, Leone F, Papalia T, Senatore M, Greco R, Perri A, Vizza D, Lupinacci S, Toteda G, La Russa A, De Stefano R, Romeo F, Bonofiglio R. Early subclinical rejection treated with low dose i.v. steroids is not associated to graft survival impairment: 13-years’ experience at a single center. J Nephrol 2016;29:443-9. [DOI: 10.1007/s40620-015-0206-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 724 |
Lafranca JA, IJermans JN, Betjes MG, Dor FJ. Body mass index and outcome in renal transplant recipients: a systematic review and meta-analysis. BMC Med 2015;13:111. [PMID: 25963131 DOI: 10.1186/s12916-015-0340-5] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 725 |
Shi YY, Hesselink DA, van Gelder T. Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipients. Transplant Rev (Orlando) 2015;29:224-30. [PMID: 26048322 DOI: 10.1016/j.trre.2015.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 726 |
Messa PG, Alfieri C, Vettoretti S. Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance. Nephrol Dial Transplant 2016;31:730-6. [PMID: 25934992 DOI: 10.1093/ndt/gfv098] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 727 |
Keyzer CA, de Borst MH, van den Berg E, Jahnen-Dechent W, Arampatzis S, Farese S, Bergmann IP, Floege J, Navis G, Bakker SJ, van Goor H, Eisenberger U, Pasch A. Calcification Propensity and Survival among Renal Transplant Recipients. J Am Soc Nephrol 2016;27:239-48. [PMID: 25925688 DOI: 10.1681/ASN.2014070670] [Cited by in Crossref: 89] [Cited by in F6Publishing: 93] [Article Influence: 11.1] [Reference Citation Analysis]
|
| 728 |
Wang Z, Vathsala A, Tiong HY. Haematuria in postrenal transplant patients. Biomed Res Int 2015;2015:292034. [PMID: 25918706 DOI: 10.1155/2015/292034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 729 |
Mitsides N, Greenan K, Green D, Middleton R, Lamerton E, Allen J, Redshaw J, Chadwick PR, Subudhi CP, Wood G. Complications and outcomes of trimethoprim-sulphamethoxazole as chemoprophylaxis for pneumocystis pneumonia in renal transplant recipients. Nephrology (Carlton) 2014;19:157-63. [PMID: 24387294 DOI: 10.1111/nep.12201] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 730 |
Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. Ann Surg. 2014;260:886-91; discussion 891-2. [PMID: 25379858 DOI: 10.1097/sla.0000000000000969] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 731 |
Thiem U, Gessl A, Borchhardt K. Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation. Biomed Res Int. 2015;2015:292654. [PMID: 25861621 DOI: 10.1155/2015/292654] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 732 |
Hutchinson JA, Geissler EK. Now or never? The case for cell-based immunosuppression in kidney transplantation. Kidney Int 2015;87:1116-24. [PMID: 25738251 DOI: 10.1038/ki.2015.50] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 733 |
Meeuwis KA, Hilbrands LB, IntHout J, Slangen BF, Hendriks IM, Hinten F, Christiaans MH, Quint WG, van de Kerkhof PC, Massuger LF, Hoitsma AJ, van Rossum MM, Melchers WJ, de Hullu JA. Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study. Am J Transplant 2015;15:723-33. [PMID: 25675976 DOI: 10.1111/ajt.13053] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 734 |
Robertsen I, Åsberg A, Ingerø AO, Vethe NT, Bremer S, Bergan S, Midtvedt K. Use of Generic Tacrolimus in Elderly Renal Transplant Recipients: Precaution Is Needed. Transplantation 2015;99:528-32. [DOI: 10.1097/tp.0000000000000384] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 735 |
Garro R, Warshaw B, Felner E. New-onset diabetes after kidney transplant in children. Pediatr Nephrol 2015;30:405-16. [PMID: 24894384 DOI: 10.1007/s00467-014-2830-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 736 |
Ridruejo E. Antiviral treatment for chronic hepatitis B in renal transplant patients. World J Hepatol 2015;7:189-203. [PMID: 25729474 DOI: 10.4254/wjh.v7.i2.189] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 737 |
Cholongitas E, Tziomalos K, Pipili C. Management of patients with hepatitis B in special populations. World J Gastroenterol 2015; 21(6): 1738-1748 [PMID: 25684938 DOI: 10.3748/wjg.v21.i6.1738] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 38] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 738 |
Hughes LD. The transplant patient and transplant medicine in family practice. J Family Med Prim Care 2014;3:345-54. [PMID: 25657941 DOI: 10.4103/2249-4863.148106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 739 |
Weir MR, Burgess ED, Cooper JE, Fenves AZ, Goldsmith D, McKay D, Mehrotra A, Mitsnefes MM, Sica DA, Taler SJ. Assessment and management of hypertension in transplant patients. J Am Soc Nephrol 2015;26:1248-60. [PMID: 25653099 DOI: 10.1681/ASN.2014080834] [Cited by in Crossref: 108] [Cited by in F6Publishing: 109] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 740 |
van den Hoogen MW, Kamburova EG, Baas MC, Steenbergen EJ, Florquin S, M Koenen HJ, Joosten I, Hilbrands LB. Rituximab as induction therapy after renal transplantation: a randomized, double-blind, placebo-controlled study of efficacy and safety. Am J Transplant 2015;15:407-16. [PMID: 25612493 DOI: 10.1111/ajt.13052] [Cited by in Crossref: 86] [Cited by in F6Publishing: 87] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 741 |
Reusser NM, Downing C, Guidry J, Tyring SK. HPV Carcinomas in Immunocompromised Patients. J Clin Med. 2015;4:260-281. [PMID: 26239127 DOI: 10.3390/jcm4020260] [Cited by in Crossref: 73] [Cited by in F6Publishing: 76] [Article Influence: 9.1] [Reference Citation Analysis]
|
| 742 |
Wohlfahrtova M, Viklicky O. Recent trials in immunosuppression and their consequences for current therapy. Curr Opin Organ Transplant 2014;19:387-94. [PMID: 24905020 DOI: 10.1097/MOT.0000000000000093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 743 |
Carvalho-Filho RJ, Feldner ACC, Silva AEB, Ferraz MLG. Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol 2015; 21(2): 408-422 [PMID: 25593456 DOI: 10.3748/wjg.v21.i2.408] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 744 |
Toyoda S, Eguchi T, Toma H, Okabe Y, Hirota I, Kitada H. Acute Diverticulitis with Transverse Colon Perforation 9 Years after Kidney Transplantation. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 2015;76:2476-2481. [DOI: 10.3919/jjsa.76.2476] [Reference Citation Analysis]
|
| 745 |
Byung Ha Chung, Kyoung Woon Kim, Bo-Mi Kim, Kyoung Chan Doh, Mi-La Cho, Chul Woo Yang. Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction. PLoS One 2015;10:e0145258. [PMID: 26717145 DOI: 10.1371/journal.pone.0145258] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 746 |
Gunderson A, Said A. Liver disease in kidney transplant recipients. Transplantation Reviews 2015;29:1-7. [DOI: 10.1016/j.trre.2014.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 747 |
Israni A, Dean CE, Salkowski N, Li S, Ratner LE, Rabb H, Powe NR, Kim SJ. Variation in structure and delivery of care between kidney transplant centers in the United States. Transplantation 2014;98:520-8. [PMID: 24825518 DOI: 10.1097/TP.0000000000000094] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 748 |
Lipshultz SE, Chandar JJ, Rusconi PG, Fornoni A, Abitbol CL, Burke GW 3rd, Zilleruelo GE, Pham SM, Perez EE, Karnik R, Hunter JA, Dauphin DD, Wilkinson JD. Issues in solid-organ transplantation in children: translational research from bench to bedside. Clinics (Sao Paulo) 2014;69 Suppl 1:55-72. [PMID: 24860861 DOI: 10.6061/clinics/2014(sup01)11] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 749 |
Patel RK, Pennington C, Stevens KK, Taylor A, Gillis K, Rutherford E, Johnston N, Jardine AG, Mark PB. Effect of left atrial and ventricular abnormalities on renal transplant recipient outcome-a single-center study. Transplant Res 2014;3:20. [PMID: 25505546 DOI: 10.1186/s13737-014-0020-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 750 |
Bernat-garcía J, Morales Suárez-varela M, Vilata-corell J, Marquina-vila A, Pallardo L, Crespo J. The Role of New Immunosuppressive Drugs in Nonmelanoma Skin Cancer in Renal Transplant Recipients. Actas Dermo-Sifiliográficas (English Edition) 2014;105:940-6. [DOI: 10.1016/j.adengl.2014.06.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 751 |
Chancharoenthana W, Townamchai N, Pongpirul K, Kittiskulnam P, Leelahavanichkul A, Avihingsanon Y, Suankratay C, Wattanatorn S, Kittikowit W, Praditpornsilpa K, Tungsanga K, Eiam-Ong S. The outcomes of kidney transplantation in hepatitis B surface antigen (HBsAg)-negative recipients receiving graft from HBsAg-positive donors: a retrospective, propensity score-matched study. Am J Transplant 2014;14:2814-20. [PMID: 25395260 DOI: 10.1111/ajt.12921] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 752 |
Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. Am J Transplant 2014;14:2796-806. [PMID: 25278376 DOI: 10.1111/ajt.12955] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 753 |
Dounousi E, Leivaditis K, Eleftheriadis T, Liakopoulos V. Osteoporosis after renal transplantation. Int Urol Nephrol 2015;47:503-11. [PMID: 25384432 DOI: 10.1007/s11255-014-0862-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 754 |
Mccormack PL. Extended-Release Tacrolimus: A Review of Its Use in De Novo Kidney Transplantation. Drugs 2014;74:2053-64. [DOI: 10.1007/s40265-014-0316-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 755 |
Laskin BL, Mitsnefes MM, Dahhou M, Zhang X, Foster BJ. The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States. Kidney Int 2015;87:575-83. [PMID: 25317931 DOI: 10.1038/ki.2014.342] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 756 |
Franchin M, Tozzi M, Soldini G, Piffaretti G. A case of continuous negative pressure wound therapy for abdominal infected lymphocele after kidney transplantation. Case Rep Transplant 2014;2014:742161. [PMID: 25374744 DOI: 10.1155/2014/742161] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 757 |
Sureshkumar KK, Hussain SM, Thai NL, Ko TY, Nashar K, Marcus RJ. Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type. World J Transplant 2014; 4(3): 188-195 [PMID: 25346892 DOI: 10.5500/wjt.v4.i3.188] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 758 |
Kotton CN. Immunization after kidney transplantation-what is necessary and what is safe? Nat Rev Nephrol. 2014;10:555-562. [PMID: 25072119 DOI: 10.1038/nrneph.2014.122] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 759 |
Bernat-García J, Morales Suárez-Varela M, Vilata-Corell JJ, Marquina-Vila A, Pallardo L, Crespo J. The role of new immunosuppressive drugs in nonmelanoma skin cancer in renal transplant recipients. Actas Dermosifiliogr 2014;105:940-6. [PMID: 25062648 DOI: 10.1016/j.ad.2014.06.001] [ |
